ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
BP	GO:0002576	platelet degranulation	15/223	128/18670	3.598e-11	1.15e-07	1.057e-07	F13A1/SPARC/CLU/ITGB3/PPBP/ITGA2B/PROS1/EGF/SELP/PF4/POTEKP/VCL/PDGFA/DMTN/ENDOD1	15
BP	GO:0007596	blood coagulation	20/223	336/18670	4.177e-09	3.609e-06	3.316e-06	MYL9/F13A1/ITGB3/TREML1/ITGA2B/PROS1/GP1BB/ANO6/PRKAR2B/GP9/MPL/GNAS/SELP/PF4/VCL/PDGFA/DMTN/GGCX/FAP/PEAR1	20
BP	GO:0030168	platelet activation	14/223	153/18670	4.425e-09	3.609e-06	3.316e-06	MYL9/ITGB3/TREML1/ITGA2B/GP1BB/GP9/MPL/GNAS/SELP/PF4/VCL/PDGFA/DMTN/PEAR1	14
BP	GO:0007599	hemostasis	20/223	341/18670	5.371e-09	3.609e-06	3.316e-06	MYL9/F13A1/ITGB3/TREML1/ITGA2B/PROS1/GP1BB/ANO6/PRKAR2B/GP9/MPL/GNAS/SELP/PF4/VCL/PDGFA/DMTN/GGCX/FAP/PEAR1	20
BP	GO:0050817	coagulation	20/223	342/18670	5.646e-09	3.609e-06	3.316e-06	MYL9/F13A1/ITGB3/TREML1/ITGA2B/PROS1/GP1BB/ANO6/PRKAR2B/GP9/MPL/GNAS/SELP/PF4/VCL/PDGFA/DMTN/GGCX/FAP/PEAR1	20
BP	GO:0070527	platelet aggregation	8/223	59/18670	4.799e-07	0.0002556	0.0002349	MYL9/ITGB3/ITGA2B/MPL/GNAS/VCL/DMTN/PEAR1	8
BP	GO:0061041	regulation of wound healing	11/223	148/18670	1.682e-06	0.0006738	0.0006191	CDKN1A/PROS1/ANO6/GJA1/SELP/MYLK/PDGFA/DMTN/MIR29B1/FAP/VIL1	11
BP	GO:1903034	regulation of response to wounding	12/223	179/18670	1.686e-06	0.0006738	0.0006191	CDKN1A/PROS1/ANO6/GJA1/SELP/MYLK/PDGFA/DMTN/MIR29B1/FAP/VIL1/MIR21	12
BP	GO:0034109	homotypic cell-cell adhesion	8/223	81/18670	5.557e-06	0.001973	0.001813	MYL9/ITGB3/ITGA2B/MPL/GNAS/VCL/DMTN/PEAR1	8
BP	GO:0090287	regulation of cellular response to growth factor stimulus	13/223	292/18670	5.214e-05	0.01666	0.01531	TMEM108/DAB2/ITGB3/ING2/PCSK6/LTBP1/LOX/VEPH1/SULF1/RBPMS2/CAV2/MIR29B1/MMRN2	13
BP	GO:0050680	negative regulation of epithelial cell proliferation	9/223	165/18670	0.0001684	0.04891	0.04495	SPARC/MIR29C/GJA1/SULF1/CAV2/RGN/MIR29B1/MIR21/KRT4	9
BP	GO:0001937	negative regulation of endothelial cell proliferation	6/223	76/18670	0.0002957	0.07133	0.06555	SPARC/MIR29C/GJA1/SULF1/CAV2/MIR21	6
BP	GO:1902904	negative regulation of supramolecular fiber organization	8/223	142/18670	0.0003112	0.07133	0.06555	CLU/CAMSAP3/SNCA/DMTN/MIR29B1/VIL1/MIR21/ARHGAP6	8
BP	GO:0019369	arachidonic acid metabolic process	5/223	51/18670	0.0003491	0.07133	0.06555	PTGES3/CYP2C18/PTGS1/CYP1A1/CYP2E1	5
BP	GO:0030193	regulation of blood coagulation	6/223	79/18670	0.000365	0.07133	0.06555	PROS1/ANO6/SELP/PDGFA/DMTN/FAP	6
BP	GO:0007160	cell-matrix adhesion	10/223	225/18670	0.0003881	0.07133	0.06555	MIR29C/ITGB3/EPB41L5/ITGA2B/CAMSAP3/CTTN/ITGB5/VCL/DMTN/ARHGAP6	10
BP	GO:1900046	regulation of hemostasis	6/223	80/18670	0.0003907	0.07133	0.06555	PROS1/ANO6/SELP/PDGFA/DMTN/FAP	6
BP	GO:0006936	muscle contraction	13/223	360/18670	0.0004103	0.07133	0.06555	MYL9/CALM3/CALD1/PDE5A/SPX/CTTN/GJA1/MYLK/SULF1/ITGB5/VCL/ARG2/MIR21	13
BP	GO:0006898	receptor-mediated endocytosis	12/223	316/18670	0.0004369	0.07133	0.06555	TMEM108/SPARC/ARR3/FCHO1/CLU/DAB2/ITGB3/EGF/CTTN/C3/SNCA/CAV2	12
BP	GO:0097581	lamellipodium organization	6/223	82/18670	0.0004464	0.07133	0.06555	ABLIM3/MIR196A2/CTTN/VCL/DMTN/VIL1	6
BP	GO:0030198	extracellular matrix organization	13/223	368/18670	0.0005048	0.07381	0.06782	SPARC/ITGB3/ITGA2B/PLOD2/IBSP/DSPP/LOX/SULF1/ITGB5/MMP7/PDGFA/MIR29B1/FAP	13
BP	GO:0050818	regulation of coagulation	6/223	84/18670	0.000508	0.07381	0.06782	PROS1/ANO6/SELP/PDGFA/DMTN/FAP	6
BP	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	7/223	120/18670	0.0005995	0.08143	0.07483	DAB2/ING2/LTBP1/LOX/VEPH1/CAV2/MIR29B1	7
BP	GO:1903844	regulation of cellular response to transforming growth factor beta stimulus	7/223	122/18670	0.0006617	0.08143	0.07483	DAB2/ING2/LTBP1/LOX/VEPH1/CAV2/MIR29B1	7
BP	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	10/223	241/18670	0.0006632	0.08143	0.07483	DAB2/ING2/PCSK6/LTBP1/LOX/VEPH1/SULF1/RBPMS2/CAV2/MIR29B1	10
BP	GO:0007179	transforming growth factor beta receptor signaling pathway	9/223	199/18670	0.0006669	0.08143	0.07483	DAB2/ING2/LTBP1/LOX/VEPH1/ITGB5/CAV2/MIR29B1/MIR21	9
BP	GO:0090136	epithelial cell-cell adhesion	3/223	15/18670	0.000688	0.08143	0.07483	CAMSAP3/ITGB5/VCL	3
BP	GO:0034333	adherens junction assembly	6/223	90/18670	0.0007334	0.08143	0.07483	EPB41L5/CAMSAP3/CTTN/VCL/DMTN/ARHGAP6	6
BP	GO:0006805	xenobiotic metabolic process	7/223	125/18670	0.0007644	0.08143	0.07483	UGT2B11/PTGES3/CYP2C18/PTGS1/CYP1A1/UGT1A1/CYP2E1	7
BP	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	7/223	125/18670	0.0007644	0.08143	0.07483	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/MIR29B1/MIR21	7
BP	GO:0061684	chaperone-mediated autophagy	3/223	16/18670	0.0008393	0.08508	0.07818	CTSA/CLU/SNCA	3
BP	GO:0071560	cellular response to transforming growth factor beta stimulus	10/223	249/18670	0.0008519	0.08508	0.07818	DAB2/EPB41L5/ING2/LTBP1/LOX/VEPH1/ITGB5/CAV2/MIR29B1/MIR21	10
BP	GO:1902807	negative regulation of cell cycle G1/S phase transition	7/223	131/18670	0.001007	0.09516	0.08745	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/MIR29B1/MIR21	7
BP	GO:0071559	response to transforming growth factor beta	10/223	255/18670	0.001021	0.09516	0.08745	DAB2/EPB41L5/ING2/LTBP1/LOX/VEPH1/ITGB5/CAV2/MIR29B1/MIR21	10
BP	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	12/223	349/18670	0.001042	0.09516	0.08745	DAB2/ING2/PCSK6/LTBP1/LOX/VEPH1/SULF1/RBPMS2/ITGB5/CAV2/MIR29B1/MIR21	12
BP	GO:1904683	regulation of metalloendopeptidase activity	3/223	19/18670	0.001414	0.1256	0.1154	MIR29C/MIR29B1/MIR21	3
BP	GO:0038127	ERBB signaling pathway	7/223	142/18670	0.001607	0.1352	0.1242	SH3TC2/EGF/CAMLG/BTC/NRG1/VIL1/MIR21	7
BP	GO:0007009	plasma membrane organization	6/223	105/18670	0.001635	0.1352	0.1242	SH3TC2/FCHO1/CLU/ANO6/CAV2/SYT7	6
BP	GO:0019373	epoxygenase P450 pathway	3/223	20/18670	0.001649	0.1352	0.1242	CYP2C18/CYP1A1/CYP2E1	3
BP	GO:2000045	regulation of G1/S transition of mitotic cell cycle	8/223	184/18670	0.001693	0.1353	0.1243	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/CYP1A1/MIR29B1/MIR21	8
BP	GO:0043062	extracellular structure organization	13/223	422/18670	0.001754	0.1367	0.1256	SPARC/ITGB3/ITGA2B/PLOD2/IBSP/DSPP/LOX/SULF1/ITGB5/MMP7/PDGFA/MIR29B1/FAP	13
BP	GO:1903036	positive regulation of response to wounding	5/223	74/18670	0.001918	0.146	0.1341	ANO6/SELP/MYLK/DMTN/MIR21	5
BP	GO:0061045	negative regulation of wound healing	5/223	76/18670	0.002158	0.1521	0.1398	CDKN1A/PROS1/GJA1/PDGFA/FAP	5
BP	GO:0042176	regulation of protein catabolic process	12/223	381/18670	0.002178	0.1521	0.1398	CTSA/ODC1/CLU/DAB2/EGF/CAMLG/GJA1/NRG1/FAM122A/SNCA/RGN/MAP1A	12
BP	GO:0043277	apoptotic cell clearance	4/223	46/18670	0.002183	0.1521	0.1398	ITGB3/RHOBTB1/C3/PEAR1	4
BP	GO:0010866	regulation of triglyceride biosynthetic process	3/223	22/18670	0.002189	0.1521	0.1398	C3/RGN/MIR29B1	3
BP	GO:0006631	fatty acid metabolic process	12/223	383/18670	0.002274	0.1546	0.1421	AMACR/PTGES3/CYP2C18/PRKAR2B/PTGS1/CRAT/CYP1A1/C3/SNCA/RGN/PRKAA2/CYP2E1	12
BP	GO:0009410	response to xenobiotic stimulus	10/223	292/18670	0.002769	0.1823	0.1676	CALM3/UGT2B11/PTGES3/CYP2C18/PRKAR2B/PTGS1/CYP1A1/UGT1A1/SNCA/CYP2E1	10
BP	GO:0007045	cell-substrate adherens junction assembly	5/223	81/18670	0.002853	0.1823	0.1676	EPB41L5/CAMSAP3/CTTN/DMTN/ARHGAP6	5
BP	GO:0048041	focal adhesion assembly	5/223	81/18670	0.002853	0.1823	0.1676	EPB41L5/CAMSAP3/CTTN/DMTN/ARHGAP6	5
BP	GO:1902806	regulation of cell cycle G1/S phase transition	8/223	202/18670	0.003021	0.1893	0.174	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/CYP1A1/MIR29B1/MIR21	8
BP	GO:0048260	positive regulation of receptor-mediated endocytosis	4/223	51/18670	0.003191	0.1934	0.1778	CLU/DAB2/EGF/C3	4
BP	GO:0034764	positive regulation of transmembrane transport	8/223	204/18670	0.003208	0.1934	0.1778	CALM3/ANO6/C3/SNCA/RGN/EPHB2/MIR21/ITLN1	8
BP	GO:1903409	reactive oxygen species biosynthetic process	6/223	122/18670	0.003477	0.1967	0.1807	CLU/CYP1A1/SNCA/RGN/ARG2/MIR21	6
BP	GO:1902903	regulation of supramolecular fiber organization	11/223	352/18670	0.003496	0.1967	0.1807	CLU/CAMSAP3/CTTN/RHOBTB1/SNCA/DMTN/MIR29B1/MAP1A/VIL1/MIR21/ARHGAP6	11
BP	GO:0030194	positive regulation of blood coagulation	3/223	26/18670	0.003569	0.1967	0.1807	ANO6/SELP/DMTN	3
BP	GO:1900048	positive regulation of hemostasis	3/223	26/18670	0.003569	0.1967	0.1807	ANO6/SELP/DMTN	3
BP	GO:1905048	regulation of metallopeptidase activity	3/223	26/18670	0.003569	0.1967	0.1807	MIR29C/MIR29B1/MIR21	3
BP	GO:0031589	cell-substrate adhesion	11/223	354/18670	0.003648	0.1976	0.1816	MIR29C/ITGB3/EPB41L5/ITGA2B/CAMSAP3/CTTN/ITGB5/VCL/DMTN/MMRN2/ARHGAP6	11
BP	GO:0090288	negative regulation of cellular response to growth factor stimulus	7/223	166/18670	0.003859	0.2037	0.1872	LTBP1/VEPH1/SULF1/RBPMS2/CAV2/MIR29B1/MMRN2	7
BP	GO:0050820	positive regulation of coagulation	3/223	27/18670	0.00398	0.2037	0.1872	ANO6/SELP/DMTN	3
BP	GO:0072378	blood coagulation, fibrin clot formation	3/223	27/18670	0.00398	0.2037	0.1872	F13A1/GP1BB/GP9	3
BP	GO:0003012	muscle system process	13/223	465/18670	0.00403	0.2037	0.1872	MYL9/CALM3/CALD1/PDE5A/SPX/CTTN/GJA1/MYLK/SULF1/ITGB5/VCL/ARG2/MIR21	13
BP	GO:1901888	regulation of cell junction assembly	5/223	88/18670	0.004079	0.2037	0.1872	EPB41L5/CAMSAP3/GJA1/DMTN/ARHGAP6	5
BP	GO:0045862	positive regulation of proteolysis	11/223	363/18670	0.0044	0.2164	0.1988	CLU/DAB2/EGF/CRADD/FAM122A/C3/SNCA/RGN/MIR29B1/CASC2/MIR21	11
BP	GO:1903035	negative regulation of response to wounding	5/223	90/18670	0.004489	0.2174	0.1998	CDKN1A/PROS1/GJA1/PDGFA/FAP	5
BP	GO:0016525	negative regulation of angiogenesis	7/223	173/18670	0.004832	0.2296	0.211	SPARC/MIR29C/MIR196A2/PF4/SULF1/MMRN2/MIR21	7
BP	GO:0018200	peptidyl-glutamic acid modification	3/223	29/18670	0.004886	0.2296	0.211	AGBL5/TTLL7/GGCX	3
BP	GO:0035904	aorta development	4/223	58/18670	0.005078	0.2327	0.2139	LTBP1/LOX/MYLK/MIR29B1	4
BP	GO:2000181	negative regulation of blood vessel morphogenesis	7/223	175/18670	0.005142	0.2327	0.2139	SPARC/MIR29C/MIR196A2/PF4/SULF1/MMRN2/MIR21	7
BP	GO:0043491	protein kinase B signaling	9/223	269/18670	0.00517	0.2327	0.2139	MIR29C/LOX/EGF/BTC/NRG1/PDGFA/MIR29B1/PEAR1/MIR21	9
BP	GO:0001936	regulation of endothelial cell proliferation	7/223	176/18670	0.005302	0.2353	0.2162	SPARC/MIR29C/ITGB3/GJA1/SULF1/CAV2/MIR21	7
BP	GO:0050911	detection of chemical stimulus involved in sensory perception of smell	12/223	427/18670	0.005417	0.2372	0.2179	OR2T27/OR13C2/OR51D1/OR5M10/OR2AJ1/OR2B8P/OR52N2/OR5P3/OR56B2P/OR4N5/OR9Q1/OR10K2	12
BP	GO:0001933	negative regulation of protein phosphorylation	12/223	429/18670	0.005617	0.2395	0.2201	CALM3/CDKN1A/CTDSPL/PRKAR2B/SNCA/RGN/DMTN/MIR29B1/CASC2/EPHB2/MIR21/SOCS3	12
BP	GO:0051893	regulation of focal adhesion assembly	4/223	60/18670	0.005729	0.2395	0.2201	EPB41L5/CAMSAP3/DMTN/ARHGAP6	4
BP	GO:0090109	regulation of cell-substrate junction assembly	4/223	60/18670	0.005729	0.2395	0.2201	EPB41L5/CAMSAP3/DMTN/ARHGAP6	4
BP	GO:0010543	regulation of platelet activation	3/223	31/18670	0.005906	0.2395	0.2201	SELP/PDGFA/DMTN	3
BP	GO:0071466	cellular response to xenobiotic stimulus	7/223	180/18670	0.005979	0.2395	0.2201	UGT2B11/PTGES3/CYP2C18/PTGS1/CYP1A1/UGT1A1/CYP2E1	7
BP	GO:0032463	negative regulation of protein homooligomerization	2/223	10/18670	0.006	0.2395	0.2201	CLU/PEX14	2
BP	GO:0090303	positive regulation of wound healing	4/223	61/18670	0.006075	0.2395	0.2201	ANO6/SELP/MYLK/DMTN	4
BP	GO:0007044	cell-substrate junction assembly	5/223	97/18670	0.006157	0.2395	0.2201	EPB41L5/CAMSAP3/CTTN/DMTN/ARHGAP6	5
BP	GO:0008210	estrogen metabolic process	3/223	32/18670	0.00646	0.2395	0.2201	UGT2B11/CYP1A1/UGT1A1	3
BP	GO:0038128	ERBB2 signaling pathway	3/223	32/18670	0.00646	0.2395	0.2201	EGF/BTC/NRG1	3
BP	GO:0042573	retinoic acid metabolic process	3/223	32/18670	0.00646	0.2395	0.2201	CYP2C18/CYP1A1/UGT1A1	3
BP	GO:0045987	positive regulation of smooth muscle contraction	3/223	32/18670	0.00646	0.2395	0.2201	SPX/CTTN/MIR21	3
BP	GO:0032496	response to lipopolysaccharide	10/223	330/18670	0.006498	0.2395	0.2201	SPARC/PPBP/GJA1/SELP/PF4/CYP1A1/UGT1A1/SNCA/GNG12/MIR21	10
BP	GO:0000082	G1/S transition of mitotic cell cycle	9/223	279/18670	0.00652	0.2395	0.2201	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/CYP1A1/MIR29B1/MIR21/SPDYA	9
BP	GO:0034394	protein localization to cell surface	4/223	63/18670	0.006807	0.2398	0.2203	TAX1BP3/EGF/VCL/MAP1A	4
BP	GO:0030100	regulation of endocytosis	9/223	281/18670	0.00682	0.2398	0.2203	CALM3/CLU/DAB2/ITGB3/ANO6/EGF/C3/SNCA/SYT7	9
BP	GO:0030032	lamellipodium assembly	4/223	64/18670	0.007195	0.2398	0.2203	ABLIM3/MIR196A2/VCL/DMTN	4
BP	GO:0034332	adherens junction organization	6/223	142/18670	0.007237	0.2398	0.2203	EPB41L5/CAMSAP3/CTTN/VCL/DMTN/ARHGAP6	6
BP	GO:0019371	cyclooxygenase pathway	2/223	11/18670	0.007276	0.2398	0.2203	PTGES3/PTGS1	2
BP	GO:0032060	bleb assembly	2/223	11/18670	0.007276	0.2398	0.2203	ANO6/MYLK	2
BP	GO:0052697	xenobiotic glucuronidation	2/223	11/18670	0.007276	0.2398	0.2203	UGT2B11/UGT1A1	2
BP	GO:0072321	chaperone-mediated protein transport	2/223	11/18670	0.007276	0.2398	0.2203	CLU/TIMM8B	2
BP	GO:1903426	regulation of reactive oxygen species biosynthetic process	5/223	101/18670	0.007284	0.2398	0.2203	CLU/SNCA/RGN/ARG2/MIR21	5
BP	GO:1901343	negative regulation of vasculature development	7/223	187/18670	0.007319	0.2398	0.2203	SPARC/MIR29C/MIR196A2/PF4/SULF1/MMRN2/MIR21	7
BP	GO:0010574	regulation of vascular endothelial growth factor production	3/223	34/18670	0.007659	0.2398	0.2203	SULF1/C3/NUTF2	3
BP	GO:1904064	positive regulation of cation transmembrane transport	6/223	144/18670	0.007731	0.2398	0.2203	CALM3/ANO6/SNCA/RGN/EPHB2/MIR21	6
BP	GO:0048259	regulation of receptor-mediated endocytosis	5/223	103/18670	0.007899	0.2398	0.2203	CLU/DAB2/ITGB3/EGF/C3	5
BP	GO:0001935	endothelial cell proliferation	7/223	191/18670	0.008178	0.2398	0.2203	SPARC/MIR29C/ITGB3/GJA1/SULF1/CAV2/MIR21	7
BP	GO:0002237	response to molecule of bacterial origin	10/223	343/18670	0.008419	0.2398	0.2203	SPARC/PPBP/GJA1/SELP/PF4/CYP1A1/UGT1A1/SNCA/GNG12/MIR21	10
BP	GO:1903391	regulation of adherens junction organization	4/223	67/18670	0.008443	0.2398	0.2203	EPB41L5/CAMSAP3/DMTN/ARHGAP6	4
BP	GO:0010632	regulation of epithelial cell migration	9/223	291/18670	0.008481	0.2398	0.2203	SPARC/MIR29C/ITGB3/EPB41L5/MIR196A2/MMRN2/VIL1/MIR21/AMOTL1	9
BP	GO:0034329	cell junction assembly	8/223	241/18670	0.008575	0.2398	0.2203	EPB41L5/CAMSAP3/CTTN/GJA1/ESAM/VCL/DMTN/ARHGAP6	8
BP	GO:0007608	sensory perception of smell	12/223	454/18670	0.008638	0.2398	0.2203	OR2T27/OR13C2/OR51D1/OR5M10/OR2AJ1/OR2B8P/OR52N2/OR5P3/OR56B2P/OR4N5/OR9Q1/OR10K2	12
BP	GO:0006465	signal peptide processing	2/223	12/18670	0.008663	0.2398	0.2203	CLN5/SPCS2	2
BP	GO:0006527	arginine catabolic process	2/223	12/18670	0.008663	0.2398	0.2203	ARG2/MIR21	2
BP	GO:0014831	gastro-intestinal system smooth muscle contraction	2/223	12/18670	0.008663	0.2398	0.2203	SPX/SULF1	2
BP	GO:2000121	regulation of removal of superoxide radicals	2/223	12/18670	0.008663	0.2398	0.2203	RGN/MIR21	2
BP	GO:0008643	carbohydrate transport	6/223	148/18670	0.008789	0.2398	0.2203	MFSD2B/PPBP/SLC35D3/C3/VIL1/ITLN1	6
BP	GO:0051494	negative regulation of cytoskeleton organization	6/223	148/18670	0.008789	0.2398	0.2203	CAMSAP3/SNCA/DMTN/VIL1/MIR21/ARHGAP6	6
BP	GO:0010876	lipid localization	11/223	400/18670	0.008879	0.2398	0.2203	MFSD2B/CLU/ITGB3/PITPNM2/FITM1/SPX/EGF/C3/PLEKHA8P1/SYT7/PRKAA2	11
BP	GO:0006625	protein targeting to peroxisome	4/223	68/18670	0.008888	0.2398	0.2203	AMACR/PEX12/CRAT/PEX14	4
BP	GO:0072662	protein localization to peroxisome	4/223	68/18670	0.008888	0.2398	0.2203	AMACR/PEX12/CRAT/PEX14	4
BP	GO:0072663	establishment of protein localization to peroxisome	4/223	68/18670	0.008888	0.2398	0.2203	AMACR/PEX12/CRAT/PEX14	4
BP	GO:0010573	vascular endothelial growth factor production	3/223	36/18670	0.00898	0.2398	0.2203	SULF1/C3/NUTF2	3
BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	6/223	149/18670	0.009069	0.2398	0.2203	CLU/DAB2/EGF/CAMLG/FAM122A/MAP1A	6
BP	GO:0036465	synaptic vesicle recycling	4/223	69/18670	0.009349	0.2398	0.2203	CALM3/POTEKP/SNCA/SYT7	4
BP	GO:0043574	peroxisomal transport	4/223	69/18670	0.009349	0.2398	0.2203	AMACR/PEX12/CRAT/PEX14	4
BP	GO:0010631	epithelial cell migration	10/223	351/18670	0.009803	0.2398	0.2203	SPARC/MIR29C/ITGB3/EPB41L5/MIR196A2/FAP/MMRN2/VIL1/MIR21/AMOTL1	10
BP	GO:0044843	cell cycle G1/S phase transition	9/223	298/18670	0.009816	0.2398	0.2203	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/CYP1A1/MIR29B1/MIR21/SPDYA	9
BP	GO:0001676	long-chain fatty acid metabolic process	5/223	109/18670	0.009956	0.2398	0.2203	PTGES3/CYP2C18/PTGS1/CYP1A1/CYP2E1	5
BP	GO:0051261	protein depolymerization	5/223	109/18670	0.009956	0.2398	0.2203	CAMSAP3/KIF2A/DMTN/MAP1A/VIL1	5
BP	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	2/223	13/18670	0.01016	0.2398	0.2203	EGF/NRG1	2
BP	GO:0016558	protein import into peroxisome matrix	2/223	13/18670	0.01016	0.2398	0.2203	PEX12/PEX14	2
BP	GO:0021554	optic nerve development	2/223	13/18670	0.01016	0.2398	0.2203	KCNA2/EPHB2	2
BP	GO:0032536	regulation of cell projection size	2/223	13/18670	0.01016	0.2398	0.2203	XK/VIL1	2
BP	GO:0042178	xenobiotic catabolic process	2/223	13/18670	0.01016	0.2398	0.2203	CYP1A1/UGT1A1	2
BP	GO:0060100	positive regulation of phagocytosis, engulfment	2/223	13/18670	0.01016	0.2398	0.2203	ANO6/C3	2
BP	GO:0060576	intestinal epithelial cell development	2/223	13/18670	0.01016	0.2398	0.2203	CDKN1A/MIR29B1	2
BP	GO:0070986	left/right axis specification	2/223	13/18670	0.01016	0.2398	0.2203	MNS1/EPB41L5	2
BP	GO:0090399	replicative senescence	2/223	13/18670	0.01016	0.2398	0.2203	CDKN1A/MIR21	2
BP	GO:1905155	positive regulation of membrane invagination	2/223	13/18670	0.01016	0.2398	0.2203	ANO6/C3	2
BP	GO:0045807	positive regulation of endocytosis	6/223	153/18670	0.01025	0.2398	0.2203	CLU/DAB2/ANO6/EGF/C3/SNCA	6
BP	GO:0006939	smooth muscle contraction	5/223	110/18670	0.01033	0.2398	0.2203	SPX/CTTN/MYLK/SULF1/MIR21	5
BP	GO:0033559	unsaturated fatty acid metabolic process	5/223	110/18670	0.01033	0.2398	0.2203	PTGES3/CYP2C18/PTGS1/CYP1A1/CYP2E1	5
BP	GO:0090132	epithelium migration	10/223	354/18670	0.01036	0.2398	0.2203	SPARC/MIR29C/ITGB3/EPB41L5/MIR196A2/FAP/MMRN2/VIL1/MIR21/AMOTL1	10
BP	GO:0006778	porphyrin-containing compound metabolic process	3/223	38/18670	0.01043	0.2398	0.2203	EIF2AK1/CYP1A1/UGT1A1	3
BP	GO:0042326	negative regulation of phosphorylation	12/223	468/18670	0.01081	0.2459	0.2259	CALM3/CDKN1A/CTDSPL/PRKAR2B/SNCA/RGN/DMTN/MIR29B1/CASC2/EPHB2/MIR21/SOCS3	12
BP	GO:0034767	positive regulation of ion transmembrane transport	6/223	156/18670	0.01121	0.2459	0.2259	CALM3/ANO6/SNCA/RGN/EPHB2/MIR21	6
BP	GO:0031100	animal organ regeneration	4/223	73/18670	0.01135	0.2459	0.2259	SRSF5/CDKN1A/UGT1A1/RGN	4
BP	GO:0043244	regulation of protein complex disassembly	5/223	113/18670	0.01152	0.2459	0.2259	CAMSAP3/PHF23/DMTN/MAP1A/VIL1	5
BP	GO:0090130	tissue migration	10/223	360/18670	0.01156	0.2459	0.2259	SPARC/MIR29C/ITGB3/EPB41L5/MIR196A2/FAP/MMRN2/VIL1/MIR21/AMOTL1	10
BP	GO:0010867	positive regulation of triglyceride biosynthetic process	2/223	14/18670	0.01176	0.2459	0.2259	RGN/MIR29B1	2
BP	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	2/223	14/18670	0.01176	0.2459	0.2259	LOX/PDGFA	2
BP	GO:0071941	nitrogen cycle metabolic process	2/223	14/18670	0.01176	0.2459	0.2259	ARG2/SUOX	2
BP	GO:1903054	negative regulation of extracellular matrix organization	2/223	14/18670	0.01176	0.2459	0.2259	MIR29B1/FAP	2
BP	GO:1905049	negative regulation of metallopeptidase activity	2/223	14/18670	0.01176	0.2459	0.2259	MIR29C/MIR29B1	2
BP	GO:1905050	positive regulation of metallopeptidase activity	2/223	14/18670	0.01176	0.2459	0.2259	MIR29B1/MIR21	2
BP	GO:0006690	icosanoid metabolic process	5/223	114/18670	0.01193	0.2459	0.2259	PTGES3/CYP2C18/PTGS1/CYP1A1/CYP2E1	5
BP	GO:0009895	negative regulation of catabolic process	9/223	308/18670	0.01199	0.2459	0.2259	CTSA/CAMLG/PHF23/NRG1/RBM38/SNCA/RGN/MAP1A/MIR21	9
BP	GO:0014046	dopamine secretion	3/223	40/18670	0.012	0.2459	0.2259	KCNA2/SNCA/SYT7	3
BP	GO:0014059	regulation of dopamine secretion	3/223	40/18670	0.012	0.2459	0.2259	KCNA2/SNCA/SYT7	3
BP	GO:0090207	regulation of triglyceride metabolic process	3/223	40/18670	0.012	0.2459	0.2259	C3/RGN/MIR29B1	3
BP	GO:2000008	regulation of protein localization to cell surface	3/223	40/18670	0.012	0.2459	0.2259	TAX1BP3/EGF/MAP1A	3
BP	GO:0032963	collagen metabolic process	5/223	115/18670	0.01235	0.25	0.2298	PLOD2/MMP7/MIR29B1/FAP/MIR21	5
BP	GO:0050907	detection of chemical stimulus involved in sensory perception	12/223	477/18670	0.01242	0.25	0.2298	OR2T27/OR13C2/OR51D1/OR5M10/OR2AJ1/OR2B8P/OR52N2/OR5P3/OR56B2P/OR4N5/OR9Q1/OR10K2	12
BP	GO:0043242	negative regulation of protein complex disassembly	4/223	75/18670	0.01244	0.25	0.2298	CAMSAP3/PHF23/DMTN/VIL1	4
BP	GO:0019432	triglyceride biosynthetic process	3/223	41/18670	0.01284	0.2554	0.2347	C3/RGN/MIR29B1	3
BP	GO:0010970	transport along microtubule	6/223	161/18670	0.01294	0.2554	0.2347	TMEM108/KIF4A/CAMSAP3/MAP1A/ARHGAP21/PEX14	6
BP	GO:0099111	microtubule-based transport	6/223	161/18670	0.01294	0.2554	0.2347	TMEM108/KIF4A/CAMSAP3/MAP1A/ARHGAP21/PEX14	6
BP	GO:0009812	flavonoid metabolic process	2/223	15/18670	0.01346	0.2561	0.2353	CYP1A1/UGT1A1	2
BP	GO:0033540	fatty acid beta-oxidation using acyl-CoA oxidase	2/223	15/18670	0.01346	0.2561	0.2353	AMACR/CRAT	2
BP	GO:0042762	regulation of sulfur metabolic process	2/223	15/18670	0.01346	0.2561	0.2353	SNCA/MIR21	2
BP	GO:0060099	regulation of phagocytosis, engulfment	2/223	15/18670	0.01346	0.2561	0.2353	ANO6/C3	2
BP	GO:0098840	protein transport along microtubule	2/223	15/18670	0.01346	0.2561	0.2353	CAMSAP3/MAP1A	2
BP	GO:0099118	microtubule-based protein transport	2/223	15/18670	0.01346	0.2561	0.2353	CAMSAP3/MAP1A	2
BP	GO:0006633	fatty acid biosynthetic process	6/223	164/18670	0.01407	0.2594	0.2384	PTGES3/PTGS1/CYP1A1/RGN/PRKAA2/CYP2E1	6
BP	GO:0001952	regulation of cell-matrix adhesion	5/223	119/18670	0.01415	0.2594	0.2384	MIR29C/EPB41L5/CAMSAP3/DMTN/ARHGAP6	5
BP	GO:0007173	epidermal growth factor receptor signaling pathway	5/223	119/18670	0.01415	0.2594	0.2384	EGF/CAMLG/BTC/VIL1/MIR21	5
BP	GO:0031330	negative regulation of cellular catabolic process	8/223	264/18670	0.01427	0.2594	0.2384	CTSA/CAMLG/PHF23/RBM38/SNCA/RGN/MAP1A/MIR21	8
BP	GO:0001953	negative regulation of cell-matrix adhesion	3/223	43/18670	0.01461	0.2594	0.2384	MIR29C/DMTN/ARHGAP6	3
BP	GO:0032365	intracellular lipid transport	3/223	43/18670	0.01461	0.2594	0.2384	PLEKHA8P1/SYT7/PRKAA2	3
BP	GO:0046460	neutral lipid biosynthetic process	3/223	43/18670	0.01461	0.2594	0.2384	C3/RGN/MIR29B1	3
BP	GO:0046463	acylglycerol biosynthetic process	3/223	43/18670	0.01461	0.2594	0.2384	C3/RGN/MIR29B1	3
BP	GO:0050850	positive regulation of calcium-mediated signaling	3/223	43/18670	0.01461	0.2594	0.2384	CALM3/C10orf71/NRG1	3
BP	GO:1903050	regulation of proteolysis involved in cellular protein catabolic process	7/223	214/18670	0.01462	0.2594	0.2384	CLU/DAB2/EGF/CAMLG/FAM122A/RGN/MAP1A	7
BP	GO:0003014	renal system process	5/223	120/18670	0.01463	0.2594	0.2384	PRKAR2B/SPX/BTC/GJA1/SULF1	5
BP	GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	5/223	120/18670	0.01463	0.2594	0.2384	CLU/DAB2/EGF/FAM122A/RGN	5
BP	GO:0045652	regulation of megakaryocyte differentiation	4/223	79/18670	0.01482	0.2594	0.2384	MYL9/ITGA2B/LOX/PF4	4
BP	GO:0002070	epithelial cell maturation	2/223	16/18670	0.01527	0.2594	0.2384	CDKN1A/GJA1	2
BP	GO:0006837	serotonin transport	2/223	16/18670	0.01527	0.2594	0.2384	ITGB3/SNCA	2
BP	GO:0043217	myelin maintenance	2/223	16/18670	0.01527	0.2594	0.2384	SH3TC2/CLU	2
BP	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	2/223	16/18670	0.01527	0.2594	0.2384	C10orf71/NRG1	2
BP	GO:0090083	regulation of inclusion body assembly	2/223	16/18670	0.01527	0.2594	0.2384	CLU/SNCAIP	2
BP	GO:0106058	positive regulation of calcineurin-mediated signaling	2/223	16/18670	0.01527	0.2594	0.2384	C10orf71/NRG1	2
BP	GO:1905153	regulation of membrane invagination	2/223	16/18670	0.01527	0.2594	0.2384	ANO6/C3	2
BP	GO:0007019	microtubule depolymerization	3/223	44/18670	0.01554	0.2594	0.2384	CAMSAP3/KIF2A/MAP1A	3
BP	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	3/223	44/18670	0.01554	0.2594	0.2384	MIR29C/MIR196A2/MMRN2	3
BP	GO:0050673	epithelial cell proliferation	11/223	434/18670	0.01555	0.2594	0.2384	SPARC/MIR29C/ITGB3/GJA1/SULF1/CAV2/RGN/MIR29B1/FAP/MIR21/KRT4	11
BP	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	5/223	122/18670	0.01562	0.2594	0.2384	CLU/DAB2/CAMLG/FAM122A/MAP1A	5
BP	GO:0060348	bone development	7/223	217/18670	0.01567	0.2594	0.2384	SPARC/LOX/ANO6/GNAS/GJA1/SULF1/RGN	7
BP	GO:0050678	regulation of epithelial cell proliferation	10/223	378/18670	0.01578	0.2599	0.2388	SPARC/MIR29C/ITGB3/GJA1/SULF1/CAV2/RGN/MIR29B1/MIR21/KRT4	10
BP	GO:0050804	modulation of chemical synaptic transmission	11/223	436/18670	0.01603	0.2613	0.2401	CALM3/TMEM108/IGSF9B/SCGN/PRKAR2B/NRGN/SNCAIP/SNCA/MAP1A/SYT7/EPHB2	11
BP	GO:0007031	peroxisome organization	4/223	81/18670	0.01612	0.2613	0.2401	AMACR/PEX12/CRAT/PEX14	4
BP	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	4/223	81/18670	0.01612	0.2613	0.2401	LTBP1/VEPH1/CAV2/MIR29B1	4
BP	GO:1903829	positive regulation of cellular protein localization	9/223	324/18670	0.01619	0.2613	0.2401	ABLIM3/EGF/HSPA1L/SLC35D3/NUTF2/MAP1A/VIL1/PRKAA2/EPHB2	9
BP	GO:0099177	regulation of trans-synaptic signaling	11/223	437/18670	0.01628	0.2614	0.2402	CALM3/TMEM108/IGSF9B/SCGN/PRKAR2B/NRGN/SNCAIP/SNCA/MAP1A/SYT7/EPHB2	11
BP	GO:1900271	regulation of long-term synaptic potentiation	3/223	45/18670	0.01651	0.2614	0.2402	SCGN/NRGN/EPHB2	3
BP	GO:1902743	regulation of lamellipodium organization	3/223	45/18670	0.01651	0.2614	0.2402	MIR196A2/DMTN/VIL1	3
BP	GO:0019932	second-messenger-mediated signaling	11/223	439/18670	0.01678	0.2614	0.2402	CALM3/C10orf71/PDE5A/PRKAR2B/GNAS/SELP/NRG1/PF4/RGN/DMTN/MC2R	11
BP	GO:0006937	regulation of muscle contraction	6/223	171/18670	0.01696	0.2614	0.2402	MYL9/CALM3/PDE5A/SPX/CTTN/MIR21	6
BP	GO:0010634	positive regulation of epithelial cell migration	6/223	171/18670	0.01696	0.2614	0.2402	SPARC/ITGB3/EPB41L5/VIL1/MIR21/AMOTL1	6
BP	GO:0043542	endothelial cell migration	8/223	273/18670	0.01712	0.2614	0.2402	SPARC/MIR29C/ITGB3/MIR196A2/FAP/MMRN2/MIR21/AMOTL1	8
BP	GO:0015919	peroxisomal membrane transport	2/223	17/18670	0.01717	0.2614	0.2402	PEX12/PEX14	2
BP	GO:0032460	negative regulation of protein oligomerization	2/223	17/18670	0.01717	0.2614	0.2402	CLU/PEX14	2
BP	GO:0071850	mitotic cell cycle arrest	2/223	17/18670	0.01717	0.2614	0.2402	CDKN1A/FAP	2
BP	GO:1905331	negative regulation of morphogenesis of an epithelium	2/223	17/18670	0.01717	0.2614	0.2402	SULF1/MIR21	2
BP	GO:0045913	positive regulation of carbohydrate metabolic process	4/223	83/18670	0.01748	0.2614	0.2402	EGF/SNCA/RGN/PRKAA2	4
BP	GO:1901879	regulation of protein depolymerization	4/223	83/18670	0.01748	0.2614	0.2402	CAMSAP3/DMTN/MAP1A/VIL1	4
BP	GO:1903845	negative regulation of cellular response to transforming growth factor beta stimulus	4/223	83/18670	0.01748	0.2614	0.2402	LTBP1/VEPH1/CAV2/MIR29B1	4
BP	GO:0010883	regulation of lipid storage	3/223	46/18670	0.0175	0.2614	0.2402	ITGB3/FITM1/C3	3
BP	GO:0050919	negative chemotaxis	3/223	46/18670	0.0175	0.2614	0.2402	ITGB3/NRG1/PDGFA	3
BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	5/223	126/18670	0.01771	0.2633	0.242	LTBP1/VEPH1/RBPMS2/CAV2/MIR29B1	5
BP	GO:0043270	positive regulation of ion transport	8/223	275/18670	0.01781	0.2635	0.2421	CALM3/FHL1/ANO6/MYLK/SNCA/RGN/EPHB2/MIR21	8
BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	3/223	47/18670	0.01854	0.273	0.2509	CALM3/EGF/DMTN	3
BP	GO:2001057	reactive nitrogen species metabolic process	4/223	85/18670	0.01891	0.2771	0.2546	CLU/RGN/ARG2/SUOX	4
BP	GO:0007597	blood coagulation, intrinsic pathway	2/223	18/18670	0.01916	0.2771	0.2546	GP1BB/GP9	2
BP	GO:0008090	retrograde axonal transport	2/223	18/18670	0.01916	0.2771	0.2546	TMEM108/MAP1A	2
BP	GO:0051895	negative regulation of focal adhesion assembly	2/223	18/18670	0.01916	0.2771	0.2546	DMTN/ARHGAP6	2
BP	GO:0043268	positive regulation of potassium ion transport	3/223	48/18670	0.0196	0.2791	0.2565	FHL1/ANO6/MIR21	3
BP	GO:0045933	positive regulation of muscle contraction	3/223	48/18670	0.0196	0.2791	0.2565	SPX/CTTN/MIR21	3
BP	GO:0046850	regulation of bone remodeling	3/223	48/18670	0.0196	0.2791	0.2565	ITGB3/GJA1/SYT7	3
BP	GO:0060291	long-term synaptic potentiation	4/223	86/18670	0.01965	0.2791	0.2565	SCGN/NRGN/SNCA/EPHB2	4
BP	GO:0006638	neutral lipid metabolic process	5/223	130/18670	0.01999	0.2827	0.2598	C3/SNCA/RGN/MIR29B1/CYP2E1	5
BP	GO:0010594	regulation of endothelial cell migration	7/223	229/18670	0.0204	0.2859	0.2627	SPARC/MIR29C/ITGB3/MIR196A2/MMRN2/MIR21/AMOTL1	7
BP	GO:0034249	negative regulation of cellular amide metabolic process	7/223	229/18670	0.0204	0.2859	0.2627	CTSA/CLU/EIF2AK1/IGF2BP2/SNCA/MIR29B1/MIR21	7
BP	GO:0034103	regulation of tissue remodeling	4/223	88/18670	0.02119	0.289	0.2656	ITGB3/GJA1/MIR29B1/SYT7	4
BP	GO:0042177	negative regulation of protein catabolic process	5/223	132/18670	0.0212	0.289	0.2656	CTSA/CAMLG/NRG1/SNCA/MAP1A	5
BP	GO:0030705	cytoskeleton-dependent intracellular transport	6/223	180/18670	0.02124	0.289	0.2656	TMEM108/KIF4A/CAMSAP3/MAP1A/ARHGAP21/PEX14	6
BP	GO:0051131	chaperone-mediated protein complex assembly	2/223	19/18670	0.02125	0.289	0.2656	PTGES3/CLU	2
BP	GO:0052695	cellular glucuronidation	2/223	19/18670	0.02125	0.289	0.2656	UGT2B11/UGT1A1	2
BP	GO:0071435	potassium ion export	2/223	19/18670	0.02125	0.289	0.2656	ANO6/MIR21	2
BP	GO:0097623	potassium ion export across plasma membrane	2/223	19/18670	0.02125	0.289	0.2656	ANO6/MIR21	2
BP	GO:0048565	digestive tract development	5/223	134/18670	0.02245	0.3041	0.2794	EPB41L5/CDKN1A/RBPMS2/CYP1A1/MIR29B1	5
BP	GO:0015844	monoamine transport	4/223	90/18670	0.0228	0.3056	0.2808	ITGB3/KCNA2/SNCA/SYT7	4
BP	GO:0045778	positive regulation of ossification	4/223	90/18670	0.0228	0.3056	0.2808	ANO6/GNAS/MIR29B1/MIR21	4
BP	GO:0048146	positive regulation of fibroblast proliferation	3/223	51/18670	0.023	0.3056	0.2808	CDKN1A/BTC/PDGFA	3
BP	GO:0043484	regulation of RNA splicing	5/223	135/18670	0.0231	0.3056	0.2808	SRSF5/MBNL3/CLK1/CLK3/RBM38	5
BP	GO:0001667	ameboidal-type cell migration	11/223	461/18670	0.0231	0.3056	0.2808	SPARC/MIR29C/ITGB3/EPB41L5/MIR196A2/DMTN/FAP/MMRN2/VIL1/MIR21/AMOTL1	11
BP	GO:0006525	arginine metabolic process	2/223	20/18670	0.02343	0.3056	0.2808	ARG2/MIR21	2
BP	GO:0032462	regulation of protein homooligomerization	2/223	20/18670	0.02343	0.3056	0.2808	CLU/PEX14	2
BP	GO:0051580	regulation of neurotransmitter uptake	2/223	20/18670	0.02343	0.3056	0.2808	ITGB3/SNCA	2
BP	GO:1900424	regulation of defense response to bacterium	2/223	20/18670	0.02343	0.3056	0.2808	SIGLEC11/ARG2	2
BP	GO:0034330	cell junction organization	8/223	290/18670	0.02358	0.3064	0.2815	EPB41L5/CAMSAP3/CTTN/GJA1/ESAM/VCL/DMTN/ARHGAP6	8
BP	GO:0015872	dopamine transport	3/223	52/18670	0.0242	0.3131	0.2877	KCNA2/SNCA/SYT7	3
BP	GO:0051346	negative regulation of hydrolase activity	11/223	466/18670	0.02476	0.3158	0.2902	MIR29C/CAMSAP3/PROS1/SERPINB11/FAM122A/C3/SNCA/RGN/MIR29B1/VIL1/MIR21	11
BP	GO:2000146	negative regulation of cell motility	9/223	349/18670	0.02478	0.3158	0.2902	MIR29C/MIR196A2/NRG1/SULF1/RGN/VCL/MIR29B1/MMRN2/MIR21	9
BP	GO:0048167	regulation of synaptic plasticity	6/223	187/18670	0.02504	0.3158	0.2902	SCGN/NRGN/SNCA/MAP1A/SYT7/EPHB2	6
BP	GO:1901184	regulation of ERBB signaling pathway	4/223	93/18670	0.02535	0.3158	0.2902	SH3TC2/EGF/BTC/MIR21	4
BP	GO:0030195	negative regulation of blood coagulation	3/223	53/18670	0.02543	0.3158	0.2902	PROS1/PDGFA/FAP	3
BP	GO:0003094	glomerular filtration	2/223	21/18670	0.02569	0.3158	0.2902	GJA1/SULF1	2
BP	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	2/223	21/18670	0.02569	0.3158	0.2902	CALM3/DMTN	2
BP	GO:0051412	response to corticosterone	2/223	21/18670	0.02569	0.3158	0.2902	CALM3/CDKN1A	2
BP	GO:0055093	response to hyperoxia	2/223	21/18670	0.02569	0.3158	0.2902	CDKN1A/CYP1A1	2
BP	GO:0060972	left/right pattern formation	2/223	21/18670	0.02569	0.3158	0.2902	MNS1/EPB41L5	2
BP	GO:0090208	positive regulation of triglyceride metabolic process	2/223	21/18670	0.02569	0.3158	0.2902	RGN/MIR29B1	2
BP	GO:1900273	positive regulation of long-term synaptic potentiation	2/223	21/18670	0.02569	0.3158	0.2902	NRGN/EPHB2	2
BP	GO:1903392	negative regulation of adherens junction organization	2/223	21/18670	0.02569	0.3158	0.2902	DMTN/ARHGAP6	2
BP	GO:0031333	negative regulation of protein complex assembly	5/223	139/18670	0.0258	0.3159	0.2903	CLU/SNCA/DMTN/VIL1/PEX14	5
BP	GO:0019216	regulation of lipid metabolic process	10/223	410/18670	0.02596	0.3166	0.291	CCDC3/CYP1A1/C3/UGT1A1/SNCA/RGN/PDGFA/MIR29B1/PRKAA2/SOCS3	10
BP	GO:1903364	positive regulation of cellular protein catabolic process	5/223	140/18670	0.0265	0.3207	0.2947	CLU/DAB2/EGF/FAM122A/RGN	5
BP	GO:0030199	collagen fibril organization	3/223	54/18670	0.02669	0.3207	0.2947	PLOD2/LOX/MIR29B1	3
BP	GO:0051353	positive regulation of oxidoreductase activity	3/223	54/18670	0.02669	0.3207	0.2947	CALM3/SNCA/RGN	3
BP	GO:1900047	negative regulation of hemostasis	3/223	54/18670	0.02669	0.3207	0.2947	PROS1/PDGFA/FAP	3
BP	GO:0001505	regulation of neurotransmitter levels	9/223	354/18670	0.02683	0.3212	0.2951	CALM3/UPB1/CLU/ITGB3/SNCAIP/SNCA/RGN/ARG2/SYT7	9
BP	GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process	4/223	95/18670	0.02714	0.3237	0.2974	CLU/DAB2/EGF/FAM122A	4
BP	GO:0051896	regulation of protein kinase B signaling	7/223	244/18670	0.02761	0.3238	0.2975	MIR29C/EGF/BTC/NRG1/PDGFA/MIR29B1/MIR21	7
BP	GO:0043112	receptor metabolic process	6/223	192/18670	0.02802	0.3238	0.2975	ARR3/ITGB3/EGF/CAMLG/NRG1/SNCA	6
BP	GO:0007398	ectoderm development	2/223	22/18670	0.02804	0.3238	0.2975	EPB41L5/KRT6B	2
BP	GO:0010884	positive regulation of lipid storage	2/223	22/18670	0.02804	0.3238	0.2975	FITM1/C3	2
BP	GO:0035584	calcium-mediated signaling using intracellular calcium source	2/223	22/18670	0.02804	0.3238	0.2975	SELP/DMTN	2
BP	GO:0060390	regulation of SMAD protein signal transduction	2/223	22/18670	0.02804	0.3238	0.2975	DAB2/VEPH1	2
BP	GO:0060575	intestinal epithelial cell differentiation	2/223	22/18670	0.02804	0.3238	0.2975	CDKN1A/MIR29B1	2
BP	GO:0097205	renal filtration	2/223	22/18670	0.02804	0.3238	0.2975	GJA1/SULF1	2
BP	GO:0030219	megakaryocyte differentiation	4/223	96/18670	0.02806	0.3238	0.2975	MYL9/ITGA2B/LOX/PF4	4
BP	GO:0010596	negative regulation of endothelial cell migration	4/223	97/18670	0.02901	0.3311	0.3042	MIR29C/MIR196A2/MMRN2/MIR21	4
BP	GO:1990868	response to chemokine	4/223	97/18670	0.02901	0.3311	0.3042	PPBP/LOX/MPL/PF4	4
BP	GO:1990869	cellular response to chemokine	4/223	97/18670	0.02901	0.3311	0.3042	PPBP/LOX/MPL/PF4	4
BP	GO:1903362	regulation of cellular protein catabolic process	7/223	247/18670	0.02923	0.3311	0.3043	CLU/DAB2/EGF/CAMLG/FAM122A/RGN/MAP1A	7
BP	GO:0048488	synaptic vesicle endocytosis	3/223	56/18670	0.02932	0.3311	0.3043	CALM3/POTEKP/SNCA	3
BP	GO:0140238	presynaptic endocytosis	3/223	56/18670	0.02932	0.3311	0.3043	CALM3/POTEKP/SNCA	3
BP	GO:1901991	negative regulation of mitotic cell cycle phase transition	7/223	248/18670	0.02979	0.3326	0.3056	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/MIR29B1/MIR21	7
BP	GO:2000377	regulation of reactive oxygen species metabolic process	6/223	195/18670	0.02991	0.3326	0.3056	CLU/CDKN1A/SNCA/RGN/ARG2/MIR21	6
BP	GO:0050848	regulation of calcium-mediated signaling	4/223	98/18670	0.02997	0.3326	0.3056	CALM3/C10orf71/NRG1/RGN	4
BP	GO:0051151	negative regulation of smooth muscle cell differentiation	2/223	23/18670	0.03048	0.3326	0.3056	RBPMS2/MIR21	2
BP	GO:0070841	inclusion body assembly	2/223	23/18670	0.03048	0.3326	0.3056	CLU/SNCAIP	2
BP	GO:0090343	positive regulation of cell aging	2/223	23/18670	0.03048	0.3326	0.3056	ARG2/MIR21	2
BP	GO:1901889	negative regulation of cell junction assembly	2/223	23/18670	0.03048	0.3326	0.3056	DMTN/ARHGAP6	2
BP	GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	2/223	23/18670	0.03048	0.3326	0.3056	ING2/MIR21	2
BP	GO:0048008	platelet-derived growth factor receptor signaling pathway	3/223	57/18670	0.03069	0.3326	0.3056	LOX/SNCA/PDGFA	3
BP	GO:0050819	negative regulation of coagulation	3/223	57/18670	0.03069	0.3326	0.3056	PROS1/PDGFA/FAP	3
BP	GO:0018108	peptidyl-tyrosine phosphorylation	9/223	363/18670	0.03081	0.3326	0.3056	ITGB3/EGF/CLK1/NRG1/CLK3/PDGFA/DMTN/EPHB2/SOCS3	9
BP	GO:0045861	negative regulation of proteolysis	9/223	363/18670	0.03081	0.3326	0.3056	MIR29C/PROS1/CAMLG/SERPINB11/C3/SNCA/MIR29B1/MAP1A/VIL1	9
BP	GO:0055123	digestive system development	5/223	146/18670	0.03099	0.3326	0.3056	EPB41L5/CDKN1A/RBPMS2/CYP1A1/MIR29B1	5
BP	GO:0045017	glycerolipid biosynthetic process	7/223	251/18670	0.0315	0.3326	0.3056	PITPNM2/PCYT1B/C3/RGN/PDGFA/MIR29B1/PI4K2A	7
BP	GO:0006869	lipid transport	9/223	365/18670	0.03175	0.3326	0.3056	MFSD2B/CLU/ITGB3/PITPNM2/SPX/EGF/PLEKHA8P1/SYT7/PRKAA2	9
BP	GO:0032102	negative regulation of response to external stimulus	9/223	365/18670	0.03175	0.3326	0.3056	CDKN1A/PROS1/SPX/SIGLEC11/GJA1/PDGFA/ARG2/FAP/SOCS3	9
BP	GO:0031099	regeneration	6/223	198/18670	0.03189	0.3326	0.3056	SRSF5/CDKN1A/GJA1/UGT1A1/RGN/MIR29B1	6
BP	GO:0046890	regulation of lipid biosynthetic process	6/223	198/18670	0.03189	0.3326	0.3056	CCDC3/C3/RGN/PDGFA/MIR29B1/PRKAA2	6
BP	GO:0072376	protein activation cascade	6/223	198/18670	0.03189	0.3326	0.3056	F13A1/CLU/PROS1/GP1BB/GP9/C3	6
BP	GO:0060840	artery development	4/223	100/18670	0.03194	0.3326	0.3056	LTBP1/LOX/MYLK/MIR29B1	4
BP	GO:2001023	regulation of response to drug	4/223	100/18670	0.03194	0.3326	0.3056	KCNA2/SNCA/SYT7/MIR21	4
BP	GO:0052548	regulation of endopeptidase activity	10/223	425/18670	0.03208	0.3326	0.3056	MIR29C/PROS1/CRADD/SERPINB11/C3/SNCA/MIR29B1/VIL1/CASC2/MIR21	10
BP	GO:0098930	axonal transport	3/223	58/18670	0.03208	0.3326	0.3056	TMEM108/KIF4A/MAP1A	3
BP	GO:0018212	peptidyl-tyrosine modification	9/223	366/18670	0.03223	0.3326	0.3056	ITGB3/EGF/CLK1/NRG1/CLK3/PDGFA/DMTN/EPHB2/SOCS3	9
BP	GO:0051592	response to calcium ion	5/223	148/18670	0.03258	0.3326	0.3056	CALM3/SPARC/DMTN/SYT7/PRKAA2	5
BP	GO:0006063	uronic acid metabolic process	2/223	24/18670	0.03299	0.3326	0.3056	UGT2B11/UGT1A1	2
BP	GO:0010640	regulation of platelet-derived growth factor receptor signaling pathway	2/223	24/18670	0.03299	0.3326	0.3056	LOX/SNCA	2
BP	GO:0019585	glucuronate metabolic process	2/223	24/18670	0.03299	0.3326	0.3056	UGT2B11/UGT1A1	2
BP	GO:0042537	benzene-containing compound metabolic process	2/223	24/18670	0.03299	0.3326	0.3056	UGT1A1/CYP2E1	2
BP	GO:0042738	exogenous drug catabolic process	2/223	24/18670	0.03299	0.3326	0.3056	CYP2C18/CYP2E1	2
BP	GO:0046135	pyrimidine nucleoside catabolic process	2/223	24/18670	0.03299	0.3326	0.3056	UPB1/UPP2	2
BP	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	2/223	24/18670	0.03299	0.3326	0.3056	CALM3/GJA1	2
BP	GO:1903010	regulation of bone development	2/223	24/18670	0.03299	0.3326	0.3056	LOX/RGN	2
BP	GO:1903421	regulation of synaptic vesicle recycling	2/223	24/18670	0.03299	0.3326	0.3056	CALM3/SNCA	2
BP	GO:0051924	regulation of calcium ion transport	7/223	254/18670	0.03328	0.3326	0.3056	CALM3/EGF/GJA1/MYLK/SNCA/RGN/MIR21	7
BP	GO:0061077	chaperone-mediated protein folding	3/223	59/18670	0.03351	0.3326	0.3056	PTGES3/CLU/HSPA1L	3
BP	GO:0072413	signal transduction involved in mitotic cell cycle checkpoint	3/223	59/18670	0.03351	0.3326	0.3056	CDKN1A/CRADD/MIR21	3
BP	GO:1902402	signal transduction involved in mitotic DNA damage checkpoint	3/223	59/18670	0.03351	0.3326	0.3056	CDKN1A/CRADD/MIR21	3
BP	GO:1902403	signal transduction involved in mitotic DNA integrity checkpoint	3/223	59/18670	0.03351	0.3326	0.3056	CDKN1A/CRADD/MIR21	3
BP	GO:2000379	positive regulation of reactive oxygen species metabolic process	4/223	102/18670	0.034	0.3364	0.3091	CLU/CDKN1A/SNCA/RGN	4
BP	GO:0006839	mitochondrial transport	7/223	256/18670	0.0345	0.3403	0.3127	ABLIM3/MIR29C/HSPA1L/TIMM8B/MIR29B1/PRKAA2/MCUR1	7
BP	GO:0033013	tetrapyrrole metabolic process	3/223	60/18670	0.03497	0.3426	0.3148	EIF2AK1/CYP1A1/UGT1A1	3
BP	GO:0090342	regulation of cell aging	3/223	60/18670	0.03497	0.3426	0.3148	ING2/ARG2/MIR21	3
BP	GO:0007229	integrin-mediated signaling pathway	4/223	103/18670	0.03505	0.3426	0.3148	ITGB3/ITGA2B/ITGB5/DMTN	4
BP	GO:0006605	protein targeting	10/223	432/18670	0.03526	0.3435	0.3157	AMACR/ABLIM3/CLU/PEX12/HSPA1L/TIMM8B/CRAT/DMTN/SPCS2/PEX14	10
BP	GO:0009404	toxin metabolic process	2/223	25/18670	0.03558	0.3446	0.3166	CYP1A1/MIR21	2
BP	GO:0019430	removal of superoxide radicals	2/223	25/18670	0.03558	0.3446	0.3166	RGN/MIR21	2
BP	GO:0051017	actin filament bundle assembly	5/223	153/18670	0.03679	0.3553	0.3265	ITGB5/DMTN/VIL1/MIR21/ARHGAP6	5
BP	GO:0006641	triglyceride metabolic process	4/223	105/18670	0.03722	0.3583	0.3292	C3/RGN/MIR29B1/CYP2E1	4
BP	GO:0050433	regulation of catecholamine secretion	3/223	62/18670	0.038	0.3583	0.3292	KCNA2/SNCA/SYT7	3
BP	GO:0010256	endomembrane system organization	10/223	438/18670	0.03815	0.3583	0.3292	SH3TC2/FCHO1/CLU/CAMSAP3/ANO6/ZFYVE27/CAV2/SYT7/PI4K2A/ARHGAP21	10
BP	GO:0022011	myelination in peripheral nervous system	2/223	26/18670	0.03825	0.3583	0.3292	SH3TC2/NRG1	2
BP	GO:0031954	positive regulation of protein autophosphorylation	2/223	26/18670	0.03825	0.3583	0.3292	CALM3/PDGFA	2
BP	GO:0032292	peripheral nervous system axon ensheathment	2/223	26/18670	0.03825	0.3583	0.3292	SH3TC2/NRG1	2
BP	GO:0034453	microtubule anchoring	2/223	26/18670	0.03825	0.3583	0.3292	CAMSAP3/PEX14	2
BP	GO:0048169	regulation of long-term neuronal synaptic plasticity	2/223	26/18670	0.03825	0.3583	0.3292	SNCA/EPHB2	2
BP	GO:0051497	negative regulation of stress fiber assembly	2/223	26/18670	0.03825	0.3583	0.3292	MIR21/ARHGAP6	2
BP	GO:0042136	neurotransmitter biosynthetic process	4/223	106/18670	0.03833	0.3583	0.3292	UPB1/CLU/RGN/ARG2	4
BP	GO:0010466	negative regulation of peptidase activity	7/223	262/18670	0.03834	0.3583	0.3292	MIR29C/PROS1/SERPINB11/C3/SNCA/MIR29B1/VIL1	7
BP	GO:0051341	regulation of oxidoreductase activity	4/223	107/18670	0.03946	0.3666	0.3369	CALM3/SNCA/RGN/MIR21	4
BP	GO:0007568	aging	8/223	321/18670	0.03946	0.3666	0.3369	CDKN1A/ING2/CYP1A1/MMP7/SNCA/RGN/ARG2/MIR21	8
BP	GO:0061572	actin filament bundle organization	5/223	157/18670	0.04039	0.3715	0.3414	ITGB5/DMTN/VIL1/MIR21/ARHGAP6	5
BP	GO:0015696	ammonium transport	4/223	108/18670	0.04061	0.3715	0.3414	ITGB3/KCNA2/SNCA/SYT7	4
BP	GO:2000278	regulation of DNA biosynthetic process	4/223	108/18670	0.04061	0.3715	0.3414	PTGES3/CDKN1A/GJA1/RGN	4
BP	GO:0071450	cellular response to oxygen radical	2/223	27/18670	0.04099	0.3715	0.3414	RGN/MIR21	2
BP	GO:0071451	cellular response to superoxide	2/223	27/18670	0.04099	0.3715	0.3414	RGN/MIR21	2
BP	GO:0098810	neurotransmitter reuptake	2/223	27/18670	0.04099	0.3715	0.3414	ITGB3/SNCA	2
BP	GO:0043297	apical junction assembly	3/223	64/18670	0.04115	0.3715	0.3414	GJA1/ESAM/VCL	3
BP	GO:0045600	positive regulation of fat cell differentiation	3/223	64/18670	0.04115	0.3715	0.3414	CCDC3/MIR29B1/MIR21	3
BP	GO:0045669	positive regulation of osteoblast differentiation	3/223	64/18670	0.04115	0.3715	0.3414	GNAS/MIR29B1/MIR21	3
BP	GO:0050432	catecholamine secretion	3/223	64/18670	0.04115	0.3715	0.3414	KCNA2/SNCA/SYT7	3
BP	GO:0051271	negative regulation of cellular component movement	9/223	384/18670	0.04167	0.3748	0.3444	MIR29C/MIR196A2/NRG1/SULF1/RGN/VCL/MIR29B1/MMRN2/MIR21	9
BP	GO:1901988	negative regulation of cell cycle phase transition	7/223	267/18670	0.04174	0.3748	0.3444	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/MIR29B1/MIR21	7
BP	GO:0006940	regulation of smooth muscle contraction	3/223	65/18670	0.04277	0.3818	0.3509	SPX/CTTN/MIR21	3
BP	GO:0071806	protein transmembrane transport	3/223	65/18670	0.04277	0.3818	0.3509	CLU/PEX12/PEX14	3
BP	GO:0001516	prostaglandin biosynthetic process	2/223	28/18670	0.0438	0.384	0.3529	PTGES3/PTGS1	2
BP	GO:0009065	glutamine family amino acid catabolic process	2/223	28/18670	0.0438	0.384	0.3529	ARG2/MIR21	2
BP	GO:0036296	response to increased oxygen levels	2/223	28/18670	0.0438	0.384	0.3529	CDKN1A/CYP1A1	2
BP	GO:0042730	fibrinolysis	2/223	28/18670	0.0438	0.384	0.3529	PROS1/FAP	2
BP	GO:0046457	prostanoid biosynthetic process	2/223	28/18670	0.0438	0.384	0.3529	PTGES3/PTGS1	2
BP	GO:0085029	extracellular matrix assembly	2/223	28/18670	0.0438	0.384	0.3529	LOX/MIR29B1	2
BP	GO:0045732	positive regulation of protein catabolic process	6/223	214/18670	0.04385	0.384	0.3529	CLU/DAB2/EGF/GJA1/FAM122A/RGN	6
BP	GO:0031623	receptor internalization	4/223	111/18670	0.04417	0.3846	0.3534	ARR3/ITGB3/EGF/SNCA	4
BP	GO:1901880	negative regulation of protein depolymerization	3/223	66/18670	0.04443	0.3846	0.3534	CAMSAP3/DMTN/VIL1	3
BP	GO:0010810	regulation of cell-substrate adhesion	6/223	215/18670	0.04468	0.3846	0.3534	MIR29C/EPB41L5/CAMSAP3/DMTN/MMRN2/ARHGAP6	6
BP	GO:0031109	microtubule polymerization or depolymerization	4/223	112/18670	0.04539	0.3846	0.3534	CAMSAP3/KIF2A/SNCA/MAP1A	4
BP	GO:1903828	negative regulation of cellular protein localization	4/223	112/18670	0.04539	0.3846	0.3534	DAB2/TAX1BP3/DMTN/MAP1A	4
BP	GO:0052547	regulation of peptidase activity	10/223	452/18670	0.04554	0.3846	0.3534	MIR29C/PROS1/CRADD/SERPINB11/C3/SNCA/MIR29B1/VIL1/CASC2/MIR21	10
BP	GO:0048747	muscle fiber development	3/223	67/18670	0.04611	0.3846	0.3534	XK/LOX/CAV2	3
BP	GO:0031214	biomineral tissue development	5/223	163/18670	0.04617	0.3846	0.3534	IBSP/DSPP/LOX/ANO6/GJA1	5
BP	GO:0043624	cellular protein complex disassembly	6/223	217/18670	0.04637	0.3846	0.3534	CAMSAP3/KIF2A/DMTN/MAP1A/VIL1/PEX14	6
BP	GO:0000303	response to superoxide	2/223	29/18670	0.04669	0.3846	0.3534	RGN/MIR21	2
BP	GO:0006929	substrate-dependent cell migration	2/223	29/18670	0.04669	0.3846	0.3534	EPB41L5/CTTN	2
BP	GO:0010575	positive regulation of vascular endothelial growth factor production	2/223	29/18670	0.04669	0.3846	0.3534	SULF1/C3	2
BP	GO:0010644	cell communication by electrical coupling	2/223	29/18670	0.04669	0.3846	0.3534	CALM3/GJA1	2
BP	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	2/223	29/18670	0.04669	0.3846	0.3534	CALM3/EGF	2
BP	GO:0014044	Schwann cell development	2/223	29/18670	0.04669	0.3846	0.3534	SH3TC2/NRG1	2
BP	GO:0021602	cranial nerve morphogenesis	2/223	29/18670	0.04669	0.3846	0.3534	KCNA2/EPHB2	2
BP	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	2/223	29/18670	0.04669	0.3846	0.3534	DAB2/ING2	2
BP	GO:0031114	regulation of microtubule depolymerization	2/223	29/18670	0.04669	0.3846	0.3534	CAMSAP3/MAP1A	2
BP	GO:0032232	negative regulation of actin filament bundle assembly	2/223	29/18670	0.04669	0.3846	0.3534	MIR21/ARHGAP6	2
BP	GO:0044030	regulation of DNA methylation	2/223	29/18670	0.04669	0.3846	0.3534	MIR29C/MIR29B1	2
BP	GO:0045822	negative regulation of heart contraction	2/223	29/18670	0.04669	0.3846	0.3534	PDE5A/SPX	2
BP	GO:0071280	cellular response to copper ion	2/223	29/18670	0.04669	0.3846	0.3534	CYP1A1/SNCA	2
BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	2/223	29/18670	0.04669	0.3846	0.3534	DAB2/ING2	2
BP	GO:0019722	calcium-mediated signaling	6/223	218/18670	0.04723	0.3865	0.3552	CALM3/C10orf71/SELP/NRG1/RGN/DMTN	6
BP	GO:0032271	regulation of protein polymerization	6/223	218/18670	0.04723	0.3865	0.3552	CAMSAP3/CTTN/RHOBTB1/SNCA/DMTN/VIL1	6
BP	GO:0010959	regulation of metal ion transport	9/223	394/18670	0.04765	0.3865	0.3552	CALM3/FHL1/ANO6/EGF/GJA1/MYLK/SNCA/RGN/MIR21	9
BP	GO:0010812	negative regulation of cell-substrate adhesion	3/223	68/18670	0.04783	0.3865	0.3552	MIR29C/DMTN/ARHGAP6	3
BP	GO:0019915	lipid storage	3/223	68/18670	0.04783	0.3865	0.3552	ITGB3/FITM1/C3	3
BP	GO:0030336	negative regulation of cell migration	8/223	334/18670	0.04785	0.3865	0.3552	MIR29C/MIR196A2/NRG1/SULF1/VCL/MIR29B1/MMRN2/MIR21	8
BP	GO:0010633	negative regulation of epithelial cell migration	4/223	114/18670	0.0479	0.3865	0.3552	MIR29C/MIR196A2/MMRN2/MIR21	4
BP	GO:0030282	bone mineralization	4/223	114/18670	0.0479	0.3865	0.3552	IBSP/LOX/ANO6/GJA1	4
BP	GO:0071695	anatomical structure maturation	5/223	165/18670	0.04821	0.3876	0.3562	CDKN1A/ANO6/GJA1/CLN5/C3	5
BP	GO:0010639	negative regulation of organelle organization	9/223	395/18670	0.04827	0.3876	0.3562	CLU/CAMSAP3/RTEL1/PHF23/SNCA/DMTN/VIL1/MIR21/ARHGAP6	9
BP	GO:0040013	negative regulation of locomotion	9/223	396/18670	0.04891	0.3907	0.359	MIR29C/MIR196A2/NRG1/SULF1/RGN/VCL/MIR29B1/MMRN2/MIR21	9
BP	GO:0002526	acute inflammatory response	6/223	220/18670	0.04898	0.3907	0.359	CLU/PROS1/EIF2AK1/ANO6/C3/UGT1A1	6
BP	GO:0008088	axo-dendritic transport	3/223	69/18670	0.04958	0.3907	0.359	TMEM108/KIF4A/MAP1A	3
BP	GO:0000305	response to oxygen radical	2/223	30/18670	0.04964	0.3907	0.359	RGN/MIR21	2
BP	GO:0010743	regulation of macrophage derived foam cell differentiation	2/223	30/18670	0.04964	0.3907	0.359	ITGB3/PF4	2
BP	GO:0042759	long-chain fatty acid biosynthetic process	2/223	30/18670	0.04964	0.3907	0.359	CYP1A1/CYP2E1	2
BP	GO:0097421	liver regeneration	2/223	30/18670	0.04964	0.3907	0.359	SRSF5/RGN	2
BP	GO:1905476	negative regulation of protein localization to membrane	2/223	30/18670	0.04964	0.3907	0.359	DAB2/DMTN	2
BP	GO:0001503	ossification	9/223	398/18670	0.05019	0.394	0.362	SPARC/IBSP/DSPP/LOX/ANO6/GNAS/GJA1/MIR29B1/MIR21	9
BP	GO:1901568	fatty acid derivative metabolic process	5/223	167/18670	0.05029	0.394	0.362	PTGES3/CYP2C18/PTGS1/CYP1A1/CYP2E1	5
BP	GO:0007569	cell aging	4/223	116/18670	0.05048	0.3944	0.3624	CDKN1A/ING2/ARG2/MIR21	4
BP	GO:0045930	negative regulation of mitotic cell cycle	8/223	338/18670	0.05065	0.3948	0.3628	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/MIR29B1/FAP/MIR21	8
BP	GO:0050806	positive regulation of synaptic transmission	5/223	168/18670	0.05135	0.3985	0.3662	IGSF9B/SCGN/NRGN/SNCA/EPHB2	5
BP	GO:0046394	carboxylic acid biosynthetic process	10/223	462/18670	0.05137	0.3985	0.3662	AMACR/UPB1/PTGES3/PLOD2/EGF/PTGS1/CYP1A1/RGN/PRKAA2/CYP2E1	10
BP	GO:0016053	organic acid biosynthetic process	10/223	463/18670	0.05198	0.4023	0.3697	AMACR/UPB1/PTGES3/PLOD2/EGF/PTGS1/CYP1A1/RGN/PRKAA2/CYP2E1	10
BP	GO:0040018	positive regulation of multicellular organism growth	2/223	31/18670	0.05265	0.4045	0.3717	FOXS1/VIL1	2
BP	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	2/223	31/18670	0.05265	0.4045	0.3717	CLU/ING2	2
BP	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	2/223	31/18670	0.05265	0.4045	0.3717	ING2/MIR21	2
BP	GO:1904427	positive regulation of calcium ion transmembrane transport	3/223	71/18670	0.05317	0.4075	0.3745	CALM3/SNCA/RGN	3
BP	GO:0001649	osteoblast differentiation	6/223	225/18670	0.05352	0.4082	0.3751	IBSP/LOX/GNAS/GJA1/MIR29B1/MIR21	6
BP	GO:0033157	regulation of intracellular protein transport	6/223	225/18670	0.05352	0.4082	0.3751	SH3TC2/ABLIM3/HSPA1L/SLC35D3/DMTN/NUTF2	6
BP	GO:0007018	microtubule-based movement	7/223	283/18670	0.05394	0.4095	0.3763	TMEM108/KIF4A/CAMSAP3/KIF2A/MAP1A/ARHGAP21/PEX14	7
BP	GO:0051258	protein polymerization	7/223	283/18670	0.05394	0.4095	0.3763	CAMSAP3/CTTN/RHOBTB1/SNCA/DMTN/VIL1/ARHGAP6	7
BP	GO:0043254	regulation of protein complex assembly	10/223	467/18670	0.05447	0.4095	0.3763	CLU/CAMSAP3/CTTN/SELP/RHOBTB1/SNCA/DMTN/VIL1/PRKAA2/PEX14	10
BP	GO:0031647	regulation of protein stability	7/223	284/18670	0.05477	0.4095	0.3763	CTSA/PTGES3/CLU/CDKN1A/PIM1/CAMLG/SNCA	7
BP	GO:0072593	reactive oxygen species metabolic process	7/223	284/18670	0.05477	0.4095	0.3763	CLU/CDKN1A/CYP1A1/SNCA/RGN/ARG2/MIR21	7
BP	GO:0006305	DNA alkylation	3/223	72/18670	0.05501	0.4095	0.3763	MIR29C/GNAS/MIR29B1	3
BP	GO:0006306	DNA methylation	3/223	72/18670	0.05501	0.4095	0.3763	MIR29C/GNAS/MIR29B1	3
BP	GO:0032272	negative regulation of protein polymerization	3/223	72/18670	0.05501	0.4095	0.3763	SNCA/DMTN/VIL1	3
BP	GO:0006457	protein folding	6/223	227/18670	0.0554	0.4095	0.3763	PTGES3/CLU/GNAZ/HSPA1L/TBCC/HSP90B2P	6
BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	2/223	32/18670	0.05573	0.4095	0.3763	C3/CAV2	2
BP	GO:0045907	positive regulation of vasoconstriction	2/223	32/18670	0.05573	0.4095	0.3763	GJA1/MIR21	2
BP	GO:0046685	response to arsenic-containing substance	2/223	32/18670	0.05573	0.4095	0.3763	CDKN1A/CYP1A1	2
BP	GO:0048741	skeletal muscle fiber development	2/223	32/18670	0.05573	0.4095	0.3763	XK/CAV2	2
BP	GO:0051085	chaperone cofactor-dependent protein refolding	2/223	32/18670	0.05573	0.4095	0.3763	PTGES3/HSPA1L	2
BP	GO:0051385	response to mineralocorticoid	2/223	32/18670	0.05573	0.4095	0.3763	CALM3/CDKN1A	2
BP	GO:1903955	positive regulation of protein targeting to mitochondrion	2/223	32/18670	0.05573	0.4095	0.3763	ABLIM3/HSPA1L	2
BP	GO:0006721	terpenoid metabolic process	4/223	120/18670	0.05586	0.4095	0.3763	CYP2C18/CYP1A1/UGT1A1/CYP2E1	4
BP	GO:0072401	signal transduction involved in DNA integrity checkpoint	3/223	73/18670	0.05688	0.4145	0.3809	CDKN1A/CRADD/MIR21	3
BP	GO:0072422	signal transduction involved in DNA damage checkpoint	3/223	73/18670	0.05688	0.4145	0.3809	CDKN1A/CRADD/MIR21	3
BP	GO:0050808	synapse organization	9/223	408/18670	0.05694	0.4145	0.3809	TMEM108/SPARC/IGSF9B/CTTN/NRG1/POTEKP/C3/SNCA/EPHB2	9
BP	GO:0048638	regulation of developmental growth	8/223	347/18670	0.05733	0.4164	0.3827	CDKN1A/PIM1/ZFYVE27/CTTN/GJA1/FOXS1/MIR29B1/VIL1	8
BP	GO:0019730	antimicrobial humoral response	4/223	122/18670	0.05866	0.4181	0.3842	CLU/PPBP/PF4/ITLN1	4
BP	GO:0072395	signal transduction involved in cell cycle checkpoint	3/223	74/18670	0.05878	0.4181	0.3842	CDKN1A/CRADD/MIR21	3
BP	GO:1903671	negative regulation of sprouting angiogenesis	3/223	74/18670	0.05878	0.4181	0.3842	MIR29C/MIR196A2/MMRN2	3
BP	GO:0010039	response to iron ion	2/223	33/18670	0.05887	0.4181	0.3842	CYP1A1/SNCA	2
BP	GO:0010591	regulation of lamellipodium assembly	2/223	33/18670	0.05887	0.4181	0.3842	MIR196A2/DMTN	2
BP	GO:0048011	neurotrophin TRK receptor signaling pathway	2/223	33/18670	0.05887	0.4181	0.3842	TMEM108/ZFYVE27	2
BP	GO:0051194	positive regulation of cofactor metabolic process	2/223	33/18670	0.05887	0.4181	0.3842	SNCA/PRKAA2	2
BP	GO:1901223	negative regulation of NIK/NF-kappaB signaling	2/223	33/18670	0.05887	0.4181	0.3842	MIR29B1/MIR21	2
BP	GO:1901797	negative regulation of signal transduction by p53 class mediator	2/223	33/18670	0.05887	0.4181	0.3842	ING2/MIR21	2
BP	GO:2001024	negative regulation of response to drug	2/223	33/18670	0.05887	0.4181	0.3842	SNCA/MIR21	2
BP	GO:0007162	negative regulation of cell adhesion	7/223	289/18670	0.05903	0.4183	0.3844	MIR29C/EPB41L5/PDE5A/DMTN/ARG2/MIR21/ARHGAP6	7
BP	GO:0051928	positive regulation of calcium ion transport	4/223	123/18670	0.06009	0.4249	0.3905	CALM3/MYLK/SNCA/RGN	4
BP	GO:0051897	positive regulation of protein kinase B signaling	5/223	176/18670	0.06032	0.4256	0.3911	EGF/BTC/NRG1/PDGFA/MIR21	5
BP	GO:0046486	glycerolipid metabolic process	9/223	414/18670	0.06126	0.4276	0.3929	PITPNM2/PCYT1B/C3/RGN/PDGFA/MIR29B1/PI4K2A/SOCS3/CYP2E1	9
BP	GO:0097305	response to alcohol	6/223	233/18670	0.0613	0.4276	0.3929	CALM3/SPARC/CDKN1A/UGT1A1/PRKAA2/CYP2E1	6
BP	GO:0009164	nucleoside catabolic process	2/223	34/18670	0.06207	0.4276	0.3929	UPB1/UPP2	2
BP	GO:0010922	positive regulation of phosphatase activity	2/223	34/18670	0.06207	0.4276	0.3929	CALM3/RGN	2
BP	GO:0032148	activation of protein kinase B activity	2/223	34/18670	0.06207	0.4276	0.3929	NRG1/MIR21	2
BP	GO:0043094	cellular metabolic compound salvage	2/223	34/18670	0.06207	0.4276	0.3929	GMPR/UPP2	2
BP	GO:0070050	neuron cellular homeostasis	2/223	34/18670	0.06207	0.4276	0.3929	SCGN/MAP1A	2
BP	GO:0070884	regulation of calcineurin-NFAT signaling cascade	2/223	34/18670	0.06207	0.4276	0.3929	C10orf71/NRG1	2
BP	GO:0097009	energy homeostasis	2/223	34/18670	0.06207	0.4276	0.3929	SLC35D3/PRKAA2	2
BP	GO:0106056	regulation of calcineurin-mediated signaling	2/223	34/18670	0.06207	0.4276	0.3929	C10orf71/NRG1	2
BP	GO:0140115	export across plasma membrane	2/223	34/18670	0.06207	0.4276	0.3929	ANO6/MIR21	2
BP	GO:0010950	positive regulation of endopeptidase activity	5/223	178/18670	0.06269	0.43	0.3951	CRADD/SNCA/MIR29B1/CASC2/MIR21	5
BP	GO:0050821	protein stabilization	5/223	178/18670	0.06269	0.43	0.3951	PTGES3/CLU/CDKN1A/PIM1/CAMLG	5
BP	GO:0046777	protein autophosphorylation	6/223	235/18670	0.06335	0.4335	0.3984	CALM3/PIM1/EIF2AK1/CLK1/CLK3/PDGFA	6
BP	GO:0018107	peptidyl-threonine phosphorylation	4/223	126/18670	0.0645	0.4368	0.4014	CALM3/EGF/CLK1/DMTN	4
BP	GO:0006809	nitric oxide biosynthetic process	3/223	77/18670	0.06466	0.4368	0.4014	CLU/RGN/ARG2	3
BP	GO:0051851	modification by host of symbiont morphology or physiology	3/223	77/18670	0.06466	0.4368	0.4014	CALM3/PF4/CAV2	3
BP	GO:0051937	catecholamine transport	3/223	77/18670	0.06466	0.4368	0.4014	KCNA2/SNCA/SYT7	3
BP	GO:0001881	receptor recycling	2/223	35/18670	0.06533	0.4368	0.4014	CAMLG/SNCA	2
BP	GO:0014904	myotube cell development	2/223	35/18670	0.06533	0.4368	0.4014	XK/CAV2	2
BP	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	2/223	35/18670	0.06533	0.4368	0.4014	CAMLG/MAP1A	2
BP	GO:0035909	aorta morphogenesis	2/223	35/18670	0.06533	0.4368	0.4014	MYLK/MIR29B1	2
BP	GO:0051354	negative regulation of oxidoreductase activity	2/223	35/18670	0.06533	0.4368	0.4014	SNCA/MIR21	2
BP	GO:0098801	regulation of renal system process	2/223	35/18670	0.06533	0.4368	0.4014	SPX/GJA1	2
BP	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	2/223	35/18670	0.06533	0.4368	0.4014	CDKN1A/SPDYA	2
BP	GO:0010565	regulation of cellular ketone metabolic process	5/223	181/18670	0.06635	0.4379	0.4024	ODC1/SNCA/RGN/PRKAA2/MIR21	5
BP	GO:0048015	phosphatidylinositol-mediated signaling	5/223	181/18670	0.06635	0.4379	0.4024	PITPNM2/SELP/PDGFA/PEAR1/MIR21	5
BP	GO:0030258	lipid modification	6/223	238/18670	0.06649	0.4379	0.4024	AMACR/CRAT/CYP1A1/PI4K2A/SOCS3/CYP2E1	6
BP	GO:0051048	negative regulation of secretion	6/223	238/18670	0.06649	0.4379	0.4024	SPX/EGF/NRG1/SNCA/ARG2/MIR29B1	6
BP	GO:0042246	tissue regeneration	3/223	78/18670	0.06668	0.4379	0.4024	CDKN1A/GJA1/MIR29B1	3
BP	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	3/223	78/18670	0.06668	0.4379	0.4024	CDKN1A/ING2/MIR21	3
BP	GO:0090398	cellular senescence	3/223	78/18670	0.06668	0.4379	0.4024	CDKN1A/ING2/ARG2	3
BP	GO:0070661	leukocyte proliferation	7/223	298/18670	0.06721	0.4379	0.4024	CLU/CDKN1A/PDE5A/MPL/GJA1/ARG2/MIR21	7
BP	GO:1901342	regulation of vasculature development	9/223	422/18670	0.06733	0.4379	0.4024	SPARC/MIR29C/MIR196A2/PF4/SULF1/C3/MIR29B1/MMRN2/MIR21	9
BP	GO:0010595	positive regulation of endothelial cell migration	4/223	128/18670	0.06752	0.4379	0.4024	SPARC/ITGB3/MIR21/AMOTL1	4
BP	GO:0030041	actin filament polymerization	5/223	182/18670	0.06759	0.4379	0.4024	CTTN/RHOBTB1/DMTN/VIL1/ARHGAP6	5
BP	GO:0000578	embryonic axis specification	2/223	36/18670	0.06865	0.4379	0.4024	EPB41L5/PCSK6	2
BP	GO:0010742	macrophage derived foam cell differentiation	2/223	36/18670	0.06865	0.4379	0.4024	ITGB3/PF4	2
BP	GO:0030947	regulation of vascular endothelial growth factor receptor signaling pathway	2/223	36/18670	0.06865	0.4379	0.4024	ITGB3/MMRN2	2
BP	GO:0046627	negative regulation of insulin receptor signaling pathway	2/223	36/18670	0.06865	0.4379	0.4024	GRB14/SOCS3	2
BP	GO:0071709	membrane assembly	2/223	36/18670	0.06865	0.4379	0.4024	CAV2/EPHB2	2
BP	GO:0090077	foam cell differentiation	2/223	36/18670	0.06865	0.4379	0.4024	ITGB3/PF4	2
BP	GO:0090322	regulation of superoxide metabolic process	2/223	36/18670	0.06865	0.4379	0.4024	RGN/MIR21	2
BP	GO:0097242	amyloid-beta clearance	2/223	36/18670	0.06865	0.4379	0.4024	CLU/C3	2
BP	GO:0021675	nerve development	3/223	79/18670	0.06873	0.4379	0.4024	KCNA2/SULF1/EPHB2	3
BP	GO:0031110	regulation of microtubule polymerization or depolymerization	3/223	79/18670	0.06873	0.4379	0.4024	CAMSAP3/SNCA/MAP1A	3
BP	GO:0043537	negative regulation of blood vessel endothelial cell migration	3/223	79/18670	0.06873	0.4379	0.4024	MIR29C/MIR196A2/MMRN2	3
BP	GO:0071260	cellular response to mechanical stimulus	3/223	79/18670	0.06873	0.4379	0.4024	GJA1/CRADD/MMP7	3
BP	GO:0061136	regulation of proteasomal protein catabolic process	5/223	183/18670	0.06885	0.4379	0.4024	CLU/DAB2/CAMLG/FAM122A/MAP1A	5
BP	GO:0006639	acylglycerol metabolic process	4/223	129/18670	0.06906	0.4379	0.4024	C3/RGN/MIR29B1/CYP2E1	4
BP	GO:0034754	cellular hormone metabolic process	4/223	129/18670	0.06906	0.4379	0.4024	UGT2B11/CYP2C18/CYP1A1/UGT1A1	4
BP	GO:0048017	inositol lipid-mediated signaling	5/223	184/18670	0.07012	0.4438	0.4078	PITPNM2/SELP/PDGFA/PEAR1/MIR21	5
BP	GO:0003156	regulation of animal organ formation	2/223	37/18670	0.07202	0.4495	0.4131	PIM1/SULF1	2
BP	GO:0014037	Schwann cell differentiation	2/223	37/18670	0.07202	0.4495	0.4131	SH3TC2/NRG1	2
BP	GO:0030212	hyaluronan metabolic process	2/223	37/18670	0.07202	0.4495	0.4131	PIM1/EGF	2
BP	GO:0031111	negative regulation of microtubule polymerization or depolymerization	2/223	37/18670	0.07202	0.4495	0.4131	CAMSAP3/SNCA	2
BP	GO:0051084	'de novo' posttranslational protein folding	2/223	37/18670	0.07202	0.4495	0.4131	PTGES3/HSPA1L	2
BP	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	2/223	37/18670	0.07202	0.4495	0.4131	RGN/MIR21	2
BP	GO:2000273	positive regulation of signaling receptor activity	2/223	37/18670	0.07202	0.4495	0.4131	EGF/EPHB2	2
BP	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	3/223	81/18670	0.07291	0.4516	0.415	CLU/DAB2/FAM122A	3
BP	GO:0033238	regulation of cellular amine metabolic process	3/223	81/18670	0.07291	0.4516	0.415	ODC1/SNCA/MIR21	3
BP	GO:1903533	regulation of protein targeting	3/223	81/18670	0.07291	0.4516	0.415	ABLIM3/HSPA1L/DMTN	3
BP	GO:2001021	negative regulation of response to DNA damage stimulus	3/223	81/18670	0.07291	0.4516	0.415	CLU/ING2/RTEL1	3
BP	GO:0006520	cellular amino acid metabolic process	8/223	366/18670	0.0732	0.4525	0.4158	UPB1/ODC1/HGD/PLOD2/PTS/HARS2/ARG2/MIR21	8
BP	GO:0042552	myelination	4/223	132/18670	0.07379	0.4553	0.4183	SH3TC2/XK/CLU/NRG1	4
BP	GO:0046209	nitric oxide metabolic process	3/223	82/18670	0.07504	0.4566	0.4196	CLU/RGN/ARG2	3
BP	GO:0051702	interaction with symbiont	3/223	82/18670	0.07504	0.4566	0.4196	CALM3/PF4/CAV2	3
BP	GO:0071158	positive regulation of cell cycle arrest	3/223	82/18670	0.07504	0.4566	0.4196	CDKN1A/CRADD/FAP	3
BP	GO:0090049	regulation of cell migration involved in sprouting angiogenesis	3/223	82/18670	0.07504	0.4566	0.4196	MIR29C/MIR196A2/MMRN2	3
BP	GO:0032094	response to food	2/223	38/18670	0.07544	0.4566	0.4196	SPX/CYP1A1	2
BP	GO:0051693	actin filament capping	2/223	38/18670	0.07544	0.4566	0.4196	DMTN/VIL1	2
BP	GO:1900077	negative regulation of cellular response to insulin stimulus	2/223	38/18670	0.07544	0.4566	0.4196	GRB14/SOCS3	2
BP	GO:1901021	positive regulation of calcium ion transmembrane transporter activity	2/223	38/18670	0.07544	0.4566	0.4196	CALM3/RGN	2
BP	GO:1903523	negative regulation of blood circulation	2/223	38/18670	0.07544	0.4566	0.4196	PDE5A/SPX	2
BP	GO:2000279	negative regulation of DNA biosynthetic process	2/223	38/18670	0.07544	0.4566	0.4196	GJA1/RGN	2
BP	GO:0007006	mitochondrial membrane organization	4/223	134/18670	0.07703	0.4603	0.423	CALM3/MIR29C/SNCA/MIR29B1	4
BP	GO:0007272	ensheathment of neurons	4/223	134/18670	0.07703	0.4603	0.423	SH3TC2/XK/CLU/NRG1	4
BP	GO:0008366	axon ensheathment	4/223	134/18670	0.07703	0.4603	0.423	SH3TC2/XK/CLU/NRG1	4
BP	GO:0018210	peptidyl-threonine modification	4/223	134/18670	0.07703	0.4603	0.423	CALM3/EGF/CLK1/DMTN	4
BP	GO:0006816	calcium ion transport	9/223	434/18670	0.07714	0.4603	0.423	CALM3/ANO6/EGF/GJA1/MYLK/SNCA/RGN/MCUR1/MIR21	9
BP	GO:0048732	gland development	9/223	434/18670	0.07714	0.4603	0.423	SRSF5/EGF/GJA1/NRG1/SULF1/CYP1A1/UGT1A1/RGN/PDGFA	9
BP	GO:0048145	regulation of fibroblast proliferation	3/223	83/18670	0.0772	0.4603	0.423	CDKN1A/BTC/PDGFA	3
BP	GO:0071277	cellular response to calcium ion	3/223	83/18670	0.0772	0.4603	0.423	DMTN/SYT7/PRKAA2	3
BP	GO:0071248	cellular response to metal ion	5/223	190/18670	0.07801	0.4643	0.4267	CYP1A1/SNCA/DMTN/SYT7/PRKAA2	5
BP	GO:0001889	liver development	4/223	135/18670	0.07867	0.4653	0.4276	SRSF5/CYP1A1/UGT1A1/RGN	4
BP	GO:0038179	neurotrophin signaling pathway	2/223	39/18670	0.07891	0.4653	0.4276	TMEM108/ZFYVE27	2
BP	GO:0042417	dopamine metabolic process	2/223	39/18670	0.07891	0.4653	0.4276	SNCAIP/SNCA	2
BP	GO:0072529	pyrimidine-containing compound catabolic process	2/223	39/18670	0.07891	0.4653	0.4276	UPB1/UPP2	2
BP	GO:1902229	regulation of intrinsic apoptotic signaling pathway in response to DNA damage	2/223	39/18670	0.07891	0.4653	0.4276	CLU/ING2	2
BP	GO:0010507	negative regulation of autophagy	3/223	84/18670	0.07938	0.4655	0.4278	CTSA/PHF23/SNCA	3
BP	GO:0046889	positive regulation of lipid biosynthetic process	3/223	84/18670	0.07938	0.4655	0.4278	CCDC3/RGN/MIR29B1	3
BP	GO:0048144	fibroblast proliferation	3/223	84/18670	0.07938	0.4655	0.4278	CDKN1A/BTC/PDGFA	3
BP	GO:0051098	regulation of binding	8/223	373/18670	0.07966	0.4663	0.4285	CALM3/DAB2/EPB41L5/LOX/EGF/NRG1/CLN5/PEX14	8
BP	GO:0010951	negative regulation of endopeptidase activity	6/223	250/18670	0.07995	0.4672	0.4293	MIR29C/PROS1/SERPINB11/C3/SNCA/VIL1	6
BP	GO:0021537	telencephalon development	6/223	251/18670	0.08114	0.4724	0.4341	TMEM108/EZH1/NRGN/NRG1/EPHB2/GNG12	6
BP	GO:0045637	regulation of myeloid cell differentiation	6/223	251/18670	0.08114	0.4724	0.4341	MYL9/ITGA2B/LOX/MPL/GNAS/PF4	6
BP	GO:0009798	axis specification	3/223	85/18670	0.0816	0.4742	0.4357	MNS1/EPB41L5/PCSK6	3
BP	GO:0072655	establishment of protein localization to mitochondrion	4/223	137/18670	0.08202	0.4755	0.437	CALM3/ABLIM3/HSPA1L/TIMM8B	4
BP	GO:0019835	cytolysis	2/223	40/18670	0.08243	0.4755	0.437	MMD/PF4	2
BP	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	2/223	40/18670	0.08243	0.4755	0.437	CALM3/SNCA	2
BP	GO:0072583	clathrin-dependent endocytosis	2/223	40/18670	0.08243	0.4755	0.437	FCHO1/DAB2	2
BP	GO:0009308	amine metabolic process	4/223	138/18670	0.08372	0.4802	0.4412	ODC1/CYP1A1/SNCA/MIR21	4
BP	GO:0061008	hepaticobiliary system development	4/223	138/18670	0.08372	0.4802	0.4412	SRSF5/CYP1A1/UGT1A1/RGN	4
BP	GO:0006890	retrograde vesicle-mediated transport, Golgi to ER	3/223	86/18670	0.08384	0.4802	0.4412	KIF4A/KIF2A/RAB6B	3
BP	GO:0042058	regulation of epidermal growth factor receptor signaling pathway	3/223	86/18670	0.08384	0.4802	0.4412	EGF/BTC/MIR21	3
BP	GO:0006720	isoprenoid metabolic process	4/223	139/18670	0.08543	0.4819	0.4428	CYP2C18/CYP1A1/UGT1A1/CYP2E1	4
BP	GO:0051588	regulation of neurotransmitter transport	4/223	139/18670	0.08543	0.4819	0.4428	CALM3/ITGB3/SNCAIP/SNCA	4
BP	GO:1901990	regulation of mitotic cell cycle phase transition	9/223	444/18670	0.08594	0.4819	0.4428	MIR29C/CDKN1A/FHL1/CTDSPL/PRKAR2B/CRADD/CYP1A1/MIR29B1/MIR21	9
BP	GO:0006458	'de novo' protein folding	2/223	41/18670	0.086	0.4819	0.4428	PTGES3/HSPA1L	2
BP	GO:0030835	negative regulation of actin filament depolymerization	2/223	41/18670	0.086	0.4819	0.4428	DMTN/VIL1	2
BP	GO:0044091	membrane biogenesis	2/223	41/18670	0.086	0.4819	0.4428	CAV2/EPHB2	2
BP	GO:0044743	protein transmembrane import into intracellular organelle	2/223	41/18670	0.086	0.4819	0.4428	PEX12/PEX14	2
BP	GO:1901381	positive regulation of potassium ion transmembrane transport	2/223	41/18670	0.086	0.4819	0.4428	ANO6/MIR21	2
BP	GO:1903053	regulation of extracellular matrix organization	2/223	41/18670	0.086	0.4819	0.4428	MIR29B1/FAP	2
BP	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	3/223	87/18670	0.0861	0.4819	0.4428	SELP/PDGFA/MIR21	3
BP	GO:0045844	positive regulation of striated muscle tissue development	3/223	87/18670	0.0861	0.4819	0.4428	PIM1/GJA1/NRG1	3
BP	GO:0048636	positive regulation of muscle organ development	3/223	87/18670	0.0861	0.4819	0.4428	PIM1/GJA1/NRG1	3
BP	GO:0051781	positive regulation of cell division	3/223	87/18670	0.0861	0.4819	0.4428	PPBP/BTC/PDGFA	3
BP	GO:0071897	DNA biosynthetic process	5/223	196/18670	0.08636	0.4826	0.4434	PTGES3/CDKN1A/LOX/GJA1/RGN	5
BP	GO:0001837	epithelial to mesenchymal transition	4/223	140/18670	0.08717	0.484	0.4447	DAB2/EPB41L5/MIR29B1/MIR21	4
BP	GO:0042737	drug catabolic process	4/223	140/18670	0.08717	0.484	0.4447	CYP2C18/HGD/SNCA/CYP2E1	4
BP	GO:0060078	regulation of postsynaptic membrane potential	4/223	140/18670	0.08717	0.484	0.4447	TMEM108/IGSF9B/GABRA3/SNCA	4
BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	6/223	256/18670	0.08722	0.484	0.4447	ITGB3/EGF/NRG1/PDGFA/DMTN/SOCS3	6
BP	GO:0010952	positive regulation of peptidase activity	5/223	197/18670	0.0878	0.4862	0.4468	CRADD/SNCA/MIR29B1/CASC2/MIR21	5
BP	GO:0070098	chemokine-mediated signaling pathway	3/223	88/18670	0.08839	0.4862	0.4468	PPBP/MPL/PF4	3
BP	GO:0106027	neuron projection organization	3/223	88/18670	0.08839	0.4862	0.4468	CTTN/MAP1A/EPHB2	3
BP	GO:1900407	regulation of cellular response to oxidative stress	3/223	88/18670	0.08839	0.4862	0.4468	RGN/MIR29B1/MIR21	3
BP	GO:1901863	positive regulation of muscle tissue development	3/223	88/18670	0.08839	0.4862	0.4468	PIM1/GJA1/NRG1	3
BP	GO:0070585	protein localization to mitochondrion	4/223	141/18670	0.08892	0.4883	0.4487	CALM3/ABLIM3/HSPA1L/TIMM8B	4
BP	GO:0045765	regulation of angiogenesis	8/223	383/18670	0.08945	0.4893	0.4496	SPARC/MIR29C/MIR196A2/PF4/SULF1/C3/MMRN2/MIR21	8
BP	GO:0010613	positive regulation of cardiac muscle hypertrophy	2/223	42/18670	0.08961	0.4893	0.4496	PDE5A/MIR21	2
BP	GO:1901031	regulation of response to reactive oxygen species	2/223	42/18670	0.08961	0.4893	0.4496	RGN/MIR21	2
BP	GO:0048285	organelle fission	9/223	449/18670	0.09056	0.4893	0.4496	GGNBP1/KIF4A/ING2/KIF2A/EGF/PHF23/BTC/CAV2/SPDYA	9
BP	GO:0032410	negative regulation of transporter activity	3/223	89/18670	0.09071	0.4893	0.4496	CALM3/SNCA/EPHB2	3
BP	GO:0017038	protein import	5/223	199/18670	0.09071	0.4893	0.4496	CLU/CDKN1A/PEX12/NUTF2/PEX14	5
BP	GO:0090257	regulation of muscle system process	6/223	259/18670	0.09099	0.4893	0.4496	MYL9/CALM3/PDE5A/SPX/CTTN/MIR21	6
BP	GO:0048545	response to steroid hormone	8/223	385/18670	0.09149	0.4893	0.4496	CALM3/SPARC/DAB2/CDKN1A/LOX/HNF4G/RXRB/UGT1A1	8
BP	GO:0006979	response to oxidative stress	9/223	451/18670	0.09245	0.4893	0.4496	NDUFS8/PTGS1/PDLIM1/SNCA/RGN/MIR29B1/PRKAA2/MIR21/CYP2E1	9
BP	GO:0010717	regulation of epithelial to mesenchymal transition	3/223	90/18670	0.09305	0.4893	0.4496	DAB2/MIR29B1/MIR21	3
BP	GO:0046849	bone remodeling	3/223	90/18670	0.09305	0.4893	0.4496	ITGB3/GJA1/SYT7	3
BP	GO:1901379	regulation of potassium ion transmembrane transport	3/223	90/18670	0.09305	0.4893	0.4496	FHL1/ANO6/MIR21	3
BP	GO:0006692	prostanoid metabolic process	2/223	43/18670	0.09327	0.4893	0.4496	PTGES3/PTGS1	2
BP	GO:0006693	prostaglandin metabolic process	2/223	43/18670	0.09327	0.4893	0.4496	PTGES3/PTGS1	2
BP	GO:0014742	positive regulation of muscle hypertrophy	2/223	43/18670	0.09327	0.4893	0.4496	PDE5A/MIR21	2
BP	GO:0032459	regulation of protein oligomerization	2/223	43/18670	0.09327	0.4893	0.4496	CLU/PEX14	2
BP	GO:0033173	calcineurin-NFAT signaling cascade	2/223	43/18670	0.09327	0.4893	0.4496	C10orf71/NRG1	2
BP	GO:0045746	negative regulation of Notch signaling pathway	2/223	43/18670	0.09327	0.4893	0.4496	EGF/PEAR1	2
BP	GO:1901658	glycosyl compound catabolic process	2/223	43/18670	0.09327	0.4893	0.4496	UPB1/UPP2	2
BP	GO:0110053	regulation of actin filament organization	6/223	261/18670	0.09354	0.4893	0.4496	CTTN/RHOBTB1/DMTN/VIL1/MIR21/ARHGAP6	6
BP	GO:0015850	organic hydroxy compound transport	6/223	262/18670	0.09484	0.4893	0.4496	CLU/ITGB3/EGF/KCNA2/SNCA/SYT7	6
BP	GO:0014909	smooth muscle cell migration	3/223	91/18670	0.09542	0.4893	0.4496	ITGB3/PDGFA/MIR21	3
BP	GO:0030510	regulation of BMP signaling pathway	3/223	91/18670	0.09542	0.4893	0.4496	PCSK6/SULF1/RBPMS2	3
BP	GO:0045639	positive regulation of myeloid cell differentiation	3/223	91/18670	0.09542	0.4893	0.4496	MPL/GNAS/PF4	3
BP	GO:0007612	learning	4/223	145/18670	0.09609	0.4893	0.4496	PRKAR2B/NRGN/MAP1A/EPHB2	4
BP	GO:0030278	regulation of ossification	5/223	203/18670	0.09668	0.4893	0.4496	ANO6/GNAS/GJA1/MIR29B1/MIR21	5
BP	GO:0007212	dopamine receptor signaling pathway	2/223	44/18670	0.09698	0.4893	0.4496	GNAS/CAV2	2
BP	GO:0010828	positive regulation of glucose transmembrane transport	2/223	44/18670	0.09698	0.4893	0.4496	C3/ITLN1	2
BP	GO:0030225	macrophage differentiation	2/223	44/18670	0.09698	0.4893	0.4496	EIF2AK1/PF4	2
BP	GO:0046688	response to copper ion	2/223	44/18670	0.09698	0.4893	0.4496	CYP1A1/SNCA	2
BP	GO:0061756	leukocyte adhesion to vascular endothelial cell	2/223	44/18670	0.09698	0.4893	0.4496	SELP/MIR21	2
BP	GO:0090311	regulation of protein deacetylation	2/223	44/18670	0.09698	0.4893	0.4496	ING2/PRKAA2	2
BP	GO:1903214	regulation of protein targeting to mitochondrion	2/223	44/18670	0.09698	0.4893	0.4496	ABLIM3/HSPA1L	2
BP	GO:0140014	mitotic nuclear division	6/223	264/18670	0.09746	0.4893	0.4496	KIF4A/KIF2A/EGF/PHF23/BTC/CAV2	6
BP	GO:0051384	response to glucocorticoid	4/223	146/18670	0.09792	0.4893	0.4496	CALM3/SPARC/CDKN1A/UGT1A1	4
BP	GO:0097164	ammonium ion metabolic process	5/223	205/18670	0.09973	0.4893	0.4496	ODC1/PCYT1B/CRAT/SNCAIP/SNCA	5
BP	GO:0033273	response to vitamin	3/223	93/18670	0.1002	0.4893	0.4496	SPARC/PIM1/CYP1A1	3
BP	GO:0032984	protein-containing complex disassembly	7/223	329/18670	0.1004	0.4893	0.4496	CAMSAP3/KIF2A/PHF23/DMTN/MAP1A/VIL1/PEX14	7
BP	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	2/223	45/18670	0.1007	0.4893	0.4496	CDKN1A/ING2	2
BP	GO:0051235	maintenance of location	7/223	330/18670	0.1016	0.4893	0.4496	CALM3/ITGB3/FITM1/LTBP1/C3/SNCA/ARHGAP21	7
BP	GO:0014065	phosphatidylinositol 3-kinase signaling	4/223	148/18670	0.1016	0.4893	0.4496	SELP/PDGFA/PEAR1/MIR21	4
BP	GO:0006906	vesicle fusion	3/223	94/18670	0.1027	0.4893	0.4496	SNCA/CAV2/SYT7	3
BP	GO:0044728	DNA methylation or demethylation	3/223	94/18670	0.1027	0.4893	0.4496	MIR29C/GNAS/MIR29B1	3
BP	GO:0008202	steroid metabolic process	7/223	331/18670	0.1028	0.4893	0.4496	UGT2B11/AMACR/CYP1A1/UGT1A1/FAXDC2/PRKAA2/CYP2E1	7
BP	GO:0022898	regulation of transmembrane transporter activity	6/223	268/18670	0.1028	0.4893	0.4496	CALM3/FHL1/GJA1/SNCA/RGN/EPHB2	6
BP	GO:0099003	vesicle-mediated transport in synapse	5/223	207/18670	0.1028	0.4893	0.4496	CALM3/ITGB3/POTEKP/SNCA/SYT7	5
BP	GO:0008277	regulation of G protein-coupled receptor signaling pathway	4/223	149/18670	0.1035	0.4893	0.4496	ARR3/C3/SNCA/CAV2	4
BP	GO:0050670	regulation of lymphocyte proliferation	5/223	208/18670	0.1044	0.4893	0.4496	CDKN1A/PDE5A/MPL/ARG2/MIR21	5
BP	GO:0001504	neurotransmitter uptake	2/223	46/18670	0.1045	0.4893	0.4496	ITGB3/SNCA	2
BP	GO:0032369	negative regulation of lipid transport	2/223	46/18670	0.1045	0.4893	0.4496	ITGB3/EGF	2
BP	GO:0097720	calcineurin-mediated signaling	2/223	46/18670	0.1045	0.4893	0.4496	C10orf71/NRG1	2
BP	GO:0051952	regulation of amine transport	3/223	95/18670	0.1051	0.4893	0.4496	KCNA2/SNCA/SYT7	3
BP	GO:1903076	regulation of protein localization to plasma membrane	3/223	95/18670	0.1051	0.4893	0.4496	DAB2/VIL1/EPHB2	3
BP	GO:0008154	actin polymerization or depolymerization	5/223	209/18670	0.106	0.4893	0.4496	CTTN/RHOBTB1/DMTN/VIL1/ARHGAP6	5
BP	GO:0032944	regulation of mononuclear cell proliferation	5/223	209/18670	0.106	0.4893	0.4496	CDKN1A/PDE5A/MPL/ARG2/MIR21	5
BP	GO:0071902	positive regulation of protein serine/threonine kinase activity	7/223	334/18670	0.1064	0.4893	0.4496	CALM3/PDE5A/EGF/NRG1/SNCA/PDGFA/SPDYA	7
BP	GO:1903169	regulation of calcium ion transmembrane transport	4/223	151/18670	0.1073	0.4893	0.4496	CALM3/SNCA/RGN/MIR21	4
BP	GO:0019217	regulation of fatty acid metabolic process	3/223	96/18670	0.1076	0.4893	0.4496	SNCA/RGN/PRKAA2	3
BP	GO:0048010	vascular endothelial growth factor receptor signaling pathway	3/223	96/18670	0.1076	0.4893	0.4496	ITGB3/SULF1/MMRN2	3
BP	GO:0046651	lymphocyte proliferation	6/223	272/18670	0.1083	0.4893	0.4496	CDKN1A/PDE5A/MPL/GJA1/ARG2/MIR21	6
BP	GO:0002832	negative regulation of response to biotic stimulus	2/223	47/18670	0.1083	0.4893	0.4496	SIGLEC11/ARG2	2
BP	GO:0030574	collagen catabolic process	2/223	47/18670	0.1083	0.4893	0.4496	MMP7/FAP	2
BP	GO:0031952	regulation of protein autophosphorylation	2/223	47/18670	0.1083	0.4893	0.4496	CALM3/PDGFA	2
BP	GO:0042551	neuron maturation	2/223	47/18670	0.1083	0.4893	0.4496	CLN5/C3	2
BP	GO:0016202	regulation of striated muscle tissue development	4/223	152/18670	0.1093	0.4893	0.4496	PIM1/LOX/GJA1/NRG1	4
BP	GO:0032231	regulation of actin filament bundle assembly	3/223	97/18670	0.1101	0.4893	0.4496	VIL1/MIR21/ARHGAP6	3
BP	GO:0044773	mitotic DNA damage checkpoint	3/223	97/18670	0.1101	0.4893	0.4496	CDKN1A/CRADD/MIR21	3
BP	GO:1902882	regulation of response to oxidative stress	3/223	97/18670	0.1101	0.4893	0.4496	RGN/MIR29B1/MIR21	3
BP	GO:0032943	mononuclear cell proliferation	6/223	274/18670	0.1111	0.4893	0.4496	CDKN1A/PDE5A/MPL/GJA1/ARG2/MIR21	6
BP	GO:0042133	neurotransmitter metabolic process	4/223	153/18670	0.1112	0.4893	0.4496	UPB1/CLU/RGN/ARG2	4
BP	GO:0062013	positive regulation of small molecule metabolic process	4/223	153/18670	0.1112	0.4893	0.4496	EGF/SNCA/RGN/PRKAA2	4
BP	GO:0090316	positive regulation of intracellular protein transport	4/223	153/18670	0.1112	0.4893	0.4496	ABLIM3/HSPA1L/SLC35D3/NUTF2	4
BP	GO:0001774	microglial cell activation	2/223	48/18670	0.1122	0.4893	0.4496	CLU/SNCA	2
BP	GO:0002269	leukocyte activation involved in inflammatory response	2/223	48/18670	0.1122	0.4893	0.4496	CLU/SNCA	2
BP	GO:0007140	male meiotic nuclear division	2/223	48/18670	0.1122	0.4893	0.4496	ING2/SPDYA	2
BP	GO:0008089	anterograde axonal transport	2/223	48/18670	0.1122	0.4893	0.4496	KIF4A/MAP1A	2
BP	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	2/223	48/18670	0.1122	0.4893	0.4496	EGF/BTC	2
BP	GO:0051150	regulation of smooth muscle cell differentiation	2/223	48/18670	0.1122	0.4893	0.4496	RBPMS2/MIR21	2
BP	GO:0101023	vascular endothelial cell proliferation	2/223	48/18670	0.1122	0.4893	0.4496	MIR29C/MIR21	2
BP	GO:1905562	regulation of vascular endothelial cell proliferation	2/223	48/18670	0.1122	0.4893	0.4496	MIR29C/MIR21	2
BP	GO:2000059	negative regulation of ubiquitin-dependent protein catabolic process	2/223	48/18670	0.1122	0.4893	0.4496	CAMLG/MAP1A	2
BP	GO:0002042	cell migration involved in sprouting angiogenesis	3/223	98/18670	0.1127	0.4893	0.4496	MIR29C/MIR196A2/MMRN2	3
BP	GO:0006626	protein targeting to mitochondrion	3/223	98/18670	0.1127	0.4893	0.4496	ABLIM3/HSPA1L/TIMM8B	3
BP	GO:0030038	contractile actin filament bundle assembly	3/223	98/18670	0.1127	0.4893	0.4496	ITGB5/MIR21/ARHGAP6	3
BP	GO:0043149	stress fiber assembly	3/223	98/18670	0.1127	0.4893	0.4496	ITGB5/MIR21/ARHGAP6	3
BP	GO:0050764	regulation of phagocytosis	3/223	98/18670	0.1127	0.4893	0.4496	ANO6/C3/SYT7	3
BP	GO:0060191	regulation of lipase activity	3/223	98/18670	0.1127	0.4893	0.4496	PCSK6/SNCA/ARHGAP6	3
BP	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	3/223	98/18670	0.1127	0.4893	0.4496	CLU/ING2/MIR21	3
BP	GO:0001840	neural plate development	1/223	10/18670	0.1132	0.4893	0.4496	EPB41L5	1
BP	GO:0006222	UMP biosynthetic process	1/223	10/18670	0.1132	0.4893	0.4496	UPP2	1
BP	GO:0006570	tyrosine metabolic process	1/223	10/18670	0.1132	0.4893	0.4496	HGD	1
BP	GO:0006930	substrate-dependent cell migration, cell extension	1/223	10/18670	0.1132	0.4893	0.4496	CTTN	1
BP	GO:0006971	hypotonic response	1/223	10/18670	0.1132	0.4893	0.4496	MYLK	1
BP	GO:0007191	adenylate cyclase-activating dopamine receptor signaling pathway	1/223	10/18670	0.1132	0.4893	0.4496	GNAS	1
BP	GO:0007440	foregut morphogenesis	1/223	10/18670	0.1132	0.4893	0.4496	EPB41L5	1
BP	GO:0009173	pyrimidine ribonucleoside monophosphate metabolic process	1/223	10/18670	0.1132	0.4893	0.4496	UPP2	1
BP	GO:0009174	pyrimidine ribonucleoside monophosphate biosynthetic process	1/223	10/18670	0.1132	0.4893	0.4496	UPP2	1
BP	GO:0010749	regulation of nitric oxide mediated signal transduction	1/223	10/18670	0.1132	0.4893	0.4496	PDE5A	1
BP	GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation	1/223	10/18670	0.1132	0.4893	0.4496	EIF2AK1	1
BP	GO:0016102	diterpenoid biosynthetic process	1/223	10/18670	0.1132	0.4893	0.4496	CYP1A1	1
BP	GO:0021924	cell proliferation in external granule layer	1/223	10/18670	0.1132	0.4893	0.4496	EGF	1
BP	GO:0021930	cerebellar granule cell precursor proliferation	1/223	10/18670	0.1132	0.4893	0.4496	EGF	1
BP	GO:0021936	regulation of cerebellar granule cell precursor proliferation	1/223	10/18670	0.1132	0.4893	0.4496	EGF	1
BP	GO:0032464	positive regulation of protein homooligomerization	1/223	10/18670	0.1132	0.4893	0.4496	CLU	1
BP	GO:0032525	somite rostral/caudal axis specification	1/223	10/18670	0.1132	0.4893	0.4496	EPB41L5	1
BP	GO:0032836	glomerular basement membrane development	1/223	10/18670	0.1132	0.4893	0.4496	SULF1	1
BP	GO:0035672	oligopeptide transmembrane transport	1/223	10/18670	0.1132	0.4893	0.4496	SLC15A5	1
BP	GO:0044539	long-chain fatty acid import	1/223	10/18670	0.1132	0.4893	0.4496	SPX	1
BP	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	1/223	10/18670	0.1132	0.4893	0.4496	ITGB3	1
BP	GO:0045741	positive regulation of epidermal growth factor-activated receptor activity	1/223	10/18670	0.1132	0.4893	0.4496	EGF	1
BP	GO:0045988	negative regulation of striated muscle contraction	1/223	10/18670	0.1132	0.4893	0.4496	PDE5A	1
BP	GO:0046049	UMP metabolic process	1/223	10/18670	0.1132	0.4893	0.4496	UPP2	1
BP	GO:0046642	negative regulation of alpha-beta T cell proliferation	1/223	10/18670	0.1132	0.4893	0.4496	ARG2	1
BP	GO:0051014	actin filament severing	1/223	10/18670	0.1132	0.4893	0.4496	VIL1	1
BP	GO:0051231	spindle elongation	1/223	10/18670	0.1132	0.4893	0.4496	KIF4A	1
BP	GO:0051255	spindle midzone assembly	1/223	10/18670	0.1132	0.4893	0.4496	KIF4A	1
BP	GO:0060281	regulation of oocyte development	1/223	10/18670	0.1132	0.4893	0.4496	PDE5A	1
BP	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	1/223	10/18670	0.1132	0.4893	0.4496	GJA1	1
BP	GO:0060513	prostatic bud formation	1/223	10/18670	0.1132	0.4893	0.4496	SULF1	1
BP	GO:0070091	glucagon secretion	1/223	10/18670	0.1132	0.4893	0.4496	SYT7	1
BP	GO:0071609	chemokine (C-C motif) ligand 5 production	1/223	10/18670	0.1132	0.4893	0.4496	ARG2	1
BP	GO:0097278	complement-dependent cytotoxicity	1/223	10/18670	0.1132	0.4893	0.4496	C3	1
BP	GO:0098722	asymmetric stem cell division	1/223	10/18670	0.1132	0.4893	0.4496	ING2	1
BP	GO:1901033	positive regulation of response to reactive oxygen species	1/223	10/18670	0.1132	0.4893	0.4496	RGN	1
BP	GO:1902033	regulation of hematopoietic stem cell proliferation	1/223	10/18670	0.1132	0.4893	0.4496	PIM1	1
BP	GO:1904684	negative regulation of metalloendopeptidase activity	1/223	10/18670	0.1132	0.4893	0.4496	MIR29C	1
BP	GO:1905879	regulation of oogenesis	1/223	10/18670	0.1132	0.4893	0.4496	PDE5A	1
BP	GO:1990416	cellular response to brain-derived neurotrophic factor stimulus	1/223	10/18670	0.1132	0.4893	0.4496	TMEM108	1
BP	GO:1990535	neuron projection maintenance	1/223	10/18670	0.1132	0.4893	0.4496	MAP1A	1
BP	GO:2000425	regulation of apoptotic cell clearance	1/223	10/18670	0.1132	0.4893	0.4496	C3	1
BP	GO:2000480	negative regulation of cAMP-dependent protein kinase activity	1/223	10/18670	0.1132	0.4893	0.4496	PRKAR2B	1
BP	GO:2000665	regulation of interleukin-13 secretion	1/223	10/18670	0.1132	0.4893	0.4496	ARG2	1
BP	GO:1901861	regulation of muscle tissue development	4/223	155/18670	0.1151	0.4893	0.4496	PIM1/LOX/GJA1/NRG1	4
BP	GO:0030838	positive regulation of actin filament polymerization	3/223	99/18670	0.1152	0.4893	0.4496	CTTN/RHOBTB1/VIL1	3
BP	GO:0000280	nuclear division	8/223	407/18670	0.1157	0.4893	0.4496	KIF4A/ING2/KIF2A/EGF/PHF23/BTC/CAV2/SPDYA	8
BP	GO:0019935	cyclic-nucleotide-mediated signaling	5/223	215/18670	0.1157	0.4893	0.4496	CALM3/PRKAR2B/GNAS/PF4/MC2R	5
BP	GO:0032388	positive regulation of intracellular transport	5/223	215/18670	0.1157	0.4893	0.4496	ABLIM3/DAB2/HSPA1L/SLC35D3/NUTF2	5
BP	GO:0003254	regulation of membrane depolarization	2/223	49/18670	0.1161	0.4893	0.4496	FHL1/GJA1	2
BP	GO:0010712	regulation of collagen metabolic process	2/223	49/18670	0.1161	0.4893	0.4496	MIR29B1/FAP	2
BP	GO:0034260	negative regulation of GTPase activity	2/223	49/18670	0.1161	0.4893	0.4496	RGN/MIR21	2
BP	GO:0048546	digestive tract morphogenesis	2/223	49/18670	0.1161	0.4893	0.4496	EPB41L5/RBPMS2	2
BP	GO:1904062	regulation of cation transmembrane transport	7/223	342/18670	0.1165	0.4893	0.4496	CALM3/FHL1/ANO6/SNCA/RGN/EPHB2/MIR21	7
BP	GO:0043535	regulation of blood vessel endothelial cell migration	4/223	156/18670	0.1171	0.4893	0.4496	MIR29C/MIR196A2/MMRN2/AMOTL1	4
BP	GO:0045216	cell-cell junction organization	4/223	156/18670	0.1171	0.4893	0.4496	CAMSAP3/GJA1/ESAM/VCL	4
BP	GO:0048634	regulation of muscle organ development	4/223	156/18670	0.1171	0.4893	0.4496	PIM1/LOX/GJA1/NRG1	4
BP	GO:0030301	cholesterol transport	3/223	100/18670	0.1178	0.4893	0.4496	CLU/EGF/SYT7	3
BP	GO:0055024	regulation of cardiac muscle tissue development	3/223	100/18670	0.1178	0.4893	0.4496	PIM1/GJA1/NRG1	3
BP	GO:0090174	organelle membrane fusion	3/223	100/18670	0.1178	0.4893	0.4496	SNCA/CAV2/SYT7	3
BP	GO:0032956	regulation of actin cytoskeleton organization	7/223	343/18670	0.1178	0.4893	0.4496	CTTN/RHOBTB1/PDGFA/DMTN/VIL1/MIR21/ARHGAP6	7
BP	GO:0072330	monocarboxylic acid biosynthetic process	7/223	343/18670	0.1178	0.4893	0.4496	AMACR/PTGES3/PTGS1/CYP1A1/RGN/PRKAA2/CYP2E1	7
BP	GO:0043393	regulation of protein binding	5/223	217/18670	0.1191	0.4893	0.4496	DAB2/EPB41L5/LOX/NRG1/PEX14	5
BP	GO:0071241	cellular response to inorganic substance	5/223	217/18670	0.1191	0.4893	0.4496	CYP1A1/SNCA/DMTN/SYT7/PRKAA2	5
BP	GO:0030509	BMP signaling pathway	4/223	157/18670	0.1191	0.4893	0.4496	PCSK6/SULF1/RBPMS2/MIR21	4
BP	GO:1905952	regulation of lipid localization	4/223	157/18670	0.1191	0.4893	0.4496	ITGB3/FITM1/EGF/C3	4
BP	GO:0007517	muscle organ development	8/223	410/18670	0.1192	0.4893	0.4496	XK/FHL1/PIM1/LOX/GJA1/NRG1/MYLK/CAV2	8
BP	GO:0009948	anterior/posterior axis specification	2/223	50/18670	0.12	0.4893	0.4496	EPB41L5/PCSK6	2
BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	2/223	50/18670	0.12	0.4893	0.4496	DAB2/MIR21	2
BP	GO:0031113	regulation of microtubule polymerization	2/223	50/18670	0.12	0.4893	0.4496	CAMSAP3/SNCA	2
BP	GO:0034656	nucleobase-containing small molecule catabolic process	2/223	50/18670	0.12	0.4893	0.4496	UPB1/UPP2	2
BP	GO:0046854	phosphatidylinositol phosphorylation	2/223	50/18670	0.12	0.4893	0.4496	PI4K2A/SOCS3	2
BP	GO:0031532	actin cytoskeleton reorganization	3/223	101/18670	0.1204	0.4893	0.4496	CTTN/RHOBTB1/DMTN	3
BP	GO:0016482	cytosolic transport	4/223	158/18670	0.1212	0.4893	0.4496	DAB2/RAB6B/CLN5/SYT7	4
BP	GO:1901987	regulation of cell cycle phase transition	9/223	480/18670	0.1224	0.4893	0.4496	MIR29C/CDKN1A/FHL1/CTDSPL/PRKAR2B/CRADD/CYP1A1/MIR29B1/MIR21	9
BP	GO:0048762	mesenchymal cell differentiation	5/223	219/18670	0.1225	0.4893	0.4496	DAB2/EPB41L5/NRG1/MIR29B1/MIR21	5
BP	GO:0015837	amine transport	3/223	102/18670	0.123	0.4893	0.4496	KCNA2/SNCA/SYT7	3
BP	GO:0098869	cellular oxidant detoxification	3/223	102/18670	0.123	0.4893	0.4496	PTGS1/RGN/MIR21	3
BP	GO:0000050	urea cycle	1/223	11/18670	0.1238	0.4893	0.4496	ARG2	1
BP	GO:0001778	plasma membrane repair	1/223	11/18670	0.1238	0.4893	0.4496	SYT7	1
BP	GO:0003093	regulation of glomerular filtration	1/223	11/18670	0.1238	0.4893	0.4496	GJA1	1
BP	GO:0003264	regulation of cardioblast proliferation	1/223	11/18670	0.1238	0.4893	0.4496	PIM1	1
BP	GO:0006558	L-phenylalanine metabolic process	1/223	11/18670	0.1238	0.4893	0.4496	HGD	1
BP	GO:0006559	L-phenylalanine catabolic process	1/223	11/18670	0.1238	0.4893	0.4496	HGD	1
BP	GO:0006853	carnitine shuttle	1/223	11/18670	0.1238	0.4893	0.4496	PRKAA2	1
BP	GO:0006857	oligopeptide transport	1/223	11/18670	0.1238	0.4893	0.4496	SLC15A5	1
BP	GO:0008655	pyrimidine-containing compound salvage	1/223	11/18670	0.1238	0.4893	0.4496	UPP2	1
BP	GO:0009629	response to gravity	1/223	11/18670	0.1238	0.4893	0.4496	SPARC	1
BP	GO:0014820	tonic smooth muscle contraction	1/223	11/18670	0.1238	0.4893	0.4496	MYLK	1
BP	GO:0016264	gap junction assembly	1/223	11/18670	0.1238	0.4893	0.4496	GJA1	1
BP	GO:0018095	protein polyglutamylation	1/223	11/18670	0.1238	0.4893	0.4496	TTLL7	1
BP	GO:0019852	L-ascorbic acid metabolic process	1/223	11/18670	0.1238	0.4893	0.4496	RGN	1
BP	GO:0021534	cell proliferation in hindbrain	1/223	11/18670	0.1238	0.4893	0.4496	EGF	1
BP	GO:0021604	cranial nerve structural organization	1/223	11/18670	0.1238	0.4893	0.4496	KCNA2	1
BP	GO:0030422	production of siRNA involved in RNA interference	1/223	11/18670	0.1238	0.4893	0.4496	TSNAX	1
BP	GO:0031915	positive regulation of synaptic plasticity	1/223	11/18670	0.1238	0.4893	0.4496	EPHB2	1
BP	GO:0035404	histone-serine phosphorylation	1/223	11/18670	0.1238	0.4893	0.4496	PRKAA2	1
BP	GO:0035739	CD4-positive, alpha-beta T cell proliferation	1/223	11/18670	0.1238	0.4893	0.4496	ARG2	1
BP	GO:0036444	calcium import into the mitochondrion	1/223	11/18670	0.1238	0.4893	0.4496	MCUR1	1
BP	GO:0043097	pyrimidine nucleoside salvage	1/223	11/18670	0.1238	0.4893	0.4496	UPP2	1
BP	GO:0045217	cell-cell junction maintenance	1/223	11/18670	0.1238	0.4893	0.4496	CAMSAP3	1
BP	GO:0046501	protoporphyrinogen IX metabolic process	1/223	11/18670	0.1238	0.4893	0.4496	EIF2AK1	1
BP	GO:0051561	positive regulation of mitochondrial calcium ion concentration	1/223	11/18670	0.1238	0.4893	0.4496	MCUR1	1
BP	GO:0051583	dopamine uptake involved in synaptic transmission	1/223	11/18670	0.1238	0.4893	0.4496	SNCA	1
BP	GO:0051934	catecholamine uptake involved in synaptic transmission	1/223	11/18670	0.1238	0.4893	0.4496	SNCA	1
BP	GO:0060159	regulation of dopamine receptor signaling pathway	1/223	11/18670	0.1238	0.4893	0.4496	CAV2	1
BP	GO:0060315	negative regulation of ryanodine-sensitive calcium-release channel activity	1/223	11/18670	0.1238	0.4893	0.4496	CALM3	1
BP	GO:0060379	cardiac muscle cell myoblast differentiation	1/223	11/18670	0.1238	0.4893	0.4496	NRG1	1
BP	GO:0072611	interleukin-13 secretion	1/223	11/18670	0.1238	0.4893	0.4496	ARG2	1
BP	GO:0090042	tubulin deacetylation	1/223	11/18670	0.1238	0.4893	0.4496	PRKAA2	1
BP	GO:0090657	telomeric loop disassembly	1/223	11/18670	0.1238	0.4893	0.4496	RTEL1	1
BP	GO:0098883	synapse pruning	1/223	11/18670	0.1238	0.4893	0.4496	C3	1
BP	GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization	1/223	11/18670	0.1238	0.4893	0.4496	ITGB3	1
BP	GO:1900115	extracellular regulation of signal transduction	1/223	11/18670	0.1238	0.4893	0.4496	LTBP1	1
BP	GO:1900116	extracellular negative regulation of signal transduction	1/223	11/18670	0.1238	0.4893	0.4496	LTBP1	1
BP	GO:1901096	regulation of autophagosome maturation	1/223	11/18670	0.1238	0.4893	0.4496	PHF23	1
BP	GO:1901201	regulation of extracellular matrix assembly	1/223	11/18670	0.1238	0.4893	0.4496	MIR29B1	1
BP	GO:1901894	regulation of calcium-transporting ATPase activity	1/223	11/18670	0.1238	0.4893	0.4496	RGN	1
BP	GO:1902221	erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process	1/223	11/18670	0.1238	0.4893	0.4496	HGD	1
BP	GO:1902222	erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process	1/223	11/18670	0.1238	0.4893	0.4496	HGD	1
BP	GO:1902946	protein localization to early endosome	1/223	11/18670	0.1238	0.4893	0.4496	EGF	1
BP	GO:1903011	negative regulation of bone development	1/223	11/18670	0.1238	0.4893	0.4496	RGN	1
BP	GO:1904468	negative regulation of tumor necrosis factor secretion	1/223	11/18670	0.1238	0.4893	0.4496	ARG2	1
BP	GO:1905383	protein localization to presynapse	1/223	11/18670	0.1238	0.4893	0.4496	MAP1A	1
BP	GO:1905668	positive regulation of protein localization to endosome	1/223	11/18670	0.1238	0.4893	0.4496	EGF	1
BP	GO:2000318	positive regulation of T-helper 17 type immune response	1/223	11/18670	0.1238	0.4893	0.4496	MIR21	1
BP	GO:2000392	regulation of lamellipodium morphogenesis	1/223	11/18670	0.1238	0.4893	0.4496	VIL1	1
BP	GO:2000561	regulation of CD4-positive, alpha-beta T cell proliferation	1/223	11/18670	0.1238	0.4893	0.4496	ARG2	1
BP	GO:0006213	pyrimidine nucleoside metabolic process	2/223	51/18670	0.124	0.4893	0.4496	UPB1/UPP2	2
BP	GO:0021545	cranial nerve development	2/223	51/18670	0.124	0.4893	0.4496	KCNA2/EPHB2	2
BP	GO:0030834	regulation of actin filament depolymerization	2/223	51/18670	0.124	0.4893	0.4496	DMTN/VIL1	2
BP	GO:0032007	negative regulation of TOR signaling	2/223	51/18670	0.124	0.4893	0.4496	TNFAIP8L1/PRKAA2	2
BP	GO:2001258	negative regulation of cation channel activity	2/223	51/18670	0.124	0.4893	0.4496	CALM3/EPHB2	2
BP	GO:0032409	regulation of transporter activity	6/223	283/18670	0.1242	0.4893	0.4496	CALM3/FHL1/GJA1/SNCA/RGN/EPHB2	6
BP	GO:0018958	phenol-containing compound metabolic process	3/223	103/18670	0.1256	0.4893	0.4496	SNCAIP/SNCA/CYP2E1	3
BP	GO:0032091	negative regulation of protein binding	3/223	103/18670	0.1256	0.4893	0.4496	DAB2/EPB41L5/PEX14	3
BP	GO:0034765	regulation of ion transmembrane transport	9/223	483/18670	0.1258	0.4893	0.4496	CALM3/FHL1/ANO6/KCNA2/GJA1/SNCA/RGN/EPHB2/MIR21	9
BP	GO:0070838	divalent metal ion transport	9/223	483/18670	0.1258	0.4893	0.4496	CALM3/ANO6/EGF/GJA1/MYLK/SNCA/RGN/MCUR1/MIR21	9
BP	GO:0030099	myeloid cell differentiation	8/223	416/18670	0.1265	0.4893	0.4496	MYL9/ITGA2B/LOX/EIF2AK1/MPL/GNAS/PF4/DMTN	8
BP	GO:0016049	cell growth	9/223	484/18670	0.1269	0.4893	0.4496	TMEM108/EPB41L5/CDKN1A/FHL1/ZFYVE27/CTTN/GJA1/FAM122A/VCL	9
BP	GO:0022604	regulation of cell morphogenesis	9/223	484/18670	0.1269	0.4893	0.4496	SPARC/XK/MPL/ZFYVE27/CTTN/DMTN/VIL1/EPHB2/MIR21	9
BP	GO:0070663	regulation of leukocyte proliferation	5/223	222/18670	0.1276	0.4893	0.4496	CDKN1A/PDE5A/MPL/ARG2/MIR21	5
BP	GO:1901605	alpha-amino acid metabolic process	5/223	222/18670	0.1276	0.4893	0.4496	ODC1/HGD/PLOD2/ARG2/MIR21	5
BP	GO:0048168	regulation of neuronal synaptic plasticity	2/223	52/18670	0.1279	0.4893	0.4496	SNCA/EPHB2	2
BP	GO:2000772	regulation of cellular senescence	2/223	52/18670	0.1279	0.4893	0.4496	ING2/ARG2	2
BP	GO:0001523	retinoid metabolic process	3/223	104/18670	0.1283	0.4893	0.4496	CYP2C18/CYP1A1/UGT1A1	3
BP	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	3/223	104/18670	0.1283	0.4893	0.4496	CLU/CDKN1A/ING2	3
BP	GO:0010923	negative regulation of phosphatase activity	3/223	104/18670	0.1283	0.4893	0.4496	CAMSAP3/FAM122A/RGN	3
BP	GO:0014812	muscle cell migration	3/223	104/18670	0.1283	0.4893	0.4496	ITGB3/PDGFA/MIR21	3
BP	GO:0032414	positive regulation of ion transmembrane transporter activity	3/223	104/18670	0.1283	0.4893	0.4496	CALM3/RGN/EPHB2	3
BP	GO:0046928	regulation of neurotransmitter secretion	3/223	104/18670	0.1283	0.4893	0.4496	CALM3/SNCAIP/SNCA	3
BP	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3/223	104/18670	0.1283	0.4893	0.4496	DAB2/ING2/SULF1	3
BP	GO:1901800	positive regulation of proteasomal protein catabolic process	3/223	104/18670	0.1283	0.4893	0.4496	CLU/DAB2/FAM122A	3
BP	GO:0030833	regulation of actin filament polymerization	4/223	162/18670	0.1294	0.4893	0.4496	CTTN/RHOBTB1/DMTN/VIL1	4
BP	GO:0031960	response to corticosteroid	4/223	162/18670	0.1294	0.4893	0.4496	CALM3/SPARC/CDKN1A/UGT1A1	4
BP	GO:0015748	organophosphate ester transport	3/223	105/18670	0.131	0.4893	0.4496	PITPNM2/GJA1/PLEKHA8P1	3
BP	GO:0043266	regulation of potassium ion transport	3/223	105/18670	0.131	0.4893	0.4496	FHL1/ANO6/MIR21	3
BP	GO:0031424	keratinization	5/223	224/18670	0.1311	0.4893	0.4496	KRT6B/PCSK6/LCE2C/KRTAP19-4/KRT4	5
BP	GO:0007033	vacuole organization	4/223	163/18670	0.1315	0.4893	0.4496	PHF23/CLN5/ATG101/SYT7	4
BP	GO:0099173	postsynapse organization	4/223	163/18670	0.1315	0.4893	0.4496	TMEM108/CTTN/POTEKP/EPHB2	4
BP	GO:0006376	mRNA splice site selection	2/223	53/18670	0.132	0.4893	0.4496	SRSF5/RNVU1-3	2
BP	GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	2/223	53/18670	0.132	0.4893	0.4496	ARR3/SNCA	2
BP	GO:0045840	positive regulation of mitotic nuclear division	2/223	53/18670	0.132	0.4893	0.4496	EGF/BTC	2
BP	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	2/223	53/18670	0.132	0.4893	0.4496	DMTN/SOCS3	2
BP	GO:1901185	negative regulation of ERBB signaling pathway	2/223	53/18670	0.132	0.4893	0.4496	EGF/BTC	2
BP	GO:0072511	divalent inorganic cation transport	9/223	489/18670	0.1327	0.4893	0.4496	CALM3/ANO6/EGF/GJA1/MYLK/SNCA/RGN/MCUR1/MIR21	9
BP	GO:0044774	mitotic DNA integrity checkpoint	3/223	106/18670	0.1337	0.4893	0.4496	CDKN1A/CRADD/MIR21	3
BP	GO:1901606	alpha-amino acid catabolic process	3/223	106/18670	0.1337	0.4893	0.4496	HGD/ARG2/MIR21	3
BP	GO:0002863	positive regulation of inflammatory response to antigenic stimulus	1/223	12/18670	0.1343	0.4893	0.4496	C3	1
BP	GO:0003161	cardiac conduction system development	1/223	12/18670	0.1343	0.4893	0.4496	NRG1	1
BP	GO:0009886	post-embryonic animal morphogenesis	1/223	12/18670	0.1343	0.4893	0.4496	GNAS	1
BP	GO:0010649	regulation of cell communication by electrical coupling	1/223	12/18670	0.1343	0.4893	0.4496	CALM3	1
BP	GO:0010889	regulation of sequestering of triglyceride	1/223	12/18670	0.1343	0.4893	0.4496	FITM1	1
BP	GO:0010960	magnesium ion homeostasis	1/223	12/18670	0.1343	0.4893	0.4496	XK	1
BP	GO:0015867	ATP transport	1/223	12/18670	0.1343	0.4893	0.4496	GJA1	1
BP	GO:0035630	bone mineralization involved in bone maturation	1/223	12/18670	0.1343	0.4893	0.4496	ANO6	1
BP	GO:0035751	regulation of lysosomal lumen pH	1/223	12/18670	0.1343	0.4893	0.4496	CLN5	1
BP	GO:0042416	dopamine biosynthetic process	1/223	12/18670	0.1343	0.4893	0.4496	SNCA	1
BP	GO:0051657	maintenance of organelle location	1/223	12/18670	0.1343	0.4893	0.4496	ARHGAP21	1
BP	GO:0051873	killing by host of symbiont cells	1/223	12/18670	0.1343	0.4893	0.4496	PF4	1
BP	GO:0060391	positive regulation of SMAD protein signal transduction	1/223	12/18670	0.1343	0.4893	0.4496	DAB2	1
BP	GO:0060670	branching involved in labyrinthine layer morphogenesis	1/223	12/18670	0.1343	0.4893	0.4496	SOCS3	1
BP	GO:0060707	trophoblast giant cell differentiation	1/223	12/18670	0.1343	0.4893	0.4496	SOCS3	1
BP	GO:0070493	thrombin-activated receptor signaling pathway	1/223	12/18670	0.1343	0.4893	0.4496	SNCA	1
BP	GO:0071107	response to parathyroid hormone	1/223	12/18670	0.1343	0.4893	0.4496	GJA1	1
BP	GO:0071679	commissural neuron axon guidance	1/223	12/18670	0.1343	0.4893	0.4496	EPHB2	1
BP	GO:0072520	seminiferous tubule development	1/223	12/18670	0.1343	0.4893	0.4496	ING2	1
BP	GO:0097104	postsynaptic membrane assembly	1/223	12/18670	0.1343	0.4893	0.4496	EPHB2	1
BP	GO:0098974	postsynaptic actin cytoskeleton organization	1/223	12/18670	0.1343	0.4893	0.4496	POTEKP	1
BP	GO:0099550	trans-synaptic signaling, modulating synaptic transmission	1/223	12/18670	0.1343	0.4893	0.4496	EPHB2	1
BP	GO:0099640	axo-dendritic protein transport	1/223	12/18670	0.1343	0.4893	0.4496	MAP1A	1
BP	GO:1900376	regulation of secondary metabolite biosynthetic process	1/223	12/18670	0.1343	0.4893	0.4496	MIR21	1
BP	GO:1901298	regulation of hydrogen peroxide-mediated programmed cell death	1/223	12/18670	0.1343	0.4893	0.4496	MIR21	1
BP	GO:1904424	regulation of GTP binding	1/223	12/18670	0.1343	0.4893	0.4496	CLN5	1
BP	GO:1905666	regulation of protein localization to endosome	1/223	12/18670	0.1343	0.4893	0.4496	EGF	1
BP	GO:2001223	negative regulation of neuron migration	1/223	12/18670	0.1343	0.4893	0.4496	NRG1	1
BP	GO:0009896	positive regulation of catabolic process	8/223	423/18670	0.1353	0.4893	0.4496	CLU/DAB2/EGF/GJA1/FAM122A/SNCA/RGN/PRKAA2	8
BP	GO:0032386	regulation of intracellular transport	8/223	423/18670	0.1353	0.4893	0.4496	SH3TC2/CALM3/ABLIM3/DAB2/HSPA1L/SLC35D3/DMTN/NUTF2	8
BP	GO:0002763	positive regulation of myeloid leukocyte differentiation	2/223	54/18670	0.136	0.4893	0.4496	GNAS/PF4	2
BP	GO:0006584	catecholamine metabolic process	2/223	54/18670	0.136	0.4893	0.4496	SNCAIP/SNCA	2
BP	GO:0006636	unsaturated fatty acid biosynthetic process	2/223	54/18670	0.136	0.4893	0.4496	PTGES3/PTGS1	2
BP	GO:0009712	catechol-containing compound metabolic process	2/223	54/18670	0.136	0.4893	0.4496	SNCAIP/SNCA	2
BP	GO:0010524	positive regulation of calcium ion transport into cytosol	2/223	54/18670	0.136	0.4893	0.4496	CALM3/SNCA	2
BP	GO:0030042	actin filament depolymerization	2/223	54/18670	0.136	0.4893	0.4496	DMTN/VIL1	2
BP	GO:0051225	spindle assembly	3/223	108/18670	0.1391	0.4893	0.4496	TUBB1/KIF4A/KIF2A	3
BP	GO:0071156	regulation of cell cycle arrest	3/223	108/18670	0.1391	0.4893	0.4496	CDKN1A/CRADD/FAP	3
BP	GO:0099565	chemical synaptic transmission, postsynaptic	3/223	108/18670	0.1391	0.4893	0.4496	TMEM108/IGSF9B/SNCA	3
BP	GO:1904659	glucose transmembrane transport	3/223	108/18670	0.1391	0.4893	0.4496	PPBP/C3/ITLN1	3
BP	GO:0002090	regulation of receptor internalization	2/223	55/18670	0.1401	0.4893	0.4496	ITGB3/EGF	2
BP	GO:0006120	mitochondrial electron transport, NADH to ubiquinone	2/223	55/18670	0.1401	0.4893	0.4496	NDUFS8/SNCA	2
BP	GO:0042304	regulation of fatty acid biosynthetic process	2/223	55/18670	0.1401	0.4893	0.4496	RGN/PRKAA2	2
BP	GO:0043954	cellular component maintenance	2/223	55/18670	0.1401	0.4893	0.4496	CAMSAP3/CTTN	2
BP	GO:0046456	icosanoid biosynthetic process	2/223	55/18670	0.1401	0.4893	0.4496	PTGES3/PTGS1	2
BP	GO:0048016	inositol phosphate-mediated signaling	2/223	55/18670	0.1401	0.4893	0.4496	C10orf71/NRG1	2
BP	GO:0061098	positive regulation of protein tyrosine kinase activity	2/223	55/18670	0.1401	0.4893	0.4496	EGF/NRG1	2
BP	GO:0070830	bicellular tight junction assembly	2/223	55/18670	0.1401	0.4893	0.4496	GJA1/ESAM	2
BP	GO:2001234	negative regulation of apoptotic signaling pathway	5/223	230/18670	0.1418	0.4893	0.4496	CLU/ING2/CTTN/PF4/MIR21	5
BP	GO:0051302	regulation of cell division	4/223	168/18670	0.1422	0.4893	0.4496	CALM3/PPBP/BTC/PDGFA	4
BP	GO:1990138	neuron projection extension	4/223	168/18670	0.1422	0.4893	0.4496	TMEM108/ZFYVE27/CTTN/VCL	4
BP	GO:0010948	negative regulation of cell cycle process	7/223	361/18670	0.1424	0.4893	0.4496	MIR29C/CDKN1A/FHL1/CTDSPL/CRADD/MIR29B1/MIR21	7
BP	GO:0031331	positive regulation of cellular catabolic process	7/223	361/18670	0.1424	0.4893	0.4496	CLU/DAB2/EGF/FAM122A/SNCA/RGN/PRKAA2	7
BP	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	2/223	56/18670	0.1442	0.4893	0.4496	CDKN1A/CRADD	2
BP	GO:0045292	mRNA cis splicing, via spliceosome	2/223	56/18670	0.1442	0.4893	0.4496	SRSF5/RNVU1-3	2
BP	GO:0060688	regulation of morphogenesis of a branching structure	2/223	56/18670	0.1442	0.4893	0.4496	SULF1/PDGFA	2
BP	GO:0065002	intracellular protein transmembrane transport	2/223	56/18670	0.1442	0.4893	0.4496	PEX12/PEX14	2
BP	GO:0086065	cell communication involved in cardiac conduction	2/223	56/18670	0.1442	0.4893	0.4496	CALM3/GJA1	2
BP	GO:0090307	mitotic spindle assembly	2/223	56/18670	0.1442	0.4893	0.4496	KIF4A/KIF2A	2
BP	GO:0120192	tight junction assembly	2/223	56/18670	0.1442	0.4893	0.4496	GJA1/ESAM	2
BP	GO:1903078	positive regulation of protein localization to plasma membrane	2/223	56/18670	0.1442	0.4893	0.4496	VIL1/EPHB2	2
BP	GO:1903202	negative regulation of oxidative stress-induced cell death	2/223	56/18670	0.1442	0.4893	0.4496	MIR29B1/MIR21	2
BP	GO:0007269	neurotransmitter secretion	4/223	169/18670	0.1443	0.4893	0.4496	CALM3/SNCAIP/SNCA/SYT7	4
BP	GO:0031667	response to nutrient levels	9/223	499/18670	0.1446	0.4893	0.4496	SPARC/CDKN1A/PIM1/EIF2AK1/SPX/CYP1A1/MMP7/UGT1A1/PRKAA2	9
BP	GO:0050900	leukocyte migration	9/223	499/18670	0.1446	0.4893	0.4496	GRB14/ITGB3/PPBP/ITGA2B/PROS1/ANO6/SELP/PF4/ESAM	9
BP	GO:0016101	diterpenoid metabolic process	3/223	110/18670	0.1447	0.4893	0.4496	CYP2C18/CYP1A1/UGT1A1	3
BP	GO:0001765	membrane raft assembly	1/223	13/18670	0.1447	0.4893	0.4496	CAV2	1
BP	GO:0001845	phagolysosome assembly	1/223	13/18670	0.1447	0.4893	0.4496	SYT7	1
BP	GO:0002829	negative regulation of type 2 immune response	1/223	13/18670	0.1447	0.4893	0.4496	ARG2	1
BP	GO:0002864	regulation of acute inflammatory response to antigenic stimulus	1/223	13/18670	0.1447	0.4893	0.4496	C3	1
BP	GO:0003084	positive regulation of systemic arterial blood pressure	1/223	13/18670	0.1447	0.4893	0.4496	SPX	1
BP	GO:0003157	endocardium development	1/223	13/18670	0.1447	0.4893	0.4496	NRG1	1
BP	GO:0005513	detection of calcium ion	1/223	13/18670	0.1447	0.4893	0.4496	CALM3	1
BP	GO:0006596	polyamine biosynthetic process	1/223	13/18670	0.1447	0.4893	0.4496	ODC1	1
BP	GO:0009437	carnitine metabolic process	1/223	13/18670	0.1447	0.4893	0.4496	CRAT	1
BP	GO:0009635	response to herbicide	1/223	13/18670	0.1447	0.4893	0.4496	CYP1A1	1
BP	GO:0010459	negative regulation of heart rate	1/223	13/18670	0.1447	0.4893	0.4496	SPX	1
BP	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	1/223	13/18670	0.1447	0.4893	0.4496	SNCA	1
BP	GO:0010745	negative regulation of macrophage derived foam cell differentiation	1/223	13/18670	0.1447	0.4893	0.4496	ITGB3	1
BP	GO:0010763	positive regulation of fibroblast migration	1/223	13/18670	0.1447	0.4893	0.4496	DMTN	1
BP	GO:0010838	positive regulation of keratinocyte proliferation	1/223	13/18670	0.1447	0.4893	0.4496	MIR21	1
BP	GO:0016322	neuron remodeling	1/223	13/18670	0.1447	0.4893	0.4496	C3	1
BP	GO:0019627	urea metabolic process	1/223	13/18670	0.1447	0.4893	0.4496	ARG2	1
BP	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	1/223	13/18670	0.1447	0.4893	0.4496	MMRN2	1
BP	GO:0031115	negative regulation of microtubule polymerization	1/223	13/18670	0.1447	0.4893	0.4496	SNCA	1
BP	GO:0032096	negative regulation of response to food	1/223	13/18670	0.1447	0.4893	0.4496	SPX	1
BP	GO:0032099	negative regulation of appetite	1/223	13/18670	0.1447	0.4893	0.4496	SPX	1
BP	GO:0032530	regulation of microvillus organization	1/223	13/18670	0.1447	0.4893	0.4496	VIL1	1
BP	GO:0033623	regulation of integrin activation	1/223	13/18670	0.1447	0.4893	0.4496	SELP	1
BP	GO:0035627	ceramide transport	1/223	13/18670	0.1447	0.4893	0.4496	PLEKHA8P1	1
BP	GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein	1/223	13/18670	0.1447	0.4893	0.4496	SOCS3	1
BP	GO:0043247	telomere maintenance in response to DNA damage	1/223	13/18670	0.1447	0.4893	0.4496	RTEL1	1
BP	GO:0050746	regulation of lipoprotein metabolic process	1/223	13/18670	0.1447	0.4893	0.4496	ITGB3	1
BP	GO:0051386	regulation of neurotrophin TRK receptor signaling pathway	1/223	13/18670	0.1447	0.4893	0.4496	TMEM108	1
BP	GO:0060312	regulation of blood vessel remodeling	1/223	13/18670	0.1447	0.4893	0.4496	MIR29B1	1
BP	GO:0060601	lateral sprouting from an epithelium	1/223	13/18670	0.1447	0.4893	0.4496	SULF1	1
BP	GO:0060712	spongiotrophoblast layer development	1/223	13/18670	0.1447	0.4893	0.4496	SOCS3	1
BP	GO:0071872	cellular response to epinephrine stimulus	1/223	13/18670	0.1447	0.4893	0.4496	SNCA	1
BP	GO:0090594	inflammatory response to wounding	1/223	13/18670	0.1447	0.4893	0.4496	MIR21	1
BP	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	1/223	13/18670	0.1447	0.4893	0.4496	DMTN	1
BP	GO:1902430	negative regulation of amyloid-beta formation	1/223	13/18670	0.1447	0.4893	0.4496	CLU	1
BP	GO:1902902	negative regulation of autophagosome assembly	1/223	13/18670	0.1447	0.4893	0.4496	PHF23	1
BP	GO:1902947	regulation of tau-protein kinase activity	1/223	13/18670	0.1447	0.4893	0.4496	CLU	1
BP	GO:1903651	positive regulation of cytoplasmic transport	1/223	13/18670	0.1447	0.4893	0.4496	DAB2	1
BP	GO:1903726	negative regulation of phospholipid metabolic process	1/223	13/18670	0.1447	0.4893	0.4496	PDGFA	1
BP	GO:2000009	negative regulation of protein localization to cell surface	1/223	13/18670	0.1447	0.4893	0.4496	TAX1BP3	1
BP	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	1/223	13/18670	0.1447	0.4893	0.4496	DAB2	1
BP	GO:0042445	hormone metabolic process	5/223	232/18670	0.1455	0.4901	0.4504	UGT2B11/CYP2C18/PCSK6/CYP1A1/UGT1A1	5
BP	GO:0071772	response to BMP	4/223	170/18670	0.1465	0.4901	0.4504	PCSK6/SULF1/RBPMS2/MIR21	4
BP	GO:0071773	cellular response to BMP stimulus	4/223	170/18670	0.1465	0.4901	0.4504	PCSK6/SULF1/RBPMS2/MIR21	4
BP	GO:0099643	signal release from synapse	4/223	170/18670	0.1465	0.4901	0.4504	CALM3/SNCAIP/SNCA/SYT7	4
BP	GO:0010038	response to metal ion	7/223	364/18670	0.1467	0.4901	0.4504	CALM3/SPARC/CYP1A1/SNCA/DMTN/SYT7/PRKAA2	7
BP	GO:0035305	negative regulation of dephosphorylation	3/223	111/18670	0.1474	0.4901	0.4504	CAMSAP3/FAM122A/RGN	3
BP	GO:0090068	positive regulation of cell cycle process	6/223	298/18670	0.1476	0.4901	0.4504	CDKN1A/EGF/BTC/CRADD/CYP1A1/FAP	6
BP	GO:0002066	columnar/cuboidal epithelial cell development	2/223	57/18670	0.1483	0.4901	0.4504	CDKN1A/MIR29B1	2
BP	GO:0007029	endoplasmic reticulum organization	2/223	57/18670	0.1483	0.4901	0.4504	ZFYVE27/CAV2	2
BP	GO:0042743	hydrogen peroxide metabolic process	2/223	57/18670	0.1483	0.4901	0.4504	CYP1A1/SNCA	2
BP	GO:0060043	regulation of cardiac muscle cell proliferation	2/223	57/18670	0.1483	0.4901	0.4504	PIM1/GJA1	2
BP	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	2/223	57/18670	0.1483	0.4901	0.4504	CDKN1A/CRADD	2
BP	GO:1900408	negative regulation of cellular response to oxidative stress	2/223	57/18670	0.1483	0.4901	0.4504	MIR29B1/MIR21	2
BP	GO:1901799	negative regulation of proteasomal protein catabolic process	2/223	57/18670	0.1483	0.4901	0.4504	CAMLG/MAP1A	2
BP	GO:1902400	intracellular signal transduction involved in G1 DNA damage checkpoint	2/223	57/18670	0.1483	0.4901	0.4504	CDKN1A/CRADD	2
BP	GO:0001938	positive regulation of endothelial cell proliferation	3/223	112/18670	0.1503	0.4901	0.4504	ITGB3/CAV2/MIR21	3
BP	GO:0002065	columnar/cuboidal epithelial cell differentiation	3/223	112/18670	0.1503	0.4901	0.4504	CDKN1A/DSPP/MIR29B1	3
BP	GO:0008645	hexose transmembrane transport	3/223	112/18670	0.1503	0.4901	0.4504	PPBP/C3/ITLN1	3
BP	GO:0014902	myotube differentiation	3/223	112/18670	0.1503	0.4901	0.4504	XK/RBM38/CAV2	3
BP	GO:0015918	sterol transport	3/223	112/18670	0.1503	0.4901	0.4504	CLU/EGF/SYT7	3
BP	GO:0032411	positive regulation of transporter activity	3/223	112/18670	0.1503	0.4901	0.4504	CALM3/RGN/EPHB2	3
BP	GO:0050868	negative regulation of T cell activation	3/223	112/18670	0.1503	0.4901	0.4504	PDE5A/ARG2/MIR21	3
BP	GO:0051817	modification of morphology or physiology of other organism involved in symbiotic interaction	3/223	112/18670	0.1503	0.4901	0.4504	CALM3/PF4/CAV2	3
BP	GO:0070268	cornification	3/223	112/18670	0.1503	0.4901	0.4504	KRT6B/PCSK6/KRT4	3
BP	GO:1990748	cellular detoxification	3/223	112/18670	0.1503	0.4901	0.4504	PTGS1/RGN/MIR21	3
BP	GO:0006469	negative regulation of protein kinase activity	5/223	235/18670	0.1511	0.4901	0.4504	CDKN1A/PRKAR2B/RGN/EPHB2/SOCS3	5
BP	GO:0060560	developmental growth involved in morphogenesis	5/223	235/18670	0.1511	0.4901	0.4504	TMEM108/EPB41L5/ZFYVE27/CTTN/VCL	5
BP	GO:0010769	regulation of cell morphogenesis involved in differentiation	6/223	301/18670	0.1525	0.4901	0.4504	XK/MPL/ZFYVE27/CTTN/DMTN/EPHB2	6
BP	GO:0017001	antibiotic catabolic process	2/223	58/18670	0.1525	0.4901	0.4504	UGT1A1/SNCA	2
BP	GO:0019229	regulation of vasoconstriction	2/223	58/18670	0.1525	0.4901	0.4504	GJA1/MIR21	2
BP	GO:0030837	negative regulation of actin filament polymerization	2/223	58/18670	0.1525	0.4901	0.4504	DMTN/VIL1	2
BP	GO:0035306	positive regulation of dephosphorylation	2/223	58/18670	0.1525	0.4901	0.4504	CALM3/RGN	2
BP	GO:0061900	glial cell activation	2/223	58/18670	0.1525	0.4901	0.4504	CLU/SNCA	2
BP	GO:1903749	positive regulation of establishment of protein localization to mitochondrion	2/223	58/18670	0.1525	0.4901	0.4504	ABLIM3/HSPA1L	2
BP	GO:0060249	anatomical structure homeostasis	8/223	437/18670	0.1537	0.4901	0.4504	PTGES3/ITGB3/LOX/SCGN/RTEL1/GNAS/MUC13/MAP1A	8
BP	GO:0006909	phagocytosis	7/223	369/18670	0.1541	0.4901	0.4504	ITGB3/EIF2AK1/ANO6/RHOBTB1/C3/SYT7/PEAR1	7
BP	GO:0009214	cyclic nucleotide catabolic process	1/223	14/18670	0.1549	0.4901	0.4504	PDE5A	1
BP	GO:0010421	hydrogen peroxide-mediated programmed cell death	1/223	14/18670	0.1549	0.4901	0.4504	MIR21	1
BP	GO:0020027	hemoglobin metabolic process	1/223	14/18670	0.1549	0.4901	0.4504	EIF2AK1	1
BP	GO:0021781	glial cell fate commitment	1/223	14/18670	0.1549	0.4901	0.4504	NRG1	1
BP	GO:0030213	hyaluronan biosynthetic process	1/223	14/18670	0.1549	0.4901	0.4504	EGF	1
BP	GO:0030836	positive regulation of actin filament depolymerization	1/223	14/18670	0.1549	0.4901	0.4504	VIL1	1
BP	GO:0034331	cell junction maintenance	1/223	14/18670	0.1549	0.4901	0.4504	CAMSAP3	1
BP	GO:0034392	negative regulation of smooth muscle cell apoptotic process	1/223	14/18670	0.1549	0.4901	0.4504	MIR21	1
BP	GO:0035810	positive regulation of urine volume	1/223	14/18670	0.1549	0.4901	0.4504	BTC	1
BP	GO:0043173	nucleotide salvage	1/223	14/18670	0.1549	0.4901	0.4504	UPP2	1
BP	GO:0043455	regulation of secondary metabolic process	1/223	14/18670	0.1549	0.4901	0.4504	MIR21	1
BP	GO:0043558	regulation of translational initiation in response to stress	1/223	14/18670	0.1549	0.4901	0.4504	EIF2AK1	1
BP	GO:0045198	establishment of epithelial cell apical/basal polarity	1/223	14/18670	0.1549	0.4901	0.4504	CAMSAP3	1
BP	GO:0045346	regulation of MHC class II biosynthetic process	1/223	14/18670	0.1549	0.4901	0.4504	PF4	1
BP	GO:0045651	positive regulation of macrophage differentiation	1/223	14/18670	0.1549	0.4901	0.4504	PF4	1
BP	GO:0051645	Golgi localization	1/223	14/18670	0.1549	0.4901	0.4504	ARHGAP21	1
BP	GO:0051852	disruption by host of symbiont cells	1/223	14/18670	0.1549	0.4901	0.4504	PF4	1
BP	GO:0051917	regulation of fibrinolysis	1/223	14/18670	0.1549	0.4901	0.4504	FAP	1
BP	GO:0060732	positive regulation of inositol phosphate biosynthetic process	1/223	14/18670	0.1549	0.4901	0.4504	SNCA	1
BP	GO:0071361	cellular response to ethanol	1/223	14/18670	0.1549	0.4901	0.4504	UGT1A1	1
BP	GO:0072216	positive regulation of metanephros development	1/223	14/18670	0.1549	0.4901	0.4504	PDGFA	1
BP	GO:0072425	signal transduction involved in G2 DNA damage checkpoint	1/223	14/18670	0.1549	0.4901	0.4504	MIR21	1
BP	GO:0090151	establishment of protein localization to mitochondrial membrane	1/223	14/18670	0.1549	0.4901	0.4504	CALM3	1
BP	GO:0097468	programmed cell death in response to reactive oxygen species	1/223	14/18670	0.1549	0.4901	0.4504	MIR21	1
BP	GO:0099188	postsynaptic cytoskeleton organization	1/223	14/18670	0.1549	0.4901	0.4504	POTEKP	1
BP	GO:1903624	regulation of DNA catabolic process	1/223	14/18670	0.1549	0.4901	0.4504	RGN	1
BP	GO:1905064	negative regulation of vascular smooth muscle cell differentiation	1/223	14/18670	0.1549	0.4901	0.4504	MIR21	1
BP	GO:1905651	regulation of artery morphogenesis	1/223	14/18670	0.1549	0.4901	0.4504	MIR29B1	1
BP	GO:2001044	regulation of integrin-mediated signaling pathway	1/223	14/18670	0.1549	0.4901	0.4504	DMTN	1
BP	GO:0006941	striated muscle contraction	4/223	174/18670	0.1554	0.4908	0.451	CALM3/PDE5A/GJA1/ARG2	4
BP	GO:0046488	phosphatidylinositol metabolic process	4/223	174/18670	0.1554	0.4908	0.451	PITPNM2/PDGFA/PI4K2A/SOCS3	4
BP	GO:0032535	regulation of cellular component size	7/223	370/18670	0.1556	0.4908	0.451	XK/ANO6/ZFYVE27/CTTN/RHOBTB1/DMTN/VIL1	7
BP	GO:0015749	monosaccharide transmembrane transport	3/223	114/18670	0.1559	0.4914	0.4516	PPBP/C3/ITLN1	3
BP	GO:0042130	negative regulation of T cell proliferation	2/223	59/18670	0.1566	0.4916	0.4518	PDE5A/ARG2	2
BP	GO:0043388	positive regulation of DNA binding	2/223	59/18670	0.1566	0.4916	0.4518	CALM3/EGF	2
BP	GO:1902883	negative regulation of response to oxidative stress	2/223	59/18670	0.1566	0.4916	0.4518	MIR29B1/MIR21	2
BP	GO:2000756	regulation of peptidyl-lysine acetylation	2/223	59/18670	0.1566	0.4916	0.4518	SNCA/PRKAA2	2
BP	GO:0010921	regulation of phosphatase activity	4/223	175/18670	0.1577	0.4916	0.4518	CALM3/CAMSAP3/FAM122A/RGN	4
BP	GO:0033002	muscle cell proliferation	5/223	239/18670	0.1586	0.4916	0.4518	CDKN1A/PIM1/GJA1/RBPMS2/MIR21	5
BP	GO:0030449	regulation of complement activation	3/223	115/18670	0.1588	0.4916	0.4518	CLU/PROS1/C3	3
BP	GO:1904375	regulation of protein localization to cell periphery	3/223	115/18670	0.1588	0.4916	0.4518	DAB2/VIL1/EPHB2	3
BP	GO:0018149	peptide cross-linking	2/223	60/18670	0.1608	0.4916	0.4518	F13A1/LCE2C	2
BP	GO:0032515	negative regulation of phosphoprotein phosphatase activity	2/223	60/18670	0.1608	0.4916	0.4518	FAM122A/RGN	2
BP	GO:0120193	tight junction organization	2/223	60/18670	0.1608	0.4916	0.4518	GJA1/ESAM	2
BP	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	2/223	60/18670	0.1608	0.4916	0.4518	MIR29C/MIR29B1	2
BP	GO:0006304	DNA modification	3/223	116/18670	0.1617	0.4916	0.4518	MIR29C/GNAS/MIR29B1	3
BP	GO:0006661	phosphatidylinositol biosynthetic process	3/223	116/18670	0.1617	0.4916	0.4518	PITPNM2/PDGFA/PI4K2A	3
BP	GO:0021782	glial cell development	3/223	116/18670	0.1617	0.4916	0.4518	SH3TC2/CLU/NRG1	3
BP	GO:0034219	carbohydrate transmembrane transport	3/223	116/18670	0.1617	0.4916	0.4518	PPBP/C3/ITLN1	3
BP	GO:0070252	actin-mediated cell contraction	3/223	116/18670	0.1617	0.4916	0.4518	EPB41L5/GJA1/VIL1	3
BP	GO:2000257	regulation of protein activation cascade	3/223	116/18670	0.1617	0.4916	0.4518	CLU/PROS1/C3	3
BP	GO:0048469	cell maturation	4/223	177/18670	0.1622	0.4916	0.4518	CDKN1A/GJA1/CLN5/C3	4
BP	GO:0043666	regulation of phosphoprotein phosphatase activity	3/223	117/18670	0.1645	0.4916	0.4518	CALM3/FAM122A/RGN	3
BP	GO:0044282	small molecule catabolic process	8/223	445/18670	0.1647	0.4916	0.4518	AMACR/UPB1/UPP2/HGD/CRAT/CYP1A1/ARG2/MIR21	8
BP	GO:0001325	formation of extrachromosomal circular DNA	1/223	15/18670	0.165	0.4916	0.4518	RTEL1	1
BP	GO:0001921	positive regulation of receptor recycling	1/223	15/18670	0.165	0.4916	0.4518	SNCA	1
BP	GO:0007351	tripartite regional subdivision	1/223	15/18670	0.165	0.4916	0.4518	PCSK6	1
BP	GO:0007512	adult heart development	1/223	15/18670	0.165	0.4916	0.4518	GJA1	1
BP	GO:0008595	anterior/posterior axis specification, embryo	1/223	15/18670	0.165	0.4916	0.4518	PCSK6	1
BP	GO:0018158	protein oxidation	1/223	15/18670	0.165	0.4916	0.4518	LOX	1
BP	GO:0030730	sequestering of triglyceride	1/223	15/18670	0.165	0.4916	0.4518	FITM1	1
BP	GO:0032105	negative regulation of response to extracellular stimulus	1/223	15/18670	0.165	0.4916	0.4518	SPX	1
BP	GO:0032108	negative regulation of response to nutrient levels	1/223	15/18670	0.165	0.4916	0.4518	SPX	1
BP	GO:0035067	negative regulation of histone acetylation	1/223	15/18670	0.165	0.4916	0.4518	SNCA	1
BP	GO:0042074	cell migration involved in gastrulation	1/223	15/18670	0.165	0.4916	0.4518	EPB41L5	1
BP	GO:0042559	pteridine-containing compound biosynthetic process	1/223	15/18670	0.165	0.4916	0.4518	PTS	1
BP	GO:0043101	purine-containing compound salvage	1/223	15/18670	0.165	0.4916	0.4518	GMPR	1
BP	GO:0043652	engulfment of apoptotic cell	1/223	15/18670	0.165	0.4916	0.4518	RHOBTB1	1
BP	GO:0045342	MHC class II biosynthetic process	1/223	15/18670	0.165	0.4916	0.4518	PF4	1
BP	GO:0051280	negative regulation of release of sequestered calcium ion into cytosol	1/223	15/18670	0.165	0.4916	0.4518	CALM3	1
BP	GO:0051883	killing of cells in other organism involved in symbiotic interaction	1/223	15/18670	0.165	0.4916	0.4518	PF4	1
BP	GO:0055089	fatty acid homeostasis	1/223	15/18670	0.165	0.4916	0.4518	PRKAA2	1
BP	GO:0060339	negative regulation of type I interferon-mediated signaling pathway	1/223	15/18670	0.165	0.4916	0.4518	MIR21	1
BP	GO:0060766	negative regulation of androgen receptor signaling pathway	1/223	15/18670	0.165	0.4916	0.4518	DAB2	1
BP	GO:0070365	hepatocyte differentiation	1/223	15/18670	0.165	0.4916	0.4518	CYP1A1	1
BP	GO:0090494	dopamine uptake	1/223	15/18670	0.165	0.4916	0.4518	SNCA	1
BP	GO:0090656	t-circle formation	1/223	15/18670	0.165	0.4916	0.4518	RTEL1	1
BP	GO:0090737	telomere maintenance via telomere trimming	1/223	15/18670	0.165	0.4916	0.4518	RTEL1	1
BP	GO:0097428	protein maturation by iron-sulfur cluster transfer	1/223	15/18670	0.165	0.4916	0.4518	ISCA1	1
BP	GO:1900037	regulation of cellular response to hypoxia	1/223	15/18670	0.165	0.4916	0.4518	MIR21	1
BP	GO:1900119	positive regulation of execution phase of apoptosis	1/223	15/18670	0.165	0.4916	0.4518	FAP	1
BP	GO:1901841	regulation of high voltage-gated calcium channel activity	1/223	15/18670	0.165	0.4916	0.4518	CALM3	1
BP	GO:1902188	positive regulation of viral release from host cell	1/223	15/18670	0.165	0.4916	0.4518	CAV2	1
BP	GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	1/223	15/18670	0.165	0.4916	0.4518	MIR21	1
BP	GO:1903358	regulation of Golgi organization	1/223	15/18670	0.165	0.4916	0.4518	CAMSAP3	1
BP	GO:1905065	positive regulation of vascular smooth muscle cell differentiation	1/223	15/18670	0.165	0.4916	0.4518	MIR21	1
BP	GO:2000095	regulation of Wnt signaling pathway, planar cell polarity pathway	1/223	15/18670	0.165	0.4916	0.4518	DAB2	1
BP	GO:0007040	lysosome organization	2/223	61/18670	0.1651	0.4916	0.4518	CLN5/SYT7	2
BP	GO:0048645	animal organ formation	2/223	61/18670	0.1651	0.4916	0.4518	PIM1/SULF1	2
BP	GO:0080171	lytic vacuole organization	2/223	61/18670	0.1651	0.4916	0.4518	CLN5/SYT7	2
BP	GO:1905953	negative regulation of lipid localization	2/223	61/18670	0.1651	0.4916	0.4518	ITGB3/EGF	2
BP	GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	2/223	61/18670	0.1651	0.4916	0.4518	ARG2/MIR21	2
BP	GO:0008064	regulation of actin polymerization or depolymerization	4/223	179/18670	0.1668	0.4936	0.4536	CTTN/RHOBTB1/DMTN/VIL1	4
BP	GO:0008361	regulation of cell size	4/223	179/18670	0.1668	0.4936	0.4536	XK/ANO6/ZFYVE27/CTTN	4
BP	GO:0030177	positive regulation of Wnt signaling pathway	4/223	179/18670	0.1668	0.4936	0.4536	DAB2/EGF/SULF1/MIR29B1	4
BP	GO:0048771	tissue remodeling	4/223	179/18670	0.1668	0.4936	0.4536	ITGB3/GJA1/MIR29B1/SYT7	4
BP	GO:0051099	positive regulation of binding	4/223	179/18670	0.1668	0.4936	0.4536	CALM3/EPB41L5/EGF/CLN5	4
BP	GO:0006911	phagocytosis, engulfment	3/223	118/18670	0.1675	0.4936	0.4536	ANO6/RHOBTB1/C3	3
BP	GO:0030832	regulation of actin filament length	4/223	180/18670	0.1691	0.4936	0.4536	CTTN/RHOBTB1/DMTN/VIL1	4
BP	GO:0043534	blood vessel endothelial cell migration	4/223	180/18670	0.1691	0.4936	0.4536	MIR29C/MIR196A2/MMRN2/AMOTL1	4
BP	GO:1905330	regulation of morphogenesis of an epithelium	4/223	180/18670	0.1691	0.4936	0.4536	DAB2/SULF1/PDGFA/MIR21	4
BP	GO:0006521	regulation of cellular amino acid metabolic process	2/223	62/18670	0.1693	0.4936	0.4536	ODC1/MIR21	2
BP	GO:0009880	embryonic pattern specification	2/223	62/18670	0.1693	0.4936	0.4536	EPB41L5/PCSK6	2
BP	GO:0010676	positive regulation of cellular carbohydrate metabolic process	2/223	62/18670	0.1693	0.4936	0.4536	SNCA/RGN	2
BP	GO:0051898	negative regulation of protein kinase B signaling	2/223	62/18670	0.1693	0.4936	0.4536	MIR29C/MIR29B1	2
BP	GO:0055025	positive regulation of cardiac muscle tissue development	2/223	62/18670	0.1693	0.4936	0.4536	PIM1/NRG1	2
BP	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	2/223	62/18670	0.1693	0.4936	0.4536	MIR29C/MIR29B1	2
BP	GO:0016079	synaptic vesicle exocytosis	3/223	119/18670	0.1704	0.4936	0.4536	CALM3/SNCA/SYT7	3
BP	GO:0022408	negative regulation of cell-cell adhesion	4/223	181/18670	0.1714	0.4936	0.4536	EPB41L5/PDE5A/ARG2/MIR21	4
BP	GO:0051147	regulation of muscle cell differentiation	4/223	181/18670	0.1714	0.4936	0.4536	NRG1/RBPMS2/RBM38/MIR21	4
BP	GO:0031571	mitotic G1 DNA damage checkpoint	2/223	63/18670	0.1736	0.4936	0.4536	CDKN1A/CRADD	2
BP	GO:0044819	mitotic G1/S transition checkpoint	2/223	63/18670	0.1736	0.4936	0.4536	CDKN1A/CRADD	2
BP	GO:1904377	positive regulation of protein localization to cell periphery	2/223	63/18670	0.1736	0.4936	0.4536	VIL1/EPHB2	2
BP	GO:0010821	regulation of mitochondrion organization	4/223	182/18670	0.1738	0.4936	0.4536	ABLIM3/CLU/HSPA1L/CTTN	4
BP	GO:0061138	morphogenesis of a branching epithelium	4/223	182/18670	0.1738	0.4936	0.4536	EGF/SULF1/PDGFA/SOCS3	4
BP	GO:0000086	G2/M transition of mitotic cell cycle	5/223	247/18670	0.1742	0.4936	0.4536	CALM3/CDKN1A/FHL1/PRKAR2B/MIR21	5
BP	GO:0001780	neutrophil homeostasis	1/223	16/18670	0.175	0.4936	0.4536	MPL	1
BP	GO:0001977	renal system process involved in regulation of blood volume	1/223	16/18670	0.175	0.4936	0.4536	GJA1	1
BP	GO:0003222	ventricular trabecula myocardium morphogenesis	1/223	16/18670	0.175	0.4936	0.4536	NRG1	1
BP	GO:0006957	complement activation, alternative pathway	1/223	16/18670	0.175	0.4936	0.4536	C3	1
BP	GO:0007567	parturition	1/223	16/18670	0.175	0.4936	0.4536	CYP1A1	1
BP	GO:0009130	pyrimidine nucleoside monophosphate biosynthetic process	1/223	16/18670	0.175	0.4936	0.4536	UPP2	1
BP	GO:0010919	regulation of inositol phosphate biosynthetic process	1/223	16/18670	0.175	0.4936	0.4536	SNCA	1
BP	GO:0014048	regulation of glutamate secretion	1/223	16/18670	0.175	0.4936	0.4536	SNCA	1
BP	GO:0016114	terpenoid biosynthetic process	1/223	16/18670	0.175	0.4936	0.4536	CYP1A1	1
BP	GO:0021542	dentate gyrus development	1/223	16/18670	0.175	0.4936	0.4536	TMEM108	1
BP	GO:0022038	corpus callosum development	1/223	16/18670	0.175	0.4936	0.4536	EPHB2	1
BP	GO:0030952	establishment or maintenance of cytoskeleton polarity	1/223	16/18670	0.175	0.4936	0.4536	CAMSAP3	1
BP	GO:0032225	regulation of synaptic transmission, dopaminergic	1/223	16/18670	0.175	0.4936	0.4536	SNCA	1
BP	GO:0035372	protein localization to microtubule	1/223	16/18670	0.175	0.4936	0.4536	MAP1A	1
BP	GO:0043174	nucleoside salvage	1/223	16/18670	0.175	0.4936	0.4536	UPP2	1
BP	GO:0044794	positive regulation by host of viral process	1/223	16/18670	0.175	0.4936	0.4536	CAV2	1
BP	GO:0044849	estrous cycle	1/223	16/18670	0.175	0.4936	0.4536	MMP7	1
BP	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	1/223	16/18670	0.175	0.4936	0.4536	SYT7	1
BP	GO:0051503	adenine nucleotide transport	1/223	16/18670	0.175	0.4936	0.4536	GJA1	1
BP	GO:0055119	relaxation of cardiac muscle	1/223	16/18670	0.175	0.4936	0.4536	PDE5A	1
BP	GO:0060572	morphogenesis of an epithelial bud	1/223	16/18670	0.175	0.4936	0.4536	SULF1	1
BP	GO:0070863	positive regulation of protein exit from endoplasmic reticulum	1/223	16/18670	0.175	0.4936	0.4536	SLC35D3	1
BP	GO:0071380	cellular response to prostaglandin E stimulus	1/223	16/18670	0.175	0.4936	0.4536	PRKAA2	1
BP	GO:0071786	endoplasmic reticulum tubular network organization	1/223	16/18670	0.175	0.4936	0.4536	ZFYVE27	1
BP	GO:0071871	response to epinephrine	1/223	16/18670	0.175	0.4936	0.4536	SNCA	1
BP	GO:0090493	catecholamine uptake	1/223	16/18670	0.175	0.4936	0.4536	SNCA	1
BP	GO:0099170	postsynaptic modulation of chemical synaptic transmission	1/223	16/18670	0.175	0.4936	0.4536	NRGN	1
BP	GO:1900242	regulation of synaptic vesicle endocytosis	1/223	16/18670	0.175	0.4936	0.4536	CALM3	1
BP	GO:1900451	positive regulation of glutamate receptor signaling pathway	1/223	16/18670	0.175	0.4936	0.4536	EPHB2	1
BP	GO:1902001	fatty acid transmembrane transport	1/223	16/18670	0.175	0.4936	0.4536	PRKAA2	1
BP	GO:1902004	positive regulation of amyloid-beta formation	1/223	16/18670	0.175	0.4936	0.4536	CLU	1
BP	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1/223	16/18670	0.175	0.4936	0.4536	ING2	1
BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	1/223	16/18670	0.175	0.4936	0.4536	CLU	1
BP	GO:1990000	amyloid fibril formation	1/223	16/18670	0.175	0.4936	0.4536	CLU	1
BP	GO:2000369	regulation of clathrin-dependent endocytosis	1/223	16/18670	0.175	0.4936	0.4536	DAB2	1
BP	GO:0050770	regulation of axonogenesis	4/223	183/18670	0.1761	0.4936	0.4536	XK/ZFYVE27/CTTN/EPHB2	4
BP	GO:0042180	cellular ketone metabolic process	5/223	248/18670	0.1762	0.4936	0.4536	ODC1/SNCA/RGN/PRKAA2/MIR21	5
BP	GO:0001704	formation of primary germ layer	3/223	121/18670	0.1763	0.4936	0.4536	ITGB3/EPB41L5/ITGB5	3
BP	GO:0010811	positive regulation of cell-substrate adhesion	3/223	121/18670	0.1763	0.4936	0.4536	EPB41L5/DMTN/MMRN2	3
BP	GO:0046718	viral entry into host cell	3/223	121/18670	0.1763	0.4936	0.4536	ITGB3/ITGB5/CAV2	3
BP	GO:0048675	axon extension	3/223	121/18670	0.1763	0.4936	0.4536	ZFYVE27/CTTN/VCL	3
BP	GO:0070588	calcium ion transmembrane transport	6/223	315/18670	0.1763	0.4936	0.4536	CALM3/ANO6/SNCA/RGN/MCUR1/MIR21	6
BP	GO:0032768	regulation of monooxygenase activity	2/223	64/18670	0.1778	0.4936	0.4536	CALM3/SNCA	2
BP	GO:0035794	positive regulation of mitochondrial membrane permeability	2/223	64/18670	0.1778	0.4936	0.4536	MIR29C/MIR29B1	2
BP	GO:0044783	G1 DNA damage checkpoint	2/223	64/18670	0.1778	0.4936	0.4536	CDKN1A/CRADD	2
BP	GO:0046834	lipid phosphorylation	2/223	64/18670	0.1778	0.4936	0.4536	PI4K2A/SOCS3	2
BP	GO:0060135	maternal process involved in female pregnancy	2/223	64/18670	0.1778	0.4936	0.4536	GJA1/MMP7	2
BP	GO:2000378	negative regulation of reactive oxygen species metabolic process	2/223	64/18670	0.1778	0.4936	0.4536	RGN/MIR21	2
BP	GO:0042098	T cell proliferation	4/223	184/18670	0.1785	0.4936	0.4536	PDE5A/GJA1/ARG2/MIR21	4
BP	GO:0043409	negative regulation of MAPK cascade	4/223	184/18670	0.1785	0.4936	0.4536	MIR29B1/CASC2/EPHB2/MIR21	4
BP	GO:0048639	positive regulation of developmental growth	4/223	184/18670	0.1785	0.4936	0.4536	PIM1/ZFYVE27/FOXS1/VIL1	4
BP	GO:0042692	muscle cell differentiation	7/223	385/18670	0.1787	0.4936	0.4536	XK/LOX/NRG1/RBPMS2/RBM38/CAV2/MIR21	7
BP	GO:1903708	positive regulation of hemopoiesis	4/223	185/18670	0.1808	0.4936	0.4536	MPL/GNAS/PF4/MIR21	4
BP	GO:0000381	regulation of alternative mRNA splicing, via spliceosome	2/223	65/18670	0.1821	0.4936	0.4536	SRSF5/MBNL3	2
BP	GO:0035308	negative regulation of protein dephosphorylation	2/223	65/18670	0.1821	0.4936	0.4536	FAM122A/RGN	2
BP	GO:0051148	negative regulation of muscle cell differentiation	2/223	65/18670	0.1821	0.4936	0.4536	RBPMS2/MIR21	2
BP	GO:0051187	cofactor catabolic process	2/223	65/18670	0.1821	0.4936	0.4536	UGT1A1/SNCA	2
BP	GO:0070507	regulation of microtubule cytoskeleton organization	4/223	186/18670	0.1832	0.4936	0.4536	CAMSAP3/SNCA/MAP1A/PRKAA2	4
BP	GO:0032970	regulation of actin filament-based process	7/223	388/18670	0.1835	0.4936	0.4536	CTTN/RHOBTB1/PDGFA/DMTN/VIL1/MIR21/ARHGAP6	7
BP	GO:0002031	G protein-coupled receptor internalization	1/223	17/18670	0.1848	0.4936	0.4536	ARR3	1
BP	GO:0006577	amino-acid betaine metabolic process	1/223	17/18670	0.1848	0.4936	0.4536	CRAT	1
BP	GO:0006595	polyamine metabolic process	1/223	17/18670	0.1848	0.4936	0.4536	ODC1	1
BP	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	1/223	17/18670	0.1848	0.4936	0.4536	CDKN1A	1
BP	GO:0007076	mitotic chromosome condensation	1/223	17/18670	0.1848	0.4936	0.4536	PHF23	1
BP	GO:0009129	pyrimidine nucleoside monophosphate metabolic process	1/223	17/18670	0.1848	0.4936	0.4536	UPP2	1
BP	GO:0010224	response to UV-B	1/223	17/18670	0.1848	0.4936	0.4536	CDKN1A	1
BP	GO:0010715	regulation of extracellular matrix disassembly	1/223	17/18670	0.1848	0.4936	0.4536	FAP	1
BP	GO:0010744	positive regulation of macrophage derived foam cell differentiation	1/223	17/18670	0.1848	0.4936	0.4536	PF4	1
BP	GO:0015868	purine ribonucleotide transport	1/223	17/18670	0.1848	0.4936	0.4536	GJA1	1
BP	GO:0016246	RNA interference	1/223	17/18670	0.1848	0.4936	0.4536	TSNAX	1
BP	GO:0017085	response to insecticide	1/223	17/18670	0.1848	0.4936	0.4536	CYP1A1	1
BP	GO:0017121	phospholipid scrambling	1/223	17/18670	0.1848	0.4936	0.4536	ANO6	1
BP	GO:0032780	negative regulation of ATPase activity	1/223	17/18670	0.1848	0.4936	0.4536	RGN	1
BP	GO:0032966	negative regulation of collagen biosynthetic process	1/223	17/18670	0.1848	0.4936	0.4536	MIR29B1	1
BP	GO:0035729	cellular response to hepatocyte growth factor stimulus	1/223	17/18670	0.1848	0.4936	0.4536	VIL1	1
BP	GO:0035988	chondrocyte proliferation	1/223	17/18670	0.1848	0.4936	0.4536	MIR21	1
BP	GO:0042268	regulation of cytolysis	1/223	17/18670	0.1848	0.4936	0.4536	PF4	1
BP	GO:0045187	regulation of circadian sleep/wake cycle, sleep	1/223	17/18670	0.1848	0.4936	0.4536	KCNA2	1
BP	GO:0046068	cGMP metabolic process	1/223	17/18670	0.1848	0.4936	0.4536	PDE5A	1
BP	GO:0048532	anatomical structure arrangement	1/223	17/18670	0.1848	0.4936	0.4536	KCNA2	1
BP	GO:0050665	hydrogen peroxide biosynthetic process	1/223	17/18670	0.1848	0.4936	0.4536	CYP1A1	1
BP	GO:0051284	positive regulation of sequestering of calcium ion	1/223	17/18670	0.1848	0.4936	0.4536	CALM3	1
BP	GO:0051818	disruption of cells of other organism involved in symbiotic interaction	1/223	17/18670	0.1848	0.4936	0.4536	PF4	1
BP	GO:0060080	inhibitory postsynaptic potential	1/223	17/18670	0.1848	0.4936	0.4536	IGSF9B	1
BP	GO:0061323	cell proliferation involved in heart morphogenesis	1/223	17/18670	0.1848	0.4936	0.4536	PIM1	1
BP	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	1/223	17/18670	0.1848	0.4936	0.4536	MIR21	1
BP	GO:0072673	lamellipodium morphogenesis	1/223	17/18670	0.1848	0.4936	0.4536	VIL1	1
BP	GO:0098884	postsynaptic neurotransmitter receptor internalization	1/223	17/18670	0.1848	0.4936	0.4536	ITGB3	1
BP	GO:0099509	regulation of presynaptic cytosolic calcium ion concentration	1/223	17/18670	0.1848	0.4936	0.4536	SCGN	1
BP	GO:0140239	postsynaptic endocytosis	1/223	17/18670	0.1848	0.4936	0.4536	ITGB3	1
BP	GO:1901317	regulation of flagellated sperm motility	1/223	17/18670	0.1848	0.4936	0.4536	RGN	1
BP	GO:1904355	positive regulation of telomere capping	1/223	17/18670	0.1848	0.4936	0.4536	RTEL1	1
BP	GO:1904380	endoplasmic reticulum mannose trimming	1/223	17/18670	0.1848	0.4936	0.4536	RNF103	1
BP	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	1/223	17/18670	0.1848	0.4936	0.4536	MIR21	1
BP	GO:2000001	regulation of DNA damage checkpoint	1/223	17/18670	0.1848	0.4936	0.4536	MIR21	1
BP	GO:2000136	regulation of cell proliferation involved in heart morphogenesis	1/223	17/18670	0.1848	0.4936	0.4536	PIM1	1
BP	GO:2000641	regulation of early endosome to late endosome transport	1/223	17/18670	0.1848	0.4936	0.4536	DAB2	1
BP	GO:0045787	positive regulation of cell cycle	7/223	389/18670	0.1851	0.4936	0.4536	CDKN1A/EGF/BTC/CRADD/CYP1A1/FAP/SPDYA	7
BP	GO:0007043	cell-cell junction assembly	3/223	124/18670	0.1852	0.4936	0.4536	GJA1/ESAM/VCL	3
BP	GO:0008637	apoptotic mitochondrial changes	3/223	124/18670	0.1852	0.4936	0.4536	CLU/MIR29C/MIR29B1	3
BP	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	3/223	124/18670	0.1852	0.4936	0.4536	SELP/PDGFA/MIR21	3
BP	GO:0048284	organelle fusion	3/223	124/18670	0.1852	0.4936	0.4536	SNCA/CAV2/SYT7	3
BP	GO:0019933	cAMP-mediated signaling	4/223	187/18670	0.1856	0.4936	0.4536	CALM3/GNAS/PF4/MC2R	4
BP	GO:1905475	regulation of protein localization to membrane	4/223	187/18670	0.1856	0.4936	0.4536	DAB2/DMTN/VIL1/EPHB2	4
BP	GO:0040014	regulation of multicellular organism growth	2/223	66/18670	0.1864	0.4936	0.4536	FOXS1/VIL1	2
BP	GO:0045428	regulation of nitric oxide biosynthetic process	2/223	66/18670	0.1864	0.4936	0.4536	CLU/RGN	2
BP	GO:0046626	regulation of insulin receptor signaling pathway	2/223	66/18670	0.1864	0.4936	0.4536	GRB14/SOCS3	2
BP	GO:0051785	positive regulation of nuclear division	2/223	66/18670	0.1864	0.4936	0.4536	EGF/BTC	2
BP	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	2/223	66/18670	0.1864	0.4936	0.4536	MIR29C/MIR29B1	2
BP	GO:1905710	positive regulation of membrane permeability	2/223	66/18670	0.1864	0.4936	0.4536	MIR29C/MIR29B1	2
BP	GO:0009063	cellular amino acid catabolic process	3/223	125/18670	0.1882	0.4975	0.4572	HGD/ARG2/MIR21	3
BP	GO:0045471	response to ethanol	3/223	125/18670	0.1882	0.4975	0.4572	SPARC/UGT1A1/CYP2E1	3
BP	GO:0019748	secondary metabolic process	2/223	67/18670	0.1907	0.5027	0.462	CYP1A1/MIR21	2
BP	GO:0060038	cardiac muscle cell proliferation	2/223	67/18670	0.1907	0.5027	0.462	PIM1/GJA1	2
BP	GO:0045667	regulation of osteoblast differentiation	3/223	126/18670	0.1912	0.5027	0.462	GNAS/MIR29B1/MIR21	3
BP	GO:0099024	plasma membrane invagination	3/223	127/18670	0.1942	0.5027	0.462	ANO6/RHOBTB1/C3	3
BP	GO:0033673	negative regulation of kinase activity	5/223	257/18670	0.1945	0.5027	0.462	CDKN1A/PRKAR2B/RGN/EPHB2/SOCS3	5
BP	GO:0010713	negative regulation of collagen metabolic process	1/223	18/18670	0.1946	0.5027	0.462	MIR29B1	1
BP	GO:0015865	purine nucleotide transport	1/223	18/18670	0.1946	0.5027	0.462	GJA1	1
BP	GO:0031065	positive regulation of histone deacetylation	1/223	18/18670	0.1946	0.5027	0.462	ING2	1
BP	GO:0034199	activation of protein kinase A activity	1/223	18/18670	0.1946	0.5027	0.462	PRKAR2B	1
BP	GO:0035089	establishment of apical/basal cell polarity	1/223	18/18670	0.1946	0.5027	0.462	CAMSAP3	1
BP	GO:0036166	phenotypic switching	1/223	18/18670	0.1946	0.5027	0.462	MIR21	1
BP	GO:0042772	DNA damage response, signal transduction resulting in transcription	1/223	18/18670	0.1946	0.5027	0.462	CDKN1A	1
BP	GO:0043555	regulation of translation in response to stress	1/223	18/18670	0.1946	0.5027	0.462	EIF2AK1	1
BP	GO:0045653	negative regulation of megakaryocyte differentiation	1/223	18/18670	0.1946	0.5027	0.462	PF4	1
BP	GO:0048268	clathrin coat assembly	1/223	18/18670	0.1946	0.5027	0.462	FCHO1	1
BP	GO:0048339	paraxial mesoderm development	1/223	18/18670	0.1946	0.5027	0.462	EPB41L5	1
BP	GO:0048557	embryonic digestive tract morphogenesis	1/223	18/18670	0.1946	0.5027	0.462	RBPMS2	1
BP	GO:0060749	mammary gland alveolus development	1/223	18/18670	0.1946	0.5027	0.462	EGF	1
BP	GO:0061377	mammary gland lobule development	1/223	18/18670	0.1946	0.5027	0.462	EGF	1
BP	GO:0070233	negative regulation of T cell apoptotic process	1/223	18/18670	0.1946	0.5027	0.462	ARG2	1
BP	GO:0090026	positive regulation of monocyte chemotaxis	1/223	18/18670	0.1946	0.5027	0.462	ANO6	1
BP	GO:0090330	regulation of platelet aggregation	1/223	18/18670	0.1946	0.5027	0.462	DMTN	1
BP	GO:1900221	regulation of amyloid-beta clearance	1/223	18/18670	0.1946	0.5027	0.462	CLU	1
BP	GO:1902165	regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1/223	18/18670	0.1946	0.5027	0.462	ING2	1
BP	GO:2000319	regulation of T-helper 17 cell differentiation	1/223	18/18670	0.1946	0.5027	0.462	MIR21	1
BP	GO:2000479	regulation of cAMP-dependent protein kinase activity	1/223	18/18670	0.1946	0.5027	0.462	PRKAR2B	1
BP	GO:2000647	negative regulation of stem cell proliferation	1/223	18/18670	0.1946	0.5027	0.462	MIR29B1	1
BP	GO:2000757	negative regulation of peptidyl-lysine acetylation	1/223	18/18670	0.1946	0.5027	0.462	SNCA	1
BP	GO:0033627	cell adhesion mediated by integrin	2/223	68/18670	0.1951	0.5036	0.4627	ITGB3/ITGB5	2
BP	GO:0042594	response to starvation	4/223	191/18670	0.1952	0.5036	0.4628	CDKN1A/EIF2AK1/UGT1A1/PRKAA2	4
BP	GO:0002687	positive regulation of leukocyte migration	3/223	128/18670	0.1973	0.5079	0.4667	ITGA2B/ANO6/SELP	3
BP	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	4/223	192/18670	0.1977	0.5079	0.4667	ITGB3/EGF/NRG1/SOCS3	4
BP	GO:0010506	regulation of autophagy	6/223	327/18670	0.1978	0.5079	0.4667	CTSA/PHF23/CTTN/ATG101/SNCA/PRKAA2	6
BP	GO:0046677	response to antibiotic	6/223	327/18670	0.1978	0.5079	0.4667	SPARC/CLU/CYP1A1/UGT1A1/MIR21/CYP2E1	6
BP	GO:0051604	protein maturation	7/223	397/18670	0.1982	0.5079	0.4667	ISCA1/CLU/PCSK6/PROS1/CLN5/C3/SPCS2	7
BP	GO:0015909	long-chain fatty acid transport	2/223	69/18670	0.1994	0.5079	0.4667	SPX/PRKAA2	2
BP	GO:0016485	protein processing	6/223	328/18670	0.1997	0.5079	0.4667	CLU/PCSK6/PROS1/CLN5/C3/SPCS2	6
BP	GO:0044106	cellular amine metabolic process	3/223	129/18670	0.2003	0.5079	0.4667	ODC1/SNCA/MIR21	3
BP	GO:1903038	negative regulation of leukocyte cell-cell adhesion	3/223	129/18670	0.2003	0.5079	0.4667	PDE5A/ARG2/MIR21	3
BP	GO:0008654	phospholipid biosynthetic process	5/223	260/18670	0.2007	0.5079	0.4667	PITPNM2/FITM1/PCYT1B/PDGFA/PI4K2A	5
BP	GO:0099504	synaptic vesicle cycle	4/223	194/18670	0.2026	0.5079	0.4667	CALM3/POTEKP/SNCA/SYT7	4
BP	GO:0007015	actin filament organization	7/223	400/18670	0.2032	0.5079	0.4667	CTTN/RHOBTB1/ITGB5/DMTN/VIL1/MIR21/ARHGAP6	7
BP	GO:0001655	urogenital system development	6/223	330/18670	0.2033	0.5079	0.4667	ODC1/SULF1/RGN/PDGFA/ARG2/EPHB2	6
BP	GO:0050671	positive regulation of lymphocyte proliferation	3/223	130/18670	0.2034	0.5079	0.4667	CDKN1A/MPL/MIR21	3
BP	GO:0010517	regulation of phospholipase activity	2/223	70/18670	0.2038	0.5079	0.4667	SNCA/ARHGAP6	2
BP	GO:0050766	positive regulation of phagocytosis	2/223	70/18670	0.2038	0.5079	0.4667	ANO6/C3	2
BP	GO:0060395	SMAD protein signal transduction	2/223	70/18670	0.2038	0.5079	0.4667	DAB2/VEPH1	2
BP	GO:0072091	regulation of stem cell proliferation	2/223	70/18670	0.2038	0.5079	0.4667	PIM1/MIR29B1	2
BP	GO:2001259	positive regulation of cation channel activity	2/223	70/18670	0.2038	0.5079	0.4667	CALM3/EPHB2	2
BP	GO:0002544	chronic inflammatory response	1/223	19/18670	0.2042	0.5079	0.4667	GJA1	1
BP	GO:0002922	positive regulation of humoral immune response	1/223	19/18670	0.2042	0.5079	0.4667	C3	1
BP	GO:0003159	morphogenesis of an endothelium	1/223	19/18670	0.2042	0.5079	0.4667	MIR21	1
BP	GO:0007350	blastoderm segmentation	1/223	19/18670	0.2042	0.5079	0.4667	PCSK6	1
BP	GO:0010523	negative regulation of calcium ion transport into cytosol	1/223	19/18670	0.2042	0.5079	0.4667	CALM3	1
BP	GO:0010544	negative regulation of platelet activation	1/223	19/18670	0.2042	0.5079	0.4667	PDGFA	1
BP	GO:0010888	negative regulation of lipid storage	1/223	19/18670	0.2042	0.5079	0.4667	ITGB3	1
BP	GO:0016082	synaptic vesicle priming	1/223	19/18670	0.2042	0.5079	0.4667	SNCA	1
BP	GO:0030859	polarized epithelial cell differentiation	1/223	19/18670	0.2042	0.5079	0.4667	CAMSAP3	1
BP	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	1/223	19/18670	0.2042	0.5079	0.4667	ITGB3	1
BP	GO:0032026	response to magnesium ion	1/223	19/18670	0.2042	0.5079	0.4667	SNCA	1
BP	GO:0032095	regulation of response to food	1/223	19/18670	0.2042	0.5079	0.4667	SPX	1
BP	GO:0032700	negative regulation of interleukin-17 production	1/223	19/18670	0.2042	0.5079	0.4667	ARG2	1
BP	GO:0033189	response to vitamin A	1/223	19/18670	0.2042	0.5079	0.4667	CYP1A1	1
BP	GO:0034063	stress granule assembly	1/223	19/18670	0.2042	0.5079	0.4667	PRKAA2	1
BP	GO:0034312	diol biosynthetic process	1/223	19/18670	0.2042	0.5079	0.4667	PTS	1
BP	GO:0035493	SNARE complex assembly	1/223	19/18670	0.2042	0.5079	0.4667	SNCA	1
BP	GO:0035728	response to hepatocyte growth factor	1/223	19/18670	0.2042	0.5079	0.4667	VIL1	1
BP	GO:0045947	negative regulation of translational initiation	1/223	19/18670	0.2042	0.5079	0.4667	EIF2AK1	1
BP	GO:0060004	reflex	1/223	19/18670	0.2042	0.5079	0.4667	GJA1	1
BP	GO:0061154	endothelial tube morphogenesis	1/223	19/18670	0.2042	0.5079	0.4667	MIR21	1
BP	GO:0071071	regulation of phospholipid biosynthetic process	1/223	19/18670	0.2042	0.5079	0.4667	PDGFA	1
BP	GO:0090201	negative regulation of release of cytochrome c from mitochondria	1/223	19/18670	0.2042	0.5079	0.4667	CLU	1
BP	GO:1900409	positive regulation of cellular response to oxidative stress	1/223	19/18670	0.2042	0.5079	0.4667	RGN	1
BP	GO:1905288	vascular associated smooth muscle cell apoptotic process	1/223	19/18670	0.2042	0.5079	0.4667	MIR21	1
BP	GO:1905459	regulation of vascular associated smooth muscle cell apoptotic process	1/223	19/18670	0.2042	0.5079	0.4667	MIR21	1
BP	GO:2000010	positive regulation of protein localization to cell surface	1/223	19/18670	0.2042	0.5079	0.4667	MAP1A	1
BP	GO:0032946	positive regulation of mononuclear cell proliferation	3/223	131/18670	0.2065	0.5127	0.4712	CDKN1A/MPL/MIR21	3
BP	GO:0098754	detoxification	3/223	131/18670	0.2065	0.5127	0.4712	PTGS1/RGN/MIR21	3
BP	GO:0001763	morphogenesis of a branching structure	4/223	196/18670	0.2075	0.5149	0.4731	EGF/SULF1/PDGFA/SOCS3	4
BP	GO:0050795	regulation of behavior	2/223	71/18670	0.2081	0.5153	0.4735	KCNA2/GJA1	2
BP	GO:0032147	activation of protein kinase activity	6/223	333/18670	0.2089	0.5153	0.4735	ITGB3/PRKAR2B/EGF/NRG1/MIR21/SPDYA	6
BP	GO:1903706	regulation of hemopoiesis	8/223	475/18670	0.2091	0.5153	0.4735	MYL9/PIM1/ITGA2B/LOX/MPL/GNAS/PF4/MIR21	8
BP	GO:0003158	endothelium development	3/223	132/18670	0.2096	0.5153	0.4735	GJA1/NRG1/MIR21	3
BP	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	3/223	132/18670	0.2096	0.5153	0.4735	CRADD/SNCA/CASC2	3
BP	GO:0045598	regulation of fat cell differentiation	3/223	132/18670	0.2096	0.5153	0.4735	CCDC3/MIR29B1/MIR21	3
BP	GO:0006635	fatty acid beta-oxidation	2/223	72/18670	0.2125	0.5153	0.4735	AMACR/CRAT	2
BP	GO:1903051	negative regulation of proteolysis involved in cellular protein catabolic process	2/223	72/18670	0.2125	0.5153	0.4735	CAMLG/MAP1A	2
BP	GO:1903747	regulation of establishment of protein localization to mitochondrion	2/223	72/18670	0.2125	0.5153	0.4735	ABLIM3/HSPA1L	2
BP	GO:0042770	signal transduction in response to DNA damage	3/223	133/18670	0.2127	0.5153	0.4735	CDKN1A/CRADD/MIR21	3
BP	GO:0044839	cell cycle G2/M phase transition	5/223	266/18670	0.2134	0.5153	0.4735	CALM3/CDKN1A/FHL1/PRKAR2B/MIR21	5
BP	GO:0007095	mitotic G2 DNA damage checkpoint	1/223	20/18670	0.2137	0.5153	0.4735	MIR21	1
BP	GO:0008356	asymmetric cell division	1/223	20/18670	0.2137	0.5153	0.4735	ING2	1
BP	GO:0010002	cardioblast differentiation	1/223	20/18670	0.2137	0.5153	0.4735	NRG1	1
BP	GO:0030220	platelet formation	1/223	20/18670	0.2137	0.5153	0.4735	MPL	1
BP	GO:0032769	negative regulation of monooxygenase activity	1/223	20/18670	0.2137	0.5153	0.4735	SNCA	1
BP	GO:0042053	regulation of dopamine metabolic process	1/223	20/18670	0.2137	0.5153	0.4735	SNCA	1
BP	GO:0042069	regulation of catecholamine metabolic process	1/223	20/18670	0.2137	0.5153	0.4735	SNCA	1
BP	GO:0043691	reverse cholesterol transport	1/223	20/18670	0.2137	0.5153	0.4735	CLU	1
BP	GO:0043931	ossification involved in bone maturation	1/223	20/18670	0.2137	0.5153	0.4735	ANO6	1
BP	GO:0045019	negative regulation of nitric oxide biosynthetic process	1/223	20/18670	0.2137	0.5153	0.4735	RGN	1
BP	GO:0046931	pore complex assembly	1/223	20/18670	0.2137	0.5153	0.4735	ANO6	1
BP	GO:0048148	behavioral response to cocaine	1/223	20/18670	0.2137	0.5153	0.4735	SNCA	1
BP	GO:0048745	smooth muscle tissue development	1/223	20/18670	0.2137	0.5153	0.4735	MYLK	1
BP	GO:0050802	circadian sleep/wake cycle, sleep	1/223	20/18670	0.2137	0.5153	0.4735	KCNA2	1
BP	GO:0051016	barbed-end actin filament capping	1/223	20/18670	0.2137	0.5153	0.4735	VIL1	1
BP	GO:0061162	establishment of monopolar cell polarity	1/223	20/18670	0.2137	0.5153	0.4735	CAMSAP3	1
BP	GO:0086014	atrial cardiac muscle cell action potential	1/223	20/18670	0.2137	0.5153	0.4735	GJA1	1
BP	GO:0086026	atrial cardiac muscle cell to AV node cell signaling	1/223	20/18670	0.2137	0.5153	0.4735	GJA1	1
BP	GO:0086066	atrial cardiac muscle cell to AV node cell communication	1/223	20/18670	0.2137	0.5153	0.4735	GJA1	1
BP	GO:0090370	negative regulation of cholesterol efflux	1/223	20/18670	0.2137	0.5153	0.4735	EGF	1
BP	GO:0097062	dendritic spine maintenance	1/223	20/18670	0.2137	0.5153	0.4735	CTTN	1
BP	GO:1900017	positive regulation of cytokine production involved in inflammatory response	1/223	20/18670	0.2137	0.5153	0.4735	MIR21	1
BP	GO:1901881	positive regulation of protein depolymerization	1/223	20/18670	0.2137	0.5153	0.4735	VIL1	1
BP	GO:1902993	positive regulation of amyloid precursor protein catabolic process	1/223	20/18670	0.2137	0.5153	0.4735	CLU	1
BP	GO:1904406	negative regulation of nitric oxide metabolic process	1/223	20/18670	0.2137	0.5153	0.4735	RGN	1
BP	GO:2000774	positive regulation of cellular senescence	1/223	20/18670	0.2137	0.5153	0.4735	ARG2	1
BP	GO:0031032	actomyosin structure organization	4/223	199/18670	0.215	0.5153	0.4735	EPB41L5/ITGB5/MIR21/ARHGAP6	4
BP	GO:0050866	negative regulation of cell activation	4/223	199/18670	0.215	0.5153	0.4735	PDE5A/PDGFA/ARG2/MIR21	4
BP	GO:0043087	regulation of GTPase activity	8/223	479/18670	0.2154	0.5153	0.4735	TAX1BP3/TRAPPC6B/CAV2/RGN/ARHGAP21/MIR21/ASAP2/ARHGAP6	8
BP	GO:0072331	signal transduction by p53 class mediator	5/223	267/18670	0.2155	0.5153	0.4735	CDKN1A/ING2/CRADD/PRKAA2/MIR21	5
BP	GO:0002920	regulation of humoral immune response	3/223	134/18670	0.2158	0.5153	0.4735	CLU/PROS1/C3	3
BP	GO:0030260	entry into host cell	3/223	134/18670	0.2158	0.5153	0.4735	ITGB3/ITGB5/CAV2	3
BP	GO:0032273	positive regulation of protein polymerization	3/223	134/18670	0.2158	0.5153	0.4735	CTTN/RHOBTB1/VIL1	3
BP	GO:0044409	entry into host	3/223	134/18670	0.2158	0.5153	0.4735	ITGB3/ITGB5/CAV2	3
BP	GO:0051806	entry into cell of other organism involved in symbiotic interaction	3/223	134/18670	0.2158	0.5153	0.4735	ITGB3/ITGB5/CAV2	3
BP	GO:0051828	entry into other organism involved in symbiotic interaction	3/223	134/18670	0.2158	0.5153	0.4735	ITGB3/ITGB5/CAV2	3
BP	GO:0060537	muscle tissue development	7/223	408/18670	0.2168	0.5153	0.4735	XK/PIM1/LOX/GJA1/NRG1/MYLK/CAV2	7
BP	GO:0000281	mitotic cytokinesis	2/223	73/18670	0.2169	0.5153	0.4735	KIF4A/JTB	2
BP	GO:0006801	superoxide metabolic process	2/223	73/18670	0.2169	0.5153	0.4735	RGN/MIR21	2
BP	GO:0032945	negative regulation of mononuclear cell proliferation	2/223	73/18670	0.2169	0.5153	0.4735	PDE5A/ARG2	2
BP	GO:0050672	negative regulation of lymphocyte proliferation	2/223	73/18670	0.2169	0.5153	0.4735	PDE5A/ARG2	2
BP	GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide	2/223	73/18670	0.2169	0.5153	0.4735	PPBP/PF4	2
BP	GO:1901983	regulation of protein acetylation	2/223	73/18670	0.2169	0.5153	0.4735	SNCA/PRKAA2	2
BP	GO:1903524	positive regulation of blood circulation	2/223	73/18670	0.2169	0.5153	0.4735	GJA1/MIR21	2
BP	GO:0010324	membrane invagination	3/223	135/18670	0.2189	0.5153	0.4735	ANO6/RHOBTB1/C3	3
BP	GO:0006836	neurotransmitter transport	5/223	269/18670	0.2198	0.5153	0.4735	CALM3/ITGB3/SNCAIP/SNCA/SYT7	5
BP	GO:0071496	cellular response to external stimulus	6/223	339/18670	0.2203	0.5153	0.4735	CDKN1A/PIM1/GJA1/CRADD/MMP7/PRKAA2	6
BP	GO:0009064	glutamine family amino acid metabolic process	2/223	74/18670	0.2213	0.5153	0.4735	ARG2/MIR21	2
BP	GO:0051145	smooth muscle cell differentiation	2/223	74/18670	0.2213	0.5153	0.4735	RBPMS2/MIR21	2
BP	GO:0070373	negative regulation of ERK1 and ERK2 cascade	2/223	74/18670	0.2213	0.5153	0.4735	EPHB2/MIR21	2
BP	GO:1900076	regulation of cellular response to insulin stimulus	2/223	74/18670	0.2213	0.5153	0.4735	GRB14/SOCS3	2
BP	GO:0045927	positive regulation of growth	5/223	270/18670	0.222	0.5153	0.4735	PIM1/ZFYVE27/FOXS1/FAM122A/VIL1	5
BP	GO:0001956	positive regulation of neurotransmitter secretion	1/223	21/18670	0.2231	0.5153	0.4735	SNCA	1
BP	GO:0002029	desensitization of G protein-coupled receptor signaling pathway	1/223	21/18670	0.2231	0.5153	0.4735	ARR3	1
BP	GO:0002438	acute inflammatory response to antigenic stimulus	1/223	21/18670	0.2231	0.5153	0.4735	C3	1
BP	GO:0006144	purine nucleobase metabolic process	1/223	21/18670	0.2231	0.5153	0.4735	GMPR	1
BP	GO:0006622	protein targeting to lysosome	1/223	21/18670	0.2231	0.5153	0.4735	CLU	1
BP	GO:0007035	vacuolar acidification	1/223	21/18670	0.2231	0.5153	0.4735	CLN5	1
BP	GO:0009713	catechol-containing compound biosynthetic process	1/223	21/18670	0.2231	0.5153	0.4735	SNCA	1
BP	GO:0010310	regulation of hydrogen peroxide metabolic process	1/223	21/18670	0.2231	0.5153	0.4735	SNCA	1
BP	GO:0015874	norepinephrine transport	1/223	21/18670	0.2231	0.5153	0.4735	SNCA	1
BP	GO:0017000	antibiotic biosynthetic process	1/223	21/18670	0.2231	0.5153	0.4735	CYP1A1	1
BP	GO:0022401	negative adaptation of signaling pathway	1/223	21/18670	0.2231	0.5153	0.4735	ARR3	1
BP	GO:0030277	maintenance of gastrointestinal epithelium	1/223	21/18670	0.2231	0.5153	0.4735	MUC13	1
BP	GO:0031290	retinal ganglion cell axon guidance	1/223	21/18670	0.2231	0.5153	0.4735	EPHB2	1
BP	GO:0032516	positive regulation of phosphoprotein phosphatase activity	1/223	21/18670	0.2231	0.5153	0.4735	CALM3	1
BP	GO:0032682	negative regulation of chemokine production	1/223	21/18670	0.2231	0.5153	0.4735	ARG2	1
BP	GO:0034389	lipid droplet organization	1/223	21/18670	0.2231	0.5153	0.4735	FITM1	1
BP	GO:0035590	purinergic nucleotide receptor signaling pathway	1/223	21/18670	0.2231	0.5153	0.4735	ANO6	1
BP	GO:0035813	regulation of renal sodium excretion	1/223	21/18670	0.2231	0.5153	0.4735	SPX	1
BP	GO:0036344	platelet morphogenesis	1/223	21/18670	0.2231	0.5153	0.4735	MPL	1
BP	GO:0036507	protein demannosylation	1/223	21/18670	0.2231	0.5153	0.4735	RNF103	1
BP	GO:0036508	protein alpha-1,2-demannosylation	1/223	21/18670	0.2231	0.5153	0.4735	RNF103	1
BP	GO:0042423	catecholamine biosynthetic process	1/223	21/18670	0.2231	0.5153	0.4735	SNCA	1
BP	GO:0042749	regulation of circadian sleep/wake cycle	1/223	21/18670	0.2231	0.5153	0.4735	KCNA2	1
BP	GO:0046132	pyrimidine ribonucleoside biosynthetic process	1/223	21/18670	0.2231	0.5153	0.4735	UPP2	1
BP	GO:0046716	muscle cell cellular homeostasis	1/223	21/18670	0.2231	0.5153	0.4735	LOX	1
BP	GO:0060044	negative regulation of cardiac muscle cell proliferation	1/223	21/18670	0.2231	0.5153	0.4735	GJA1	1
BP	GO:0060713	labyrinthine layer morphogenesis	1/223	21/18670	0.2231	0.5153	0.4735	SOCS3	1
BP	GO:0061339	establishment or maintenance of monopolar cell polarity	1/223	21/18670	0.2231	0.5153	0.4735	CAMSAP3	1
BP	GO:0070734	histone H3-K27 methylation	1/223	21/18670	0.2231	0.5153	0.4735	EZH1	1
BP	GO:1902884	positive regulation of response to oxidative stress	1/223	21/18670	0.2231	0.5153	0.4735	RGN	1
BP	GO:1904753	negative regulation of vascular associated smooth muscle cell migration	1/223	21/18670	0.2231	0.5153	0.4735	MIR21	1
BP	GO:2000316	regulation of T-helper 17 type immune response	1/223	21/18670	0.2231	0.5153	0.4735	MIR21	1
BP	GO:2000810	regulation of bicellular tight junction assembly	1/223	21/18670	0.2231	0.5153	0.4735	GJA1	1
BP	GO:1901617	organic hydroxy compound biosynthetic process	5/223	271/18670	0.2241	0.5163	0.4744	AMACR/PTS/SNCA/FAXDC2/PRKAA2	5
BP	GO:0031644	regulation of neurological system process	3/223	137/18670	0.2251	0.5163	0.4744	TMEM108/IGSF9B/SPX	3
BP	GO:0034605	cellular response to heat	3/223	137/18670	0.2251	0.5163	0.4744	PTGES3/CDKN1A/HSPA1L	3
BP	GO:0060048	cardiac muscle contraction	3/223	137/18670	0.2251	0.5163	0.4744	CALM3/PDE5A/GJA1	3
BP	GO:1903670	regulation of sprouting angiogenesis	3/223	137/18670	0.2251	0.5163	0.4744	MIR29C/MIR196A2/MMRN2	3
BP	GO:0001707	mesoderm formation	2/223	75/18670	0.2257	0.5163	0.4744	ITGB3/EPB41L5	2
BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	2/223	75/18670	0.2257	0.5163	0.4744	CCDC3/MIR21	2
BP	GO:0007422	peripheral nervous system development	2/223	75/18670	0.2257	0.5163	0.4744	SH3TC2/NRG1	2
BP	GO:0010611	regulation of cardiac muscle hypertrophy	2/223	75/18670	0.2257	0.5163	0.4744	PDE5A/MIR21	2
BP	GO:0015914	phospholipid transport	2/223	75/18670	0.2257	0.5163	0.4744	PITPNM2/PLEKHA8P1	2
BP	GO:0046173	polyol biosynthetic process	2/223	75/18670	0.2257	0.5163	0.4744	PTS/SNCA	2
BP	GO:0150076	neuroinflammatory response	2/223	75/18670	0.2257	0.5163	0.4744	CLU/SNCA	2
BP	GO:1903201	regulation of oxidative stress-induced cell death	2/223	75/18670	0.2257	0.5163	0.4744	MIR29B1/MIR21	2
BP	GO:1902905	positive regulation of supramolecular fiber organization	4/223	204/18670	0.2276	0.5182	0.4762	CLU/CTTN/RHOBTB1/VIL1	4
BP	GO:0030048	actin filament-based movement	3/223	138/18670	0.2283	0.5182	0.4762	EPB41L5/GJA1/VIL1	3
BP	GO:0000380	alternative mRNA splicing, via spliceosome	2/223	76/18670	0.2301	0.5182	0.4762	SRSF5/MBNL3	2
BP	GO:0007492	endoderm development	2/223	76/18670	0.2301	0.5182	0.4762	EPB41L5/ITGB5	2
BP	GO:0030500	regulation of bone mineralization	2/223	76/18670	0.2301	0.5182	0.4762	ANO6/GJA1	2
BP	GO:0042310	vasoconstriction	2/223	76/18670	0.2301	0.5182	0.4762	GJA1/MIR21	2
BP	GO:0046785	microtubule polymerization	2/223	76/18670	0.2301	0.5182	0.4762	CAMSAP3/SNCA	2
BP	GO:0046902	regulation of mitochondrial membrane permeability	2/223	76/18670	0.2301	0.5182	0.4762	MIR29C/MIR29B1	2
BP	GO:0048844	artery morphogenesis	2/223	76/18670	0.2301	0.5182	0.4762	MYLK/MIR29B1	2
BP	GO:0007189	adenylate cyclase-activating G protein-coupled receptor signaling pathway	3/223	139/18670	0.2314	0.5182	0.4762	GNAS/PF4/MC2R	3
BP	GO:0035304	regulation of protein dephosphorylation	3/223	139/18670	0.2314	0.5182	0.4762	CALM3/FAM122A/RGN	3
BP	GO:0070665	positive regulation of leukocyte proliferation	3/223	139/18670	0.2314	0.5182	0.4762	CDKN1A/MPL/MIR21	3
BP	GO:0009220	pyrimidine ribonucleotide biosynthetic process	1/223	22/18670	0.2324	0.5182	0.4762	UPP2	1
BP	GO:0010869	regulation of receptor biosynthetic process	1/223	22/18670	0.2324	0.5182	0.4762	ITGB3	1
BP	GO:0016226	iron-sulfur cluster assembly	1/223	22/18670	0.2324	0.5182	0.4762	ISCA1	1
BP	GO:0022010	central nervous system myelination	1/223	22/18670	0.2324	0.5182	0.4762	CLU	1
BP	GO:0023058	adaptation of signaling pathway	1/223	22/18670	0.2324	0.5182	0.4762	ARR3	1
BP	GO:0031163	metallo-sulfur cluster assembly	1/223	22/18670	0.2324	0.5182	0.4762	ISCA1	1
BP	GO:0032291	axon ensheathment in central nervous system	1/223	22/18670	0.2324	0.5182	0.4762	CLU	1
BP	GO:0032656	regulation of interleukin-13 production	1/223	22/18670	0.2324	0.5182	0.4762	ARG2	1
BP	GO:0033622	integrin activation	1/223	22/18670	0.2324	0.5182	0.4762	SELP	1
BP	GO:0034311	diol metabolic process	1/223	22/18670	0.2324	0.5182	0.4762	PTS	1
BP	GO:0035809	regulation of urine volume	1/223	22/18670	0.2324	0.5182	0.4762	BTC	1
BP	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	1/223	22/18670	0.2324	0.5182	0.4762	SULF1	1
BP	GO:0042359	vitamin D metabolic process	1/223	22/18670	0.2324	0.5182	0.4762	CYP1A1	1
BP	GO:0043496	regulation of protein homodimerization activity	1/223	22/18670	0.2324	0.5182	0.4762	NRG1	1
BP	GO:0045624	positive regulation of T-helper cell differentiation	1/223	22/18670	0.2324	0.5182	0.4762	MIR21	1
BP	GO:0045649	regulation of macrophage differentiation	1/223	22/18670	0.2324	0.5182	0.4762	PF4	1
BP	GO:0045723	positive regulation of fatty acid biosynthetic process	1/223	22/18670	0.2324	0.5182	0.4762	RGN	1
BP	GO:0051000	positive regulation of nitric-oxide synthase activity	1/223	22/18670	0.2324	0.5182	0.4762	CALM3	1
BP	GO:0070935	3'-UTR-mediated mRNA stabilization	1/223	22/18670	0.2324	0.5182	0.4762	RBM38	1
BP	GO:0071379	cellular response to prostaglandin stimulus	1/223	22/18670	0.2324	0.5182	0.4762	PRKAA2	1
BP	GO:0090312	positive regulation of protein deacetylation	1/223	22/18670	0.2324	0.5182	0.4762	ING2	1
BP	GO:0097320	plasma membrane tubulation	1/223	22/18670	0.2324	0.5182	0.4762	FCHO1	1
BP	GO:1901984	negative regulation of protein acetylation	1/223	22/18670	0.2324	0.5182	0.4762	SNCA	1
BP	GO:1903077	negative regulation of protein localization to plasma membrane	1/223	22/18670	0.2324	0.5182	0.4762	DAB2	1
BP	GO:0006109	regulation of carbohydrate metabolic process	4/223	206/18670	0.2327	0.5182	0.4762	EGF/SNCA/RGN/PRKAA2	4
BP	GO:0016054	organic acid catabolic process	5/223	275/18670	0.2328	0.5182	0.4762	AMACR/HGD/CRAT/ARG2/MIR21	5
BP	GO:0046395	carboxylic acid catabolic process	5/223	275/18670	0.2328	0.5182	0.4762	AMACR/HGD/CRAT/ARG2/MIR21	5
BP	GO:0048332	mesoderm morphogenesis	2/223	77/18670	0.2345	0.5215	0.4792	ITGB3/EPB41L5	2
BP	GO:0002064	epithelial cell development	4/223	207/18670	0.2352	0.5217	0.4794	EPB41L5/CDKN1A/GJA1/MIR29B1	4
BP	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	7/223	419/18670	0.2359	0.5217	0.4794	CLU/DAB2/CAMLG/SPOP/FAM122A/MAP1A/RNF103	7
BP	GO:0043588	skin development	7/223	419/18670	0.2359	0.5217	0.4794	KRT6B/PCSK6/GNAS/LCE2C/PDGFA/KRTAP19-4/KRT4	7
BP	GO:0008286	insulin receptor signaling pathway	3/223	141/18670	0.2378	0.5217	0.4794	GRB14/CAV2/SOCS3	3
BP	GO:0008306	associative learning	2/223	78/18670	0.2389	0.5217	0.4794	NRGN/MAP1A	2
BP	GO:0010827	regulation of glucose transmembrane transport	2/223	78/18670	0.2389	0.5217	0.4794	C3/ITLN1	2
BP	GO:0014743	regulation of muscle hypertrophy	2/223	78/18670	0.2389	0.5217	0.4794	PDE5A/MIR21	2
BP	GO:0032413	negative regulation of ion transmembrane transporter activity	2/223	78/18670	0.2389	0.5217	0.4794	CALM3/EPHB2	2
BP	GO:0055021	regulation of cardiac muscle tissue growth	2/223	78/18670	0.2389	0.5217	0.4794	PIM1/GJA1	2
BP	GO:0070664	negative regulation of leukocyte proliferation	2/223	78/18670	0.2389	0.5217	0.4794	PDE5A/ARG2	2
BP	GO:0001822	kidney development	5/223	278/18670	0.2394	0.5217	0.4794	ODC1/SULF1/RGN/PDGFA/ARG2	5
BP	GO:0060485	mesenchyme development	5/223	278/18670	0.2394	0.5217	0.4794	DAB2/EPB41L5/NRG1/MIR29B1/MIR21	5
BP	GO:0017148	negative regulation of translation	4/223	209/18670	0.2404	0.5217	0.4794	EIF2AK1/IGF2BP2/MIR29B1/MIR21	4
BP	GO:0035303	regulation of dephosphorylation	4/223	209/18670	0.2404	0.5217	0.4794	CALM3/CAMSAP3/FAM122A/RGN	4
BP	GO:0007030	Golgi organization	3/223	142/18670	0.2409	0.5217	0.4794	CAMSAP3/PI4K2A/ARHGAP21	3
BP	GO:0002347	response to tumor cell	1/223	23/18670	0.2416	0.5217	0.4794	CASC2	1
BP	GO:0007413	axonal fasciculation	1/223	23/18670	0.2416	0.5217	0.4794	EPHB2	1
BP	GO:0009067	aspartate family amino acid biosynthetic process	1/223	23/18670	0.2416	0.5217	0.4794	PLOD2	1
BP	GO:0009310	amine catabolic process	1/223	23/18670	0.2416	0.5217	0.4794	MIR21	1
BP	GO:0016338	calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	1/223	23/18670	0.2416	0.5217	0.4794	CLDN8	1
BP	GO:0022410	circadian sleep/wake cycle process	1/223	23/18670	0.2416	0.5217	0.4794	KCNA2	1
BP	GO:0032098	regulation of appetite	1/223	23/18670	0.2416	0.5217	0.4794	SPX	1
BP	GO:0032799	low-density lipoprotein receptor particle metabolic process	1/223	23/18670	0.2416	0.5217	0.4794	ITGB3	1
BP	GO:0034695	response to prostaglandin E	1/223	23/18670	0.2416	0.5217	0.4794	PRKAA2	1
BP	GO:0035812	renal sodium excretion	1/223	23/18670	0.2416	0.5217	0.4794	SPX	1
BP	GO:0042401	cellular biogenic amine biosynthetic process	1/223	23/18670	0.2416	0.5217	0.4794	ODC1	1
BP	GO:0043950	positive regulation of cAMP-mediated signaling	1/223	23/18670	0.2416	0.5217	0.4794	CALM3	1
BP	GO:0045821	positive regulation of glycolytic process	1/223	23/18670	0.2416	0.5217	0.4794	PRKAA2	1
BP	GO:0051004	regulation of lipoprotein lipase activity	1/223	23/18670	0.2416	0.5217	0.4794	PCSK6	1
BP	GO:0051152	positive regulation of smooth muscle cell differentiation	1/223	23/18670	0.2416	0.5217	0.4794	MIR21	1
BP	GO:0051589	negative regulation of neurotransmitter transport	1/223	23/18670	0.2416	0.5217	0.4794	SNCA	1
BP	GO:0060055	angiogenesis involved in wound healing	1/223	23/18670	0.2416	0.5217	0.4794	ITGB3	1
BP	GO:0060445	branching involved in salivary gland morphogenesis	1/223	23/18670	0.2416	0.5217	0.4794	PDGFA	1
BP	GO:0070977	bone maturation	1/223	23/18670	0.2416	0.5217	0.4794	ANO6	1
BP	GO:0071305	cellular response to vitamin D	1/223	23/18670	0.2416	0.5217	0.4794	PIM1	1
BP	GO:0071425	hematopoietic stem cell proliferation	1/223	23/18670	0.2416	0.5217	0.4794	PIM1	1
BP	GO:0071467	cellular response to pH	1/223	23/18670	0.2416	0.5217	0.4794	GJA1	1
BP	GO:0072215	regulation of metanephros development	1/223	23/18670	0.2416	0.5217	0.4794	PDGFA	1
BP	GO:0106030	neuron projection fasciculation	1/223	23/18670	0.2416	0.5217	0.4794	EPHB2	1
BP	GO:1901032	negative regulation of response to reactive oxygen species	1/223	23/18670	0.2416	0.5217	0.4794	MIR21	1
BP	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	1/223	23/18670	0.2416	0.5217	0.4794	MIR21	1
BP	GO:2000050	regulation of non-canonical Wnt signaling pathway	1/223	23/18670	0.2416	0.5217	0.4794	DAB2	1
BP	GO:2001039	negative regulation of cellular response to drug	1/223	23/18670	0.2416	0.5217	0.4794	MIR21	1
BP	GO:0055072	iron ion homeostasis	2/223	79/18670	0.2433	0.5247	0.4822	STEAP1/EIF2AK1	2
BP	GO:1900034	regulation of cellular response to heat	2/223	79/18670	0.2433	0.5247	0.4822	PTGES3/HSPA1L	2
BP	GO:0030879	mammary gland development	3/223	143/18670	0.2441	0.5261	0.4834	EGF/GJA1/NRG1	3
BP	GO:1902107	positive regulation of leukocyte differentiation	3/223	144/18670	0.2473	0.5277	0.485	GNAS/PF4/MIR21	3
BP	GO:0002088	lens development in camera-type eye	2/223	80/18670	0.2477	0.5277	0.485	CRYGN/GJA1	2
BP	GO:0022617	extracellular matrix disassembly	2/223	80/18670	0.2477	0.5277	0.485	MMP7/FAP	2
BP	GO:0070509	calcium ion import	2/223	80/18670	0.2477	0.5277	0.485	EGF/MCUR1	2
BP	GO:0097061	dendritic spine organization	2/223	80/18670	0.2477	0.5277	0.485	CTTN/EPHB2	2
BP	GO:0140029	exocytic process	2/223	80/18670	0.2477	0.5277	0.485	SNCA/DMTN	2
BP	GO:0000077	DNA damage checkpoint	3/223	145/18670	0.2505	0.5277	0.485	CDKN1A/CRADD/MIR21	3
BP	GO:0001919	regulation of receptor recycling	1/223	24/18670	0.2507	0.5277	0.485	SNCA	1
BP	GO:0002092	positive regulation of receptor internalization	1/223	24/18670	0.2507	0.5277	0.485	EGF	1
BP	GO:0002407	dendritic cell chemotaxis	1/223	24/18670	0.2507	0.5277	0.485	ANO6	1
BP	GO:0002861	regulation of inflammatory response to antigenic stimulus	1/223	24/18670	0.2507	0.5277	0.485	C3	1
BP	GO:0006862	nucleotide transport	1/223	24/18670	0.2507	0.5277	0.485	GJA1	1
BP	GO:0007141	male meiosis I	1/223	24/18670	0.2507	0.5277	0.485	ING2	1
BP	GO:0009110	vitamin biosynthetic process	1/223	24/18670	0.2507	0.5277	0.485	RGN	1
BP	GO:0009218	pyrimidine ribonucleotide metabolic process	1/223	24/18670	0.2507	0.5277	0.485	UPP2	1
BP	GO:0009309	amine biosynthetic process	1/223	24/18670	0.2507	0.5277	0.485	ODC1	1
BP	GO:0010288	response to lead ion	1/223	24/18670	0.2507	0.5277	0.485	SPARC	1
BP	GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	1/223	24/18670	0.2507	0.5277	0.485	CCDC3	1
BP	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	1/223	24/18670	0.2507	0.5277	0.485	CALM3	1
BP	GO:0014850	response to muscle activity	1/223	24/18670	0.2507	0.5277	0.485	PRKAA2	1
BP	GO:0018126	protein hydroxylation	1/223	24/18670	0.2507	0.5277	0.485	PLOD2	1
BP	GO:0031579	membrane raft organization	1/223	24/18670	0.2507	0.5277	0.485	CAV2	1
BP	GO:0032528	microvillus organization	1/223	24/18670	0.2507	0.5277	0.485	VIL1	1
BP	GO:0036010	protein localization to endosome	1/223	24/18670	0.2507	0.5277	0.485	EGF	1
BP	GO:0042104	positive regulation of activated T cell proliferation	1/223	24/18670	0.2507	0.5277	0.485	MIR21	1
BP	GO:0042832	defense response to protozoan	1/223	24/18670	0.2507	0.5277	0.485	PF4	1
BP	GO:0044062	regulation of excretion	1/223	24/18670	0.2507	0.5277	0.485	SPX	1
BP	GO:0045603	positive regulation of endothelial cell differentiation	1/223	24/18670	0.2507	0.5277	0.485	MIR21	1
BP	GO:0046426	negative regulation of JAK-STAT cascade	1/223	24/18670	0.2507	0.5277	0.485	SOCS3	1
BP	GO:0046697	decidualization	1/223	24/18670	0.2507	0.5277	0.485	GJA1	1
BP	GO:0071677	positive regulation of mononuclear cell migration	1/223	24/18670	0.2507	0.5277	0.485	ANO6	1
BP	GO:0099590	neurotransmitter receptor internalization	1/223	24/18670	0.2507	0.5277	0.485	ITGB3	1
BP	GO:1903649	regulation of cytoplasmic transport	1/223	24/18670	0.2507	0.5277	0.485	DAB2	1
BP	GO:1904376	negative regulation of protein localization to cell periphery	1/223	24/18670	0.2507	0.5277	0.485	DAB2	1
BP	GO:1905564	positive regulation of vascular endothelial cell proliferation	1/223	24/18670	0.2507	0.5277	0.485	MIR21	1
BP	GO:0014855	striated muscle cell proliferation	2/223	81/18670	0.2522	0.5288	0.486	PIM1/GJA1	2
BP	GO:0016126	sterol biosynthetic process	2/223	81/18670	0.2522	0.5288	0.486	FAXDC2/PRKAA2	2
BP	GO:0021766	hippocampus development	2/223	81/18670	0.2522	0.5288	0.486	TMEM108/EZH1	2
BP	GO:0060761	negative regulation of response to cytokine stimulus	2/223	81/18670	0.2522	0.5288	0.486	CCDC3/MIR21	2
BP	GO:0021700	developmental maturation	5/223	284/18670	0.2528	0.5288	0.486	CDKN1A/ANO6/GJA1/CLN5/C3	5
BP	GO:0015893	drug transport	4/223	214/18670	0.2533	0.5288	0.486	KCNA2/GJA1/SNCA/SYT7	4
BP	GO:2001020	regulation of response to DNA damage stimulus	4/223	214/18670	0.2533	0.5288	0.486	CLU/ING2/RTEL1/MIR21	4
BP	GO:0006959	humoral immune response	6/223	356/18670	0.2535	0.5288	0.486	CLU/PPBP/PROS1/PF4/C3/ITLN1	6
BP	GO:0035264	multicellular organism growth	3/223	146/18670	0.2537	0.5288	0.486	GNAS/FOXS1/VIL1	3
BP	GO:0045834	positive regulation of lipid metabolic process	3/223	146/18670	0.2537	0.5288	0.486	CCDC3/RGN/MIR29B1	3
BP	GO:0051250	negative regulation of lymphocyte activation	3/223	146/18670	0.2537	0.5288	0.486	PDE5A/ARG2/MIR21	3
BP	GO:0051052	regulation of DNA metabolic process	7/223	429/18670	0.2538	0.5288	0.486	PTGES3/MIR29C/CDKN1A/RTEL1/GJA1/RGN/MIR29B1	7
BP	GO:0051348	negative regulation of transferase activity	5/223	285/18670	0.255	0.5288	0.486	CDKN1A/PRKAR2B/RGN/EPHB2/SOCS3	5
BP	GO:0006644	phospholipid metabolic process	7/223	430/18670	0.2556	0.5288	0.486	PITPNM2/FITM1/PCYT1B/SNCA/PDGFA/PI4K2A/SOCS3	7
BP	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	4/223	215/18670	0.2559	0.5288	0.486	CRADD/SNCA/VIL1/CASC2	4
BP	GO:0010833	telomere maintenance via telomere lengthening	2/223	82/18670	0.2566	0.5288	0.486	PTGES3/RTEL1	2
BP	GO:0051279	regulation of release of sequestered calcium ion into cytosol	2/223	82/18670	0.2566	0.5288	0.486	CALM3/SNCA	2
BP	GO:0055117	regulation of cardiac muscle contraction	2/223	82/18670	0.2566	0.5288	0.486	CALM3/PDE5A	2
BP	GO:0060415	muscle tissue morphogenesis	2/223	82/18670	0.2566	0.5288	0.486	NRG1/MYLK	2
BP	GO:1905954	positive regulation of lipid localization	2/223	82/18670	0.2566	0.5288	0.486	FITM1/C3	2
BP	GO:0071236	cellular response to antibiotic	3/223	147/18670	0.2569	0.5288	0.486	CLU/UGT1A1/MIR21	3
BP	GO:0032869	cellular response to insulin stimulus	4/223	216/18670	0.2585	0.5288	0.486	SRSF5/GRB14/CAV2/SOCS3	4
BP	GO:0001562	response to protozoan	1/223	25/18670	0.2596	0.5288	0.486	PF4	1
BP	GO:0002053	positive regulation of mesenchymal cell proliferation	1/223	25/18670	0.2596	0.5288	0.486	PDGFA	1
BP	GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	1/223	25/18670	0.2596	0.5288	0.486	GJA1	1
BP	GO:0006851	mitochondrial calcium ion transmembrane transport	1/223	25/18670	0.2596	0.5288	0.486	MCUR1	1
BP	GO:0007026	negative regulation of microtubule depolymerization	1/223	25/18670	0.2596	0.5288	0.486	CAMSAP3	1
BP	GO:0007214	gamma-aminobutyric acid signaling pathway	1/223	25/18670	0.2596	0.5288	0.486	GABRA3	1
BP	GO:0014829	vascular smooth muscle contraction	1/223	25/18670	0.2596	0.5288	0.486	MIR21	1
BP	GO:0021952	central nervous system projection neuron axonogenesis	1/223	25/18670	0.2596	0.5288	0.486	EPHB2	1
BP	GO:0030813	positive regulation of nucleotide catabolic process	1/223	25/18670	0.2596	0.5288	0.486	PRKAA2	1
BP	GO:0032104	regulation of response to extracellular stimulus	1/223	25/18670	0.2596	0.5288	0.486	SPX	1
BP	GO:0032107	regulation of response to nutrient levels	1/223	25/18670	0.2596	0.5288	0.486	SPX	1
BP	GO:0032461	positive regulation of protein oligomerization	1/223	25/18670	0.2596	0.5288	0.486	CLU	1
BP	GO:0032616	interleukin-13 production	1/223	25/18670	0.2596	0.5288	0.486	ARG2	1
BP	GO:0034110	regulation of homotypic cell-cell adhesion	1/223	25/18670	0.2596	0.5288	0.486	DMTN	1
BP	GO:0035459	cargo loading into vesicle	1/223	25/18670	0.2596	0.5288	0.486	CTAGE1	1
BP	GO:0045662	negative regulation of myoblast differentiation	1/223	25/18670	0.2596	0.5288	0.486	MBNL3	1
BP	GO:0045672	positive regulation of osteoclast differentiation	1/223	25/18670	0.2596	0.5288	0.486	GNAS	1
BP	GO:0045724	positive regulation of cilium assembly	1/223	25/18670	0.2596	0.5288	0.486	MNS1	1
BP	GO:0045956	positive regulation of calcium ion-dependent exocytosis	1/223	25/18670	0.2596	0.5288	0.486	SYT7	1
BP	GO:0050901	leukocyte tethering or rolling	1/223	25/18670	0.2596	0.5288	0.486	SELP	1
BP	GO:0051197	positive regulation of coenzyme metabolic process	1/223	25/18670	0.2596	0.5288	0.486	PRKAA2	1
BP	GO:0051560	mitochondrial calcium ion homeostasis	1/223	25/18670	0.2596	0.5288	0.486	MCUR1	1
BP	GO:0051894	positive regulation of focal adhesion assembly	1/223	25/18670	0.2596	0.5288	0.486	EPB41L5	1
BP	GO:0060330	regulation of response to interferon-gamma	1/223	25/18670	0.2596	0.5288	0.486	SOCS3	1
BP	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	1/223	25/18670	0.2596	0.5288	0.486	SOCS3	1
BP	GO:0060571	morphogenesis of an epithelial fold	1/223	25/18670	0.2596	0.5288	0.486	SULF1	1
BP	GO:0090025	regulation of monocyte chemotaxis	1/223	25/18670	0.2596	0.5288	0.486	ANO6	1
BP	GO:1903588	negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	1/223	25/18670	0.2596	0.5288	0.486	MIR29C	1
BP	GO:2000353	positive regulation of endothelial cell apoptotic process	1/223	25/18670	0.2596	0.5288	0.486	ANO6	1
BP	GO:0008652	cellular amino acid biosynthetic process	2/223	83/18670	0.261	0.5306	0.4876	UPB1/PLOD2	2
BP	GO:0046474	glycerophospholipid biosynthetic process	4/223	217/18670	0.2612	0.5306	0.4876	PITPNM2/PCYT1B/PDGFA/PI4K2A	4
BP	GO:0071804	cellular potassium ion transport	4/223	217/18670	0.2612	0.5306	0.4876	FHL1/ANO6/KCNA2/MIR21	4
BP	GO:0071805	potassium ion transmembrane transport	4/223	217/18670	0.2612	0.5306	0.4876	FHL1/ANO6/KCNA2/MIR21	4
BP	GO:0042391	regulation of membrane potential	7/223	434/18670	0.2629	0.5339	0.4906	TMEM108/FHL1/IGSF9B/GABRA3/KCNA2/GJA1/SNCA	7
BP	GO:2001056	positive regulation of cysteine-type endopeptidase activity	3/223	149/18670	0.2633	0.5343	0.491	CRADD/SNCA/CASC2	3
BP	GO:0032886	regulation of microtubule-based process	4/223	218/18670	0.2638	0.5343	0.491	CAMSAP3/SNCA/MAP1A/PRKAA2	4
BP	GO:0000245	spliceosomal complex assembly	2/223	84/18670	0.2655	0.5343	0.491	SRSF5/RNVU1-3	2
BP	GO:0014910	regulation of smooth muscle cell migration	2/223	84/18670	0.2655	0.5343	0.491	PDGFA/MIR21	2
BP	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	2/223	84/18670	0.2655	0.5343	0.491	SNCA/VIL1	2
BP	GO:0045445	myoblast differentiation	2/223	84/18670	0.2655	0.5343	0.491	MBNL3/NRG1	2
BP	GO:0051492	regulation of stress fiber assembly	2/223	84/18670	0.2655	0.5343	0.491	MIR21/ARHGAP6	2
BP	GO:0060420	regulation of heart growth	2/223	84/18670	0.2655	0.5343	0.491	PIM1/GJA1	2
BP	GO:0097756	negative regulation of blood vessel diameter	2/223	84/18670	0.2655	0.5343	0.491	GJA1/MIR21	2
BP	GO:0007584	response to nutrient	4/223	219/18670	0.2664	0.5343	0.491	SPARC/PIM1/CYP1A1/UGT1A1	4
BP	GO:0008360	regulation of cell shape	3/223	150/18670	0.2666	0.5343	0.491	DMTN/VIL1/MIR21	3
BP	GO:0043434	response to peptide hormone	7/223	436/18670	0.2666	0.5343	0.491	SPARC/SRSF5/GRB14/PRKAR2B/GJA1/CAV2/SOCS3	7
BP	GO:0032366	intracellular sterol transport	1/223	26/18670	0.2685	0.5343	0.491	SYT7	1
BP	GO:0032367	intracellular cholesterol transport	1/223	26/18670	0.2685	0.5343	0.491	SYT7	1
BP	GO:0032800	receptor biosynthetic process	1/223	26/18670	0.2685	0.5343	0.491	ITGB3	1
BP	GO:0042745	circadian sleep/wake cycle	1/223	26/18670	0.2685	0.5343	0.491	KCNA2	1
BP	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	1/223	26/18670	0.2685	0.5343	0.491	MIR29C	1
BP	GO:0045992	negative regulation of embryonic development	1/223	26/18670	0.2685	0.5343	0.491	SULF1	1
BP	GO:0051125	regulation of actin nucleation	1/223	26/18670	0.2685	0.5343	0.491	VIL1	1
BP	GO:0051788	response to misfolded protein	1/223	26/18670	0.2685	0.5343	0.491	CLU	1
BP	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	1/223	26/18670	0.2685	0.5343	0.491	CALM3	1
BP	GO:0060669	embryonic placenta morphogenesis	1/223	26/18670	0.2685	0.5343	0.491	SOCS3	1
BP	GO:0060706	cell differentiation involved in embryonic placenta development	1/223	26/18670	0.2685	0.5343	0.491	SOCS3	1
BP	GO:0060740	prostate gland epithelium morphogenesis	1/223	26/18670	0.2685	0.5343	0.491	SULF1	1
BP	GO:0060914	heart formation	1/223	26/18670	0.2685	0.5343	0.491	PIM1	1
BP	GO:0071377	cellular response to glucagon stimulus	1/223	26/18670	0.2685	0.5343	0.491	PRKAR2B	1
BP	GO:0072539	T-helper 17 cell differentiation	1/223	26/18670	0.2685	0.5343	0.491	MIR21	1
BP	GO:0099560	synaptic membrane adhesion	1/223	26/18670	0.2685	0.5343	0.491	IGSF9B	1
BP	GO:1900120	regulation of receptor binding	1/223	26/18670	0.2685	0.5343	0.491	LOX	1
BP	GO:1903579	negative regulation of ATP metabolic process	1/223	26/18670	0.2685	0.5343	0.491	SNCA	1
BP	GO:1904353	regulation of telomere capping	1/223	26/18670	0.2685	0.5343	0.491	RTEL1	1
BP	GO:1904754	positive regulation of vascular associated smooth muscle cell migration	1/223	26/18670	0.2685	0.5343	0.491	MIR21	1
BP	GO:0016999	antibiotic metabolic process	3/223	151/18670	0.2698	0.5358	0.4923	CYP1A1/UGT1A1/SNCA	3
BP	GO:0072384	organelle transport along microtubule	2/223	85/18670	0.2699	0.5358	0.4923	ARHGAP21/PEX14	2
BP	GO:1904705	regulation of vascular smooth muscle cell proliferation	2/223	85/18670	0.2699	0.5358	0.4923	CDKN1A/MIR21	2
BP	GO:1990874	vascular smooth muscle cell proliferation	2/223	85/18670	0.2699	0.5358	0.4923	CDKN1A/MIR21	2
BP	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	4/223	221/18670	0.2717	0.539	0.4953	GNAZ/GNAS/PF4/MC2R	4
BP	GO:0001890	placenta development	3/223	152/18670	0.273	0.5399	0.4961	GJA1/MC2R/SOCS3	3
BP	GO:0048489	synaptic vesicle transport	3/223	152/18670	0.273	0.5399	0.4961	CALM3/SNCA/SYT7	3
BP	GO:0051028	mRNA transport	3/223	152/18670	0.273	0.5399	0.4961	SRSF5/IGF2BP2/NUTF2	3
BP	GO:0097480	establishment of synaptic vesicle localization	3/223	152/18670	0.273	0.5399	0.4961	CALM3/SNCA/SYT7	3
BP	GO:0051146	striated muscle cell differentiation	5/223	293/18670	0.2731	0.5399	0.4961	XK/LOX/NRG1/RBM38/CAV2	5
BP	GO:0072001	renal system development	5/223	293/18670	0.2731	0.5399	0.4961	ODC1/SULF1/RGN/PDGFA/ARG2	5
BP	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	2/223	86/18670	0.2743	0.5405	0.4967	CRADD/SNCA	2
BP	GO:0032760	positive regulation of tumor necrosis factor production	2/223	86/18670	0.2743	0.5405	0.4967	CLU/PF4	2
BP	GO:0090559	regulation of membrane permeability	2/223	86/18670	0.2743	0.5405	0.4967	MIR29C/MIR29B1	2
BP	GO:1903363	negative regulation of cellular protein catabolic process	2/223	86/18670	0.2743	0.5405	0.4967	CAMLG/MAP1A	2
BP	GO:0044706	multi-multicellular organism process	4/223	222/18670	0.2743	0.5405	0.4967	GJA1/CYP1A1/MMP7/MIR21	4
BP	GO:0050729	positive regulation of inflammatory response	3/223	153/18670	0.2763	0.5413	0.4974	C3/SNCA/MIR21	3
BP	GO:0045444	fat cell differentiation	4/223	223/18670	0.277	0.5413	0.4974	TMEM120B/CCDC3/MIR29B1/MIR21	4
BP	GO:0006884	cell volume homeostasis	1/223	27/18670	0.2772	0.5413	0.4974	ANO6	1
BP	GO:0007176	regulation of epidermal growth factor-activated receptor activity	1/223	27/18670	0.2772	0.5413	0.4974	EGF	1
BP	GO:0032201	telomere maintenance via semi-conservative replication	1/223	27/18670	0.2772	0.5413	0.4974	RTEL1	1
BP	GO:0034067	protein localization to Golgi apparatus	1/223	27/18670	0.2772	0.5413	0.4974	ARL5C	1
BP	GO:0035902	response to immobilization stress	1/223	27/18670	0.2772	0.5413	0.4974	CYP1A1	1
BP	GO:0036336	dendritic cell migration	1/223	27/18670	0.2772	0.5413	0.4974	ANO6	1
BP	GO:0045932	negative regulation of muscle contraction	1/223	27/18670	0.2772	0.5413	0.4974	PDE5A	1
BP	GO:0048799	animal organ maturation	1/223	27/18670	0.2772	0.5413	0.4974	ANO6	1
BP	GO:0051953	negative regulation of amine transport	1/223	27/18670	0.2772	0.5413	0.4974	SNCA	1
BP	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	1/223	27/18670	0.2772	0.5413	0.4974	GJA1	1
BP	GO:0060384	innervation	1/223	27/18670	0.2772	0.5413	0.4974	SULF1	1
BP	GO:0071514	genetic imprinting	1/223	27/18670	0.2772	0.5413	0.4974	GNAS	1
BP	GO:1905563	negative regulation of vascular endothelial cell proliferation	1/223	27/18670	0.2772	0.5413	0.4974	MIR29C	1
BP	GO:0048193	Golgi vesicle transport	6/223	368/18670	0.2777	0.5418	0.4978	KIF4A/TRAPPC6B/PROS1/KIF2A/RAB6B/CTAGE1	6
BP	GO:0030317	flagellated sperm motility	2/223	87/18670	0.2787	0.5432	0.4992	ING2/RGN	2
BP	GO:0097722	sperm motility	2/223	87/18670	0.2787	0.5432	0.4992	ING2/RGN	2
BP	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	3/223	154/18670	0.2795	0.5437	0.4996	MPL/ZFYVE27/DMTN	3
BP	GO:0017156	calcium ion regulated exocytosis	3/223	154/18670	0.2795	0.5437	0.4996	CALM3/SNCA/SYT7	3
BP	GO:0061025	membrane fusion	3/223	154/18670	0.2795	0.5437	0.4996	SNCA/CAV2/SYT7	3
CC	GO:0031091	platelet alpha granule	13/228	91/19717	4.059e-11	1.506e-08	1.346e-08	F13A1/SPARC/CLU/ITGB3/PPBP/TREML1/ITGA2B/PROS1/EGF/SELP/PF4/SNCA/PDGFA	13
CC	GO:0031093	platelet alpha granule lumen	8/228	67/19717	1.026e-06	0.0001352	0.0001208	F13A1/SPARC/CLU/PPBP/PROS1/EGF/PF4/PDGFA	8
CC	GO:0031092	platelet alpha granule membrane	5/228	17/19717	1.093e-06	0.0001352	0.0001208	SPARC/ITGB3/ITGA2B/SELP/SNCA	5
CC	GO:0005834	heterotrimeric G-protein complex	4/228	30/19717	0.0003769	0.02796	0.02499	GNG11/GNAZ/GNAS/GNG12	4
CC	GO:1905360	GTPase complex	4/228	30/19717	0.0003769	0.02796	0.02499	GNG11/GNAZ/GNAS/GNG12	4
CC	GO:0005925	focal adhesion	13/228	405/19717	0.0009131	0.04947	0.04421	DAB2/ITGB3/EPB41L5/FHL1/ITGA2B/CTTN/GJA1/PDLIM1/ITGB5/CAV2/VCL/FAP/TSPAN9	13
CC	GO:0005924	cell-substrate adherens junction	13/228	408/19717	0.0009765	0.04947	0.04421	DAB2/ITGB3/EPB41L5/FHL1/ITGA2B/CTTN/GJA1/PDLIM1/ITGB5/CAV2/VCL/FAP/TSPAN9	13
CC	GO:0030055	cell-substrate junction	13/228	412/19717	0.001067	0.04947	0.04421	DAB2/ITGB3/EPB41L5/FHL1/ITGA2B/CTTN/GJA1/PDLIM1/ITGB5/CAV2/VCL/FAP/TSPAN9	13
CC	GO:0034774	secretory granule lumen	11/228	321/19717	0.001337	0.0508	0.0454	F13A1/SPARC/CTSA/CLU/PPBP/PROS1/EGF/PF4/C3/VCL/PDGFA	11
CC	GO:0032432	actin filament bundle	5/228	75/19717	0.00177	0.0508	0.0454	MYL9/ABLIM3/MYLK/PDLIM1/VIL1	5
CC	GO:0005884	actin filament	6/228	111/19717	0.001848	0.0508	0.0454	CTTN/PDLIM1/POTEKP/DMTN/GNG12/ARHGAP6	6
CC	GO:0030027	lamellipodium	8/228	193/19717	0.001872	0.0508	0.0454	ABLIM3/ITGB3/KCNA2/CTTN/MYLK/FAP/VIL1/AMOTL1	8
CC	GO:0031258	lamellipodium membrane	3/228	22/19717	0.001998	0.0508	0.0454	ITGB3/KCNA2/FAP	3
CC	GO:0060205	cytoplasmic vesicle lumen	11/228	338/19717	0.002007	0.0508	0.0454	F13A1/SPARC/CTSA/CLU/PPBP/PROS1/EGF/PF4/C3/VCL/PDGFA	11
CC	GO:0031983	vesicle lumen	11/228	339/19717	0.002054	0.0508	0.0454	F13A1/SPARC/CTSA/CLU/PPBP/PROS1/EGF/PF4/C3/VCL/PDGFA	11
CC	GO:0031234	extrinsic component of cytoplasmic side of plasma membrane	5/228	91/19717	0.004111	0.09532	0.08519	GNG11/GNAZ/GNAS/CAV2/GNG12	5
CC	GO:0043025	neuronal cell body	13/228	497/19717	0.005367	0.1079	0.0964	PGRMC1/IGSF9B/PRKAR2B/MPL/KCNA2/NRGN/TTLL7/SNCAIP/SNCA/MAP1A/PI4K2A/PRKAA2/EPHB2	13
CC	GO:0008305	integrin complex	3/228	31/19717	0.005402	0.1079	0.0964	ITGB3/ITGA2B/ITGB5	3
CC	GO:0005916	fascia adherens	2/228	10/19717	0.005636	0.1079	0.0964	GJA1/VCL	2
CC	GO:0044438	microbody part	5/228	100/19717	0.006123	0.1079	0.0964	AMACR/PEX12/CRAT/SYT7/PEX14	5
CC	GO:0044439	peroxisomal part	5/228	100/19717	0.006123	0.1079	0.0964	AMACR/PEX12/CRAT/SYT7/PEX14	5
CC	GO:0031680	G-protein beta/gamma-subunit complex	2/228	11/19717	0.006836	0.1079	0.0964	GNG11/GNG12	2
CC	GO:0098636	protein complex involved in cell adhesion	3/228	34/19717	0.007012	0.1079	0.0964	ITGB3/ITGA2B/ITGB5	3
CC	GO:0072562	blood microparticle	6/228	147/19717	0.007332	0.1079	0.0964	F13A1/CLU/ITGA2B/PROS1/HSPA1L/C3	6
CC	GO:0001725	stress fiber	4/228	67/19717	0.007559	0.1079	0.0964	MYL9/ABLIM3/MYLK/PDLIM1	4
CC	GO:0097517	contractile actin filament bundle	4/228	67/19717	0.007559	0.1079	0.0964	MYL9/ABLIM3/MYLK/PDLIM1	4
CC	GO:0030665	clathrin-coated vesicle membrane	5/228	115/19717	0.01087	0.1494	0.1335	FCHO1/DAB2/EGF/BTC/NRGN	5
CC	GO:0042641	actomyosin	4/228	79/19717	0.01332	0.1764	0.1577	MYL9/ABLIM3/MYLK/PDLIM1	4
CC	GO:0033643	host cell part	2/228	16/19717	0.01436	0.1837	0.1642	PF4/PI4K2A	2
CC	GO:0031252	cell leading edge	10/228	403/19717	0.01926	0.2183	0.1951	ABLIM3/ITGB3/EPB41L5/GABRA3/KCNA2/CTTN/MYLK/FAP/VIL1/AMOTL1	10
CC	GO:0043292	contractile fiber	7/228	234/19717	0.01939	0.2183	0.1951	MYL9/CALM3/C10orf71/CALD1/GJA1/PDLIM1/VCL	7
CC	GO:0005777	peroxisome	5/228	134/19717	0.01986	0.2183	0.1951	AMACR/PEX12/CRAT/SYT7/PEX14	5
CC	GO:0042579	microbody	5/228	134/19717	0.01986	0.2183	0.1951	AMACR/PEX12/CRAT/SYT7/PEX14	5
CC	GO:0031045	dense core granule	2/228	19/19717	0.02	0.2183	0.1951	SPX/SYT7	2
CC	GO:0030667	secretory granule membrane	8/228	298/19717	0.023	0.2438	0.2179	SPARC/PGRMC1/ITGB3/ITGA2B/ANO6/SELP/SNCA/CAV2	8
CC	GO:0045111	intermediate filament cytoskeleton	7/228	251/19717	0.02713	0.2796	0.2498	MNS1/UPP2/KRT6B/GJA1/CLK3/KRTAP19-4/KRT4	7
CC	GO:1904115	axon cytoplasm	3/228	57/19717	0.02827	0.2834	0.2533	TMEM108/KIF4A/MAP1A	3
CC	GO:0097060	synaptic membrane	10/228	432/19717	0.02926	0.2848	0.2545	TMEM108/IGSF9B/GABRA3/KCNA2/NRGN/ANKS1B/SNCAIP/SYT7/PI4K2A/EPHB2	10
CC	GO:0005796	Golgi lumen	4/228	102/19717	0.03074	0.2848	0.2545	PCSK6/PROS1/MUC13/PDGFA	4
CC	GO:0005876	spindle microtubule	3/228	59/19717	0.03089	0.2848	0.2545	CALM3/KIF4A/KIF2A	3
CC	GO:0005778	peroxisomal membrane	3/228	60/19717	0.03224	0.2848	0.2545	PEX12/SYT7/PEX14	3
CC	GO:0031903	microbody membrane	3/228	60/19717	0.03224	0.2848	0.2545	PEX12/SYT7/PEX14	3
CC	GO:0009898	cytoplasmic side of plasma membrane	5/228	154/19717	0.03352	0.2892	0.2585	GNG11/GNAZ/GNAS/CAV2/GNG12	5
CC	GO:0005640	nuclear outer membrane	2/228	26/19717	0.03607	0.3041	0.2718	SNCA/NUTF2	2
CC	GO:0005882	intermediate filament	6/228	214/19717	0.03851	0.314	0.2806	MNS1/UPP2/KRT6B/GJA1/KRTAP19-4/KRT4	6
CC	GO:0042734	presynaptic membrane	5/228	161/19717	0.0394	0.314	0.2806	KCNA2/SNCAIP/SYT7/PI4K2A/EPHB2	5
CC	GO:1990351	transporter complex	8/228	332/19717	0.03978	0.314	0.2806	CALM3/PEX12/GABRA3/ANO6/KCNA2/TIMM8B/CTTN/PEX14	8
CC	GO:0019897	extrinsic component of plasma membrane	5/228	165/19717	0.04302	0.3286	0.2937	GNG11/GNAZ/GNAS/CAV2/GNG12	5
CC	GO:0005905	clathrin-coated pit	3/228	69/19717	0.04581	0.3286	0.2937	FCHO1/DAB2/CTTN	3
CC	GO:0030016	myofibril	6/228	224/19717	0.04631	0.3286	0.2937	MYL9/CALM3/C10orf71/CALD1/PDLIM1/VCL	6
CC	GO:0002102	podosome	2/228	30/19717	0.04685	0.3286	0.2937	CTTN/VCL	2
CC	GO:0005913	cell-cell adherens junction	4/228	117/19717	0.04702	0.3286	0.2937	CAMSAP3/GJA1/PDLIM1/VCL	4
CC	GO:0062023	collagen-containing extracellular matrix	9/228	406/19717	0.04714	0.3286	0.2937	F13A1/SPARC/CLU/PCSK6/LTBP1/PRG4/PF4/SULF1/MMRN2	9
CC	GO:0031256	leading edge membrane	5/228	170/19717	0.04783	0.3286	0.2937	ITGB3/EPB41L5/GABRA3/KCNA2/FAP	5
CC	GO:0098982	GABA-ergic synapse	3/228	71/19717	0.04916	0.3302	0.2951	IGSF9B/GABRA3/NRG1	3
CC	GO:0001726	ruffle	5/228	172/19717	0.04984	0.3302	0.2951	ITGB3/EPB41L5/CTTN/FAP/VIL1	5
CC	GO:0099056	integral component of presynaptic membrane	3/228	73/19717	0.05262	0.3425	0.3061	KCNA2/SYT7/EPHB2	3
CC	GO:0030427	site of polarized growth	5/228	176/19717	0.054	0.3454	0.3087	CALM3/ZFYVE27/CTTN/SNCA/PI4K2A	5
CC	GO:0098562	cytoplasmic side of membrane	5/228	178/19717	0.05615	0.3531	0.3156	GNG11/GNAZ/GNAS/CAV2/GNG12	5
CC	GO:0098793	presynapse	10/228	491/19717	0.06001	0.3686	0.3295	CALM3/RAB6B/SCGN/KCNA2/POTEKP/SNCAIP/SNCA/SYT7/PI4K2A/EPHB2	10
CC	GO:0030662	coated vesicle membrane	5/228	182/19717	0.06061	0.3686	0.3295	FCHO1/DAB2/EGF/BTC/NRGN	5
CC	GO:0005758	mitochondrial intermembrane space	3/228	79/19717	0.06367	0.3761	0.3362	TIMM8B/SNCA/SUOX	3
CC	GO:0008180	COP9 signalosome	2/228	36/19717	0.06488	0.3761	0.3362	HSPA1L/AMOTL1	2
CC	GO:0043198	dendritic shaft	2/228	36/19717	0.06488	0.3761	0.3362	PRKAR2B/MAP1A	2
CC	GO:0030136	clathrin-coated vesicle	5/228	188/19717	0.06766	0.3827	0.342	FCHO1/DAB2/EGF/BTC/NRGN	5
CC	GO:0031463	Cul3-RING ubiquitin ligase complex	2/228	37/19717	0.06808	0.3827	0.342	SPOP/KLHL7	2
CC	GO:0098889	intrinsic component of presynaptic membrane	3/228	82/19717	0.06957	0.3853	0.3443	KCNA2/SYT7/EPHB2	3
CC	GO:0005902	microvillus	3/228	83/19717	0.07159	0.3906	0.3491	ITGB3/PDGFA/VIL1	3
CC	GO:0120111	neuron projection cytoplasm	3/228	84/19717	0.07364	0.3959	0.3539	TMEM108/KIF4A/MAP1A	3
CC	GO:0033267	axon part	8/228	382/19717	0.07677	0.4069	0.3636	CALM3/TMEM108/KIF4A/KCNA2/ZFYVE27/CTTN/SNCA/MAP1A	8
CC	GO:0008076	voltage-gated potassium channel complex	3/228	87/19717	0.07993	0.4177	0.3733	CALM3/KCNA2/CTTN	3
CC	GO:0031970	organelle envelope lumen	3/228	88/19717	0.08208	0.4229	0.378	TIMM8B/SNCA/SUOX	3
CC	GO:0043296	apical junction complex	4/228	143/19717	0.08453	0.4273	0.3819	CLDN8/CAMSAP3/ESAM/AMOTL1	4
CC	GO:0030133	transport vesicle	8/228	392/19717	0.08604	0.4273	0.3819	CALM3/SCGN/SPX/NRGN/SNCAIP/SNCA/CAV2/SYT7	8
CC	GO:0005911	cell-cell junction	9/228	459/19717	0.08638	0.4273	0.3819	STEAP1/CLDN8/CAMSAP3/KCNA2/GJA1/ESAM/PDLIM1/VCL/AMOTL1	9
CC	GO:0030658	transport vesicle membrane	5/228	208/19717	0.09429	0.4502	0.4023	CALM3/SCGN/NRGN/SNCA/SYT7	5
CC	GO:0032587	ruffle membrane	3/228	94/19717	0.09547	0.4502	0.4023	ITGB3/EPB41L5/FAP	3
CC	GO:0099699	integral component of synaptic membrane	4/228	152/19717	0.1001	0.4502	0.4023	GABRA3/KCNA2/SYT7/EPHB2	4
CC	GO:0034705	potassium channel complex	3/228	96/19717	0.1001	0.4502	0.4023	CALM3/KCNA2/CTTN	3
CC	GO:0031253	cell projection membrane	7/228	345/19717	0.1065	0.4502	0.4023	ITGB3/EPB41L5/GABRA3/KCNA2/DMTN/FAP/ITLN1	7
CC	GO:0001527	microfibril	1/228	10/19717	0.1098	0.4502	0.4023	LTBP1	1
CC	GO:0033655	host cell cytoplasm part	1/228	10/19717	0.1098	0.4502	0.4023	PF4	1
CC	GO:0044224	juxtaparanode region of axon	1/228	10/19717	0.1098	0.4502	0.4023	KCNA2	1
CC	GO:0097197	tetraspanin-enriched microdomain	1/228	10/19717	0.1098	0.4502	0.4023	TSPAN9	1
CC	GO:0005874	microtubule	8/228	416/19717	0.1109	0.4502	0.4023	CALM3/TUBB1/KIF4A/CAMSAP3/KIF2A/TBCC/TTLL7/MAP1A	8
CC	GO:0098978	glutamatergic synapse	7/228	349/19717	0.1113	0.4502	0.4023	SPARC/ABLIM3/ITGB3/PRKAR2B/NRGN/NRG1/EPHB2	7
CC	GO:0014704	intercalated disc	2/228	50/19717	0.1138	0.4502	0.4023	GJA1/VCL	2
CC	GO:0034707	chloride channel complex	2/228	50/19717	0.1138	0.4502	0.4023	GABRA3/ANO6	2
CC	GO:0044449	contractile fiber part	5/228	221/19717	0.1141	0.4502	0.4023	MYL9/CALM3/C10orf71/PDLIM1/VCL	5
CC	GO:0005765	lysosomal membrane	7/228	354/19717	0.1175	0.4502	0.4023	CTSA/DAB2/MMD/EGF/CLN5/SYT7/PI4K2A	7
CC	GO:0005782	peroxisomal matrix	2/228	51/19717	0.1176	0.4502	0.4023	AMACR/CRAT	2
CC	GO:0031907	microbody lumen	2/228	51/19717	0.1176	0.4502	0.4023	AMACR/CRAT	2
CC	GO:0098852	lytic vacuole membrane	7/228	355/19717	0.1188	0.4502	0.4023	CTSA/DAB2/MMD/EGF/CLN5/SYT7/PI4K2A	7
CC	GO:0030672	synaptic vesicle membrane	3/228	104/19717	0.1196	0.4502	0.4023	CALM3/SNCA/SYT7	3
CC	GO:0099501	exocytic vesicle membrane	3/228	104/19717	0.1196	0.4502	0.4023	CALM3/SNCA/SYT7	3
CC	GO:0030430	host cell cytoplasm	1/228	11/19717	0.1201	0.4502	0.4023	PF4	1
CC	GO:0031094	platelet dense tubular network	1/228	11/19717	0.1201	0.4502	0.4023	DMTN	1
CC	GO:0032280	symmetric synapse	1/228	11/19717	0.1201	0.4502	0.4023	IGSF9B	1
CC	GO:0034663	endoplasmic reticulum chaperone complex	1/228	11/19717	0.1201	0.4502	0.4023	UGT1A1	1
CC	GO:0099240	intrinsic component of synaptic membrane	4/228	164/19717	0.1228	0.4556	0.4072	GABRA3/KCNA2/SYT7/EPHB2	4
CC	GO:0019898	extrinsic component of membrane	6/228	295/19717	0.1282	0.4708	0.4208	GNG11/GNAZ/GNAS/CAV2/GNG12/SOCS3	6
CC	GO:0032009	early phagosome	1/228	12/19717	0.1303	0.4739	0.4236	SYT7	1
CC	GO:0043197	dendritic spine	4/228	169/19717	0.1328	0.4744	0.424	PRKAR2B/NRGN/CTTN/ANKS1B	4
CC	GO:0005871	kinesin complex	2/228	55/19717	0.133	0.4744	0.424	KIF4A/KIF2A	2
CC	GO:0030426	growth cone	4/228	171/19717	0.1369	0.4778	0.427	CALM3/ZFYVE27/CTTN/SNCA	4
CC	GO:0044309	neuron spine	4/228	171/19717	0.1369	0.4778	0.427	PRKAR2B/NRGN/CTTN/ANKS1B	4
CC	GO:0005952	cAMP-dependent protein kinase complex	1/228	13/19717	0.1404	0.4778	0.427	PRKAR2B	1
CC	GO:0016580	Sin3 complex	1/228	13/19717	0.1404	0.4778	0.427	ING2	1
CC	GO:1990023	mitotic spindle midzone	1/228	13/19717	0.1404	0.4778	0.427	CTTN	1
CC	GO:0097733	photoreceptor cell cilium	3/228	113/19717	0.143	0.4793	0.4284	ARR3/TBCC/PTGS1	3
CC	GO:0005637	nuclear inner membrane	2/228	58/19717	0.1448	0.4793	0.4284	TMEM120B/NUTF2	2
CC	GO:0097731	9+0 non-motile cilium	3/228	115/19717	0.1484	0.4793	0.4284	ARR3/TBCC/PTGS1	3
CC	GO:0045171	intercellular bridge	2/228	59/19717	0.1488	0.4793	0.4284	KIF4A/AGBL5	2
CC	GO:0031588	nucleotide-activated protein kinase complex	1/228	14/19717	0.1503	0.4793	0.4284	PRKAA2	1
CC	GO:0033646	host intracellular part	1/228	14/19717	0.1503	0.4793	0.4284	PF4	1
CC	GO:0043656	intracellular region of host	1/228	14/19717	0.1503	0.4793	0.4284	PF4	1
CC	GO:0030863	cortical cytoskeleton	3/228	116/19717	0.1511	0.4793	0.4284	CALD1/CTTN/DMTN	3
CC	GO:0045121	membrane raft	6/228	315/19717	0.1591	0.481	0.4299	PRKAR2B/GJA1/SULF1/CAV2/PI4K2A/ITLN1	6
CC	GO:0005779	integral component of peroxisomal membrane	1/228	15/19717	0.1601	0.481	0.4299	PEX12	1
CC	GO:0012510	trans-Golgi network transport vesicle membrane	1/228	15/19717	0.1601	0.481	0.4299	NRGN	1
CC	GO:0030122	AP-2 adaptor complex	1/228	15/19717	0.1601	0.481	0.4299	FCHO1	1
CC	GO:0031083	BLOC-1 complex	1/228	15/19717	0.1601	0.481	0.4299	PI4K2A	1
CC	GO:0031231	intrinsic component of peroxisomal membrane	1/228	15/19717	0.1601	0.481	0.4299	PEX12	1
CC	GO:0098857	membrane microdomain	6/228	316/19717	0.1608	0.481	0.4299	PRKAR2B/GJA1/SULF1/CAV2/PI4K2A/ITLN1	6
CC	GO:0030128	clathrin coat of endocytic vesicle	1/228	16/19717	0.1699	0.4844	0.4329	FCHO1	1
CC	GO:0035098	ESC/E(Z) complex	1/228	16/19717	0.1699	0.4844	0.4329	EZH1	1
CC	GO:0070822	Sin3-type complex	1/228	16/19717	0.1699	0.4844	0.4329	ING2	1
CC	GO:0071437	invadopodium	1/228	16/19717	0.1699	0.4844	0.4329	FAP	1
CC	GO:0005923	bicellular tight junction	3/228	123/19717	0.1706	0.4844	0.4329	CLDN8/ESAM/AMOTL1	3
CC	GO:0045211	postsynaptic membrane	6/228	323/19717	0.1723	0.4844	0.4329	TMEM108/IGSF9B/GABRA3/NRGN/ANKS1B/EPHB2	6
CC	GO:0060077	inhibitory synapse	1/228	17/19717	0.1795	0.4844	0.4329	IGSF9B	1
CC	GO:0097440	apical dendrite	1/228	17/19717	0.1795	0.4844	0.4329	CLU	1
CC	GO:0008021	synaptic vesicle	4/228	191/19717	0.1807	0.4844	0.4329	CALM3/SNCAIP/SNCA/SYT7	4
CC	GO:0097223	sperm part	4/228	191/19717	0.1807	0.4844	0.4329	MNS1/KIF2A/CLK3/CAV2	4
CC	GO:0098589	membrane region	6/228	328/19717	0.1808	0.4844	0.4329	PRKAR2B/GJA1/SULF1/CAV2/PI4K2A/ITLN1	6
CC	GO:0005743	mitochondrial inner membrane	8/228	473/19717	0.1834	0.4844	0.4329	CLU/NDUFS8/TIMM8B/CRAT/CYP1A1/SNCA/MCUR1/CYP2E1	8
CC	GO:0070160	tight junction	3/228	128/19717	0.185	0.4844	0.4329	CLDN8/ESAM/AMOTL1	3
CC	GO:0044304	main axon	2/228	68/19717	0.1857	0.4844	0.4329	KCNA2/MAP1A	2
CC	GO:0005859	muscle myosin complex	1/228	18/19717	0.189	0.4844	0.4329	MYL9	1
CC	GO:0016327	apicolateral plasma membrane	1/228	18/19717	0.189	0.4844	0.4329	CLDN8	1
CC	GO:0031527	filopodium membrane	1/228	18/19717	0.189	0.4844	0.4329	ITGB3	1
CC	GO:0032433	filopodium tip	1/228	18/19717	0.189	0.4844	0.4329	VIL1	1
CC	GO:0090723	growth cone part	1/228	18/19717	0.189	0.4844	0.4329	ZFYVE27	1
CC	GO:0001650	fibrillar center	3/228	132/19717	0.1967	0.4844	0.4329	DAB2/TAX1BP3/PEX14	3
CC	GO:0030018	Z disc	3/228	132/19717	0.1967	0.4844	0.4329	MYL9/C10orf71/PDLIM1	3
CC	GO:0044291	cell-cell contact zone	2/228	71/19717	0.1983	0.4844	0.4329	GJA1/VCL	2
CC	GO:0043034	costamere	1/228	19/19717	0.1984	0.4844	0.4329	VCL	1
CC	GO:1902711	GABA-A receptor complex	1/228	19/19717	0.1984	0.4844	0.4329	GABRA3	1
CC	GO:0005774	vacuolar membrane	7/228	412/19717	0.2014	0.4844	0.4329	CTSA/DAB2/MMD/EGF/CLN5/SYT7/PI4K2A	7
CC	GO:0018995	host	2/228	73/19717	0.2067	0.4844	0.4329	PF4/PI4K2A	2
CC	GO:0043657	host cell	2/228	73/19717	0.2067	0.4844	0.4329	PF4/PI4K2A	2
CC	GO:0030132	clathrin coat of coated pit	1/228	20/19717	0.2076	0.4844	0.4329	FCHO1	1
CC	GO:0031082	BLOC complex	1/228	20/19717	0.2076	0.4844	0.4329	PI4K2A	1
CC	GO:0043194	axon initial segment	1/228	20/19717	0.2076	0.4844	0.4329	MAP1A	1
CC	GO:0071682	endocytic vesicle lumen	1/228	20/19717	0.2076	0.4844	0.4329	SPARC	1
CC	GO:0071782	endoplasmic reticulum tubular network	1/228	20/19717	0.2076	0.4844	0.4329	ZFYVE27	1
CC	GO:1902710	GABA receptor complex	1/228	20/19717	0.2076	0.4844	0.4329	GABRA3	1
CC	GO:0030017	sarcomere	4/228	204/19717	0.2113	0.4844	0.4329	MYL9/CALM3/C10orf71/PDLIM1	4
CC	GO:0005819	spindle	6/228	347/19717	0.2145	0.4844	0.4329	CALM3/KIF4A/KIF2A/AGBL5/CTTN/JTB	6
CC	GO:0099572	postsynaptic specialization	6/228	348/19717	0.2164	0.4844	0.4329	TMEM108/IGSF9B/GABRA3/NRGN/ANKS1B/DMTN	6
CC	GO:0005697	telomerase holoenzyme complex	1/228	21/19717	0.2168	0.4844	0.4329	PTGES3	1
CC	GO:0005922	connexin complex	1/228	21/19717	0.2168	0.4844	0.4329	GJA1	1
CC	GO:0042827	platelet dense granule	1/228	21/19717	0.2168	0.4844	0.4329	SELP	1
CC	GO:0070382	exocytic vesicle	4/228	207/19717	0.2185	0.4844	0.4329	CALM3/SNCAIP/SNCA/SYT7	4
CC	GO:0098984	neuron to neuron synapse	6/228	350/19717	0.22	0.4844	0.4329	TMEM108/IGSF9B/NRGN/ANKS1B/DMTN/SYT7	6
CC	GO:0032838	plasma membrane bounded cell projection cytoplasm	4/228	208/19717	0.221	0.4844	0.4329	TMEM108/MNS1/KIF4A/MAP1A	4
CC	GO:0044215	other organism	2/228	77/19717	0.2237	0.4844	0.4329	PF4/PI4K2A	2
CC	GO:0044216	other organism cell	2/228	77/19717	0.2237	0.4844	0.4329	PF4/PI4K2A	2
CC	GO:0044217	other organism part	2/228	77/19717	0.2237	0.4844	0.4329	PF4/PI4K2A	2
CC	GO:0016460	myosin II complex	1/228	22/19717	0.2259	0.4844	0.4329	MYL9	1
CC	GO:0097038	perinuclear endoplasmic reticulum	1/228	22/19717	0.2259	0.4844	0.4329	CLU	1
CC	GO:0097228	sperm principal piece	1/228	22/19717	0.2259	0.4844	0.4329	KIF2A	1
CC	GO:0101031	chaperone complex	1/228	22/19717	0.2259	0.4844	0.4329	PTGES3	1
CC	GO:0031674	I band	3/228	143/19717	0.2297	0.4898	0.4377	MYL9/C10orf71/PDLIM1	3
CC	GO:0002080	acrosomal membrane	1/228	23/19717	0.2348	0.4924	0.4401	CAV2	1
CC	GO:0031528	microvillus membrane	1/228	23/19717	0.2348	0.4924	0.4401	ITGB3	1
CC	GO:0150034	distal axon	5/228	285/19717	0.2349	0.4924	0.4401	CALM3/KCNA2/ZFYVE27/CTTN/SNCA	5
CC	GO:0030135	coated vesicle	5/228	289/19717	0.2434	0.5023	0.4489	FCHO1/DAB2/EGF/BTC/NRGN	5
CC	GO:0044305	calyx of Held	1/228	24/19717	0.2437	0.5023	0.4489	KCNA2	1
CC	GO:0044322	endoplasmic reticulum quality control compartment	1/228	24/19717	0.2437	0.5023	0.4489	RNF103	1
CC	GO:0016234	inclusion body	2/228	82/19717	0.245	0.5023	0.4489	CLU/SNCA	2
CC	GO:0097730	non-motile cilium	3/228	149/19717	0.2481	0.5058	0.4521	ARR3/TBCC/PTGS1	3
CC	GO:0005875	microtubule associated complex	3/228	152/19717	0.2574	0.518	0.463	KIF4A/KIF2A/MAP1A	3
CC	GO:0005791	rough endoplasmic reticulum	2/228	85/19717	0.2579	0.518	0.463	PLOD2/SNCA	2
CC	GO:0030867	rough endoplasmic reticulum membrane	1/228	26/19717	0.2611	0.518	0.463	PLOD2	1
CC	GO:0034364	high-density lipoprotein particle	1/228	26/19717	0.2611	0.518	0.463	CLU	1
CC	GO:0070971	endoplasmic reticulum exit site	1/228	26/19717	0.2611	0.518	0.463	CTAGE1	1
CC	GO:0034702	ion channel complex	5/228	301/19717	0.2696	0.5232	0.4676	CALM3/GABRA3/ANO6/KCNA2/CTTN	5
CC	GO:0001891	phagocytic cup	1/228	27/19717	0.2697	0.5232	0.4676	PEAR1	1
CC	GO:0005942	phosphatidylinositol 3-kinase complex	1/228	27/19717	0.2697	0.5232	0.4676	SOCS3	1
CC	GO:0032809	neuronal cell body membrane	1/228	27/19717	0.2697	0.5232	0.4676	KCNA2	1
CC	GO:0001750	photoreceptor outer segment	2/228	88/19717	0.2708	0.5232	0.4676	ARR3/PTGS1	2
CC	GO:0031227	intrinsic component of endoplasmic reticulum membrane	3/228	158/19717	0.2762	0.525	0.4693	FITM1/ZFYVE27/CYP2E1	3
CC	GO:0044298	cell body membrane	1/228	28/19717	0.2781	0.525	0.4693	KCNA2	1
CC	GO:0030864	cortical actin cytoskeleton	2/228	90/19717	0.2793	0.525	0.4693	CALD1/CTTN	2
CC	GO:0042581	specific granule	3/228	160/19717	0.2824	0.525	0.4693	PGRMC1/ANO6/VCL	3
CC	GO:0035578	azurophil granule lumen	2/228	91/19717	0.2836	0.525	0.4693	CTSA/C3	2
CC	GO:0035579	specific granule membrane	2/228	91/19717	0.2836	0.525	0.4693	PGRMC1/ANO6	2
CC	GO:0000781	chromosome, telomeric region	3/228	161/19717	0.2856	0.525	0.4693	PTGES3/EZH1/RTEL1	3
CC	GO:0030125	clathrin vesicle coat	1/228	29/19717	0.2865	0.525	0.4693	FCHO1	1
CC	GO:0030131	clathrin adaptor complex	1/228	29/19717	0.2865	0.525	0.4693	FCHO1	1
CC	GO:1990752	microtubule end	1/228	29/19717	0.2865	0.525	0.4693	CAMSAP3	1
CC	GO:0005788	endoplasmic reticulum lumen	5/228	309/19717	0.2873	0.525	0.4693	CLU/LTBP1/C3/FKBP14/PDGFA	5
CC	GO:0036126	sperm flagellum	2/228	93/19717	0.2922	0.5314	0.4749	MNS1/KIF2A	2
CC	GO:0005759	mitochondrial matrix	7/228	469/19717	0.3003	0.539	0.4817	ISCA1/NDUFS8/HSPA1L/HARS2/SNCA/ARG2/SUOX	7
CC	GO:0005604	basement membrane	2/228	95/19717	0.3007	0.539	0.4817	SPARC/MMRN2	2
CC	GO:0045095	keratin filament	2/228	95/19717	0.3007	0.539	0.4817	KRT6B/KRT4	2
CC	GO:0030140	trans-Golgi network transport vesicle	1/228	31/19717	0.3029	0.5403	0.4829	NRGN	1
CC	GO:0000407	phagophore assembly site	1/228	32/19717	0.311	0.5468	0.4887	ATG101	1
CC	GO:0005921	gap junction	1/228	32/19717	0.311	0.5468	0.4887	GJA1	1
CC	GO:0031941	filamentous actin	1/228	32/19717	0.311	0.5468	0.4887	PDLIM1	1
CC	GO:0097729	9+2 motile cilium	2/228	98/19717	0.3135	0.5486	0.4903	MNS1/KIF2A	2
CC	GO:0005903	brush border	2/228	99/19717	0.3178	0.5512	0.4926	VIL1/ITLN1	2
CC	GO:0014069	postsynaptic density	5/228	324/19717	0.3211	0.5512	0.4926	TMEM108/IGSF9B/NRGN/ANKS1B/DMTN	5
CC	GO:1902495	transmembrane transporter complex	5/228	324/19717	0.3211	0.5512	0.4926	CALM3/GABRA3/ANO6/KCNA2/CTTN	5
CC	GO:0030496	midbody	3/228	173/19717	0.3234	0.5512	0.4926	KIF4A/AGBL5/JTB	3
CC	GO:0005790	smooth endoplasmic reticulum	1/228	34/19717	0.3269	0.5512	0.4926	PGRMC1	1
CC	GO:0051233	spindle midzone	1/228	34/19717	0.3269	0.5512	0.4926	CTTN	1
CC	GO:0070069	cytochrome complex	1/228	34/19717	0.3269	0.5512	0.4926	UGT1A1	1
CC	GO:0098686	hippocampal mossy fiber to CA3 synapse	1/228	34/19717	0.3269	0.5512	0.4926	SYT7	1
CC	GO:0032279	asymmetric synapse	5/228	328/19717	0.3302	0.5543	0.4954	TMEM108/IGSF9B/NRGN/ANKS1B/DMTN	5
CC	GO:0097546	ciliary base	1/228	35/19717	0.3346	0.5593	0.4998	PRKAR2B	1
MF	GO:0008391	arachidonic acid monooxygenase activity	3/220	17/17697	0.001133	0.2663	0.2461	CYP2C18/CYP1A1/CYP2E1	3
MF	GO:0048487	beta-tubulin binding	4/220	38/17697	0.001232	0.2663	0.2461	GJA1/TTLL7/SNCA/PEX14	4
MF	GO:0030295	protein kinase activator activity	5/220	80/17697	0.003203	0.2663	0.2461	CALM3/CDKN1A/EGF/NRG1/SPDYA	5
MF	GO:0015631	tubulin binding	11/220	336/17697	0.003314	0.2663	0.2461	FCHO1/KIF4A/CAMSAP3/KIF2A/AGBL5/TBCC/GJA1/TTLL7/SNCA/MAP1A/PEX14	11
MF	GO:0019209	kinase activator activity	5/220	86/17697	0.004371	0.2663	0.2461	CALM3/CDKN1A/EGF/NRG1/SPDYA	5
MF	GO:0020037	heme binding	6/220	135/17697	0.006865	0.2663	0.2461	CYP2C18/EIF2AK1/PTGS1/CYP1A1/CYP2E1/SUOX	6
MF	GO:0016712	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	3/220	32/17697	0.007207	0.2663	0.2461	CYP2C18/CYP1A1/CYP2E1	3
MF	GO:0004984	olfactory receptor activity	12/220	427/17697	0.007333	0.2663	0.2461	OR2T27/OR13C2/OR51D1/OR5M10/OR2AJ1/OR2B8P/OR52N2/OR5P3/OR56B2P/OR4N5/OR9Q1/OR10K2	12
MF	GO:0019887	protein kinase regulator activity	7/220	180/17697	0.007369	0.2663	0.2461	CALM3/CDKN1A/PRKAR2B/EGF/NRG1/SOCS3/SPDYA	7
MF	GO:0003924	GTPase activity	10/220	324/17697	0.007493	0.2663	0.2461	TUBB1/RAB6B/GNG11/IRGC/GNAZ/GNAS/TBCC/RHOBTB1/GNG12/RAB42	10
MF	GO:0030546	receptor activator activity	2/220	11/17697	0.007859	0.2663	0.2461	EGF/NRG1	2
MF	GO:0033691	sialic acid binding	2/220	12/17697	0.009354	0.2663	0.2461	SIGLEC11/SELP	2
MF	GO:0046624	sphingolipid transporter activity	2/220	12/17697	0.009354	0.2663	0.2461	MFSD2B/PLEKHA8P1	2
MF	GO:0046906	tetrapyrrole binding	6/220	145/17697	0.009599	0.2663	0.2461	CYP2C18/EIF2AK1/PTGS1/CYP1A1/CYP2E1/SUOX	6
MF	GO:0019825	oxygen binding	3/220	36/17697	0.01	0.2663	0.2461	CYP2C18/CYP1A1/CYP2E1	3
MF	GO:0008395	steroid hydroxylase activity	3/220	38/17697	0.01161	0.2663	0.2461	CYP2C18/CYP1A1/CYP2E1	3
MF	GO:0005506	iron ion binding	6/220	152/17697	0.01192	0.2663	0.2461	CYP2C18/PLOD2/CYP1A1/SNCA/FAXDC2/CYP2E1	6
MF	GO:0016709	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	3/220	39/17697	0.01246	0.2663	0.2461	CYP1A1/FAXDC2/CYP2E1	3
MF	GO:0051879	Hsp90 protein binding	3/220	41/17697	0.01428	0.2663	0.2461	PTGES3/CYP1A1/CYP2E1	3
MF	GO:0005161	platelet-derived growth factor receptor binding	2/220	15/17697	0.01452	0.2663	0.2461	ITGB3/PDGFA	2
MF	GO:0070492	oligosaccharide binding	2/220	15/17697	0.01452	0.2663	0.2461	SELP/ITLN1	2
MF	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	6/220	159/17697	0.01462	0.2663	0.2461	CYP2C18/PLOD2/PTGS1/CYP1A1/FAXDC2/CYP2E1	6
MF	GO:0019207	kinase regulator activity	7/220	207/17697	0.01508	0.2663	0.2461	CALM3/CDKN1A/PRKAR2B/EGF/NRG1/SOCS3/SPDYA	7
MF	GO:0030544	Hsp70 protein binding	3/220	42/17697	0.01524	0.2663	0.2461	CYP1A1/SNCA/CYP2E1	3
MF	GO:0004712	protein serine/threonine/tyrosine kinase activity	3/220	43/17697	0.01623	0.2663	0.2461	CLK1/CLK3/PRKAA2	3
MF	GO:0008392	arachidonic acid epoxygenase activity	2/220	16/17697	0.01646	0.2663	0.2461	CYP2C18/CYP2E1	2
MF	GO:0043274	phospholipase binding	2/220	16/17697	0.01646	0.2663	0.2461	SNCA/ARHGAP6	2
MF	GO:0031072	heat shock protein binding	5/220	119/17697	0.01653	0.2663	0.2461	PTGES3/HSPA1L/CYP1A1/SNCA/CYP2E1	5
MF	GO:0048156	tau protein binding	3/220	45/17697	0.01833	0.2773	0.2563	CLU/SNCA/MAP1A	3
MF	GO:0004857	enzyme inhibitor activity	10/220	375/17697	0.01921	0.2773	0.2563	CDKN1A/PROS1/PRKAR2B/SERPINB11/FAM122A/C3/UGT1A1/SNCA/VIL1/SOCS3	10
MF	GO:0003779	actin binding	11/220	431/17697	0.01931	0.2773	0.2563	ABLIM3/CALD1/CAMSAP3/CTTN/MYLK/PDLIM1/SNCA/VCL/DMTN/MAP1A/VIL1	11
MF	GO:0030674	protein binding, bridging	6/220	170/17697	0.01967	0.2773	0.2563	GRB14/DAB2/CRADD/CAV2/MAP1A/ARHGAP6	6
MF	GO:0047555	3',5'-cyclic-GMP phosphodiesterase activity	2/220	18/17697	0.02065	0.2822	0.2608	PDE5A/PRKAR2B	2
MF	GO:0030296	protein tyrosine kinase activator activity	2/220	19/17697	0.02289	0.2868	0.2651	EGF/NRG1	2
MF	GO:0031681	G-protein beta-subunit binding	2/220	19/17697	0.02289	0.2868	0.2651	GNG11/GNG12	2
MF	GO:0070182	DNA polymerase binding	2/220	19/17697	0.02289	0.2868	0.2651	PTGES3/RTEL1	2
MF	GO:0005178	integrin binding	5/220	132/17697	0.02464	0.2994	0.2768	ITGB3/IBSP/NRG1/ITGB5/FAP	5
MF	GO:0031683	G-protein beta/gamma-subunit complex binding	2/220	20/17697	0.02523	0.2994	0.2768	GNAZ/GNAS	2
MF	GO:0005548	phospholipid transporter activity	3/220	52/17697	0.02681	0.31	0.2865	PITPNM2/ANO6/PLEKHA8P1	3
MF	GO:1990782	protein tyrosine kinase binding	4/220	93/17697	0.02877	0.3183	0.2942	GRB14/PITPNM2/GJA1/NRG1	4
MF	GO:0031625	ubiquitin protein ligase binding	8/220	290/17697	0.02894	0.3183	0.2942	CLU/CDKN1A/PRKAR2B/HSPA1L/CAMLG/SPOP/SNCAIP/VCL	8
MF	GO:0046625	sphingolipid binding	2/220	23/17697	0.03279	0.3512	0.3246	SELP/PLEKHA8P1	2
MF	GO:0050840	extracellular matrix binding	3/220	57/17697	0.03394	0.3512	0.3246	SPARC/ITGB3/ITGA2B	3
MF	GO:0008017	microtubule binding	7/220	246/17697	0.03447	0.3512	0.3246	FCHO1/KIF4A/CAMSAP3/KIF2A/SNCA/MAP1A/PEX14	7
MF	GO:0004497	monooxygenase activity	4/220	99/17697	0.03505	0.3512	0.3246	CYP2C18/CYP1A1/FAXDC2/CYP2E1	4
MF	GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	2/220	25/17697	0.03826	0.3748	0.3464	SNCA/VIL1	2
MF	GO:0044389	ubiquitin-like protein ligase binding	8/220	308/17697	0.03914	0.3748	0.3464	CLU/CDKN1A/PRKAR2B/HSPA1L/CAMLG/SPOP/SNCAIP/VCL	8
MF	GO:0051787	misfolded protein binding	2/220	26/17697	0.04112	0.3748	0.3464	CLU/HSPA1L	2
MF	GO:0004860	protein kinase inhibitor activity	3/220	63/17697	0.04366	0.3748	0.3464	CDKN1A/PRKAR2B/SOCS3	3
MF	GO:0051536	iron-sulfur cluster binding	3/220	63/17697	0.04366	0.3748	0.3464	ISCA1/NDUFS8/RTEL1	3
MF	GO:0051540	metal cluster binding	3/220	63/17697	0.04366	0.3748	0.3464	ISCA1/NDUFS8/RTEL1	3
MF	GO:0031210	phosphatidylcholine binding	2/220	27/17697	0.04405	0.3748	0.3464	PITPNM2/PCYT1B	2
MF	GO:0050997	quaternary ammonium group binding	2/220	27/17697	0.04405	0.3748	0.3464	PITPNM2/PCYT1B	2
MF	GO:0004114	3',5'-cyclic-nucleotide phosphodiesterase activity	2/220	28/17697	0.04706	0.3859	0.3567	PDE5A/PRKAR2B	2
MF	GO:0030507	spectrin binding	2/220	28/17697	0.04706	0.3859	0.3567	CAMSAP3/DMTN	2
MF	GO:0004112	cyclic-nucleotide phosphodiesterase activity	2/220	29/17697	0.05014	0.3953	0.3653	PDE5A/PRKAR2B	2
MF	GO:0005518	collagen binding	3/220	67/17697	0.05083	0.3953	0.3653	SPARC/DSPP/PDGFA	3
MF	GO:0019210	kinase inhibitor activity	3/220	67/17697	0.05083	0.3953	0.3653	CDKN1A/PRKAR2B/SOCS3	3
MF	GO:0005201	extracellular matrix structural constituent	5/220	163/17697	0.05308	0.399	0.3687	SPARC/DSPP/LTBP1/PRG4/MMRN2	5
MF	GO:0008083	growth factor activity	5/220	163/17697	0.05308	0.399	0.3687	PPBP/EGF/BTC/NRG1/PDGFA	5
MF	GO:0030971	receptor tyrosine kinase binding	3/220	69/17697	0.05462	0.4038	0.3732	GRB14/PITPNM2/NRG1	3
MF	GO:0019001	guanyl nucleotide binding	9/220	394/17697	0.05833	0.4125	0.3812	TUBB1/PDE5A/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	9
MF	GO:0032561	guanyl ribonucleotide binding	9/220	394/17697	0.05833	0.4125	0.3812	TUBB1/PDE5A/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	9
MF	GO:0017022	myosin binding	3/220	71/17697	0.05853	0.4125	0.3812	MYL9/CALD1/RAB6B	3
MF	GO:0030291	protein serine/threonine kinase inhibitor activity	2/220	32/17697	0.0598	0.4128	0.3815	CDKN1A/PRKAR2B	2
MF	GO:0001664	G protein-coupled receptor binding	7/220	280/17697	0.0611	0.4128	0.3815	CALM3/ARR3/PPBP/GNAZ/GNAS/PF4/C3	7
MF	GO:0005154	epidermal growth factor receptor binding	2/220	33/17697	0.06315	0.4128	0.3815	EGF/BTC	2
MF	GO:0015020	glucuronosyltransferase activity	2/220	33/17697	0.06315	0.4128	0.3815	UGT2B11/UGT1A1	2
MF	GO:0097718	disordered domain specific binding	2/220	33/17697	0.06315	0.4128	0.3815	CALM3/GJA1	2
MF	GO:0048029	monosaccharide binding	3/220	75/17697	0.06675	0.4301	0.3975	PLOD2/SELP/CLN5	3
MF	GO:0004866	endopeptidase inhibitor activity	5/220	175/17697	0.0677	0.4301	0.3975	PROS1/SERPINB11/C3/SNCA/VIL1	5
MF	GO:0016831	carboxy-lyase activity	2/220	35/17697	0.07004	0.4387	0.4055	ODC1/GGCX	2
MF	GO:0001540	amyloid-beta binding	3/220	78/17697	0.07324	0.4462	0.4124	PGRMC1/CLU/EPHB2	3
MF	GO:0030551	cyclic nucleotide binding	2/220	36/17697	0.07357	0.4462	0.4124	PDE5A/PRKAR2B	2
MF	GO:0060090	molecular adaptor activity	6/220	237/17697	0.076	0.4462	0.4124	GRB14/DAB2/CRADD/CAV2/MAP1A/ARHGAP6	6
MF	GO:0043014	alpha-tubulin binding	2/220	37/17697	0.07716	0.4462	0.4124	TTLL7/SNCA	2
MF	GO:0030414	peptidase inhibitor activity	5/220	182/17697	0.07717	0.4462	0.4124	PROS1/SERPINB11/C3/SNCA/VIL1	5
MF	GO:0061135	endopeptidase regulator activity	5/220	182/17697	0.07717	0.4462	0.4124	PROS1/SERPINB11/C3/SNCA/VIL1	5
MF	GO:0005319	lipid transporter activity	4/220	131/17697	0.08086	0.4502	0.4161	MFSD2B/PITPNM2/ANO6/PLEKHA8P1	4
MF	GO:0051082	unfolded protein binding	4/220	131/17697	0.08086	0.4502	0.4161	PTGES3/CLU/HSPA1L/HSP90B2P	4
MF	GO:0051219	phosphoprotein binding	3/220	83/17697	0.08465	0.4502	0.4161	ARR3/SNCA/SOCS3	3
MF	GO:0070851	growth factor receptor binding	4/220	134/17697	0.08618	0.4502	0.4161	ITGB3/EGF/BTC/PDGFA	4
MF	GO:0005543	phospholipid binding	9/220	427/17697	0.08624	0.4502	0.4161	FCHO1/ING2/PITPNM2/PCYT1B/NRGN/SNCA/PLEKHA8P1/SYT7/VIL1	9
MF	GO:0019838	growth factor binding	4/220	137/17697	0.09167	0.4502	0.4161	ITGB3/PCSK6/LTBP1/PDGFA	4
MF	GO:0051539	4 iron, 4 sulfur cluster binding	2/220	41/17697	0.09203	0.4502	0.4161	NDUFS8/RTEL1	2
MF	GO:0050839	cell adhesion molecule binding	10/220	499/17697	0.09427	0.4502	0.4161	ITGB3/IBSP/CALD1/CAMLG/CTTN/NRG1/PDLIM1/ITGB5/VCL/FAP	10
MF	GO:0005525	GTP binding	8/220	374/17697	0.09584	0.4502	0.4161	TUBB1/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	8
MF	GO:0019894	kinesin binding	2/220	42/17697	0.09587	0.4502	0.4161	KCNA2/SNCA	2
MF	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	2/220	42/17697	0.09587	0.4502	0.4161	SNCA/VIL1	2
MF	GO:0032550	purine ribonucleoside binding	8/220	378/17697	0.1003	0.4502	0.4161	TUBB1/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	8
MF	GO:0051015	actin filament binding	5/220	198/17697	0.1013	0.4502	0.4161	ABLIM3/CAMSAP3/CTTN/DMTN/VIL1	5
MF	GO:0001883	purine nucleoside binding	8/220	381/17697	0.1037	0.4502	0.4161	TUBB1/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	8
MF	GO:0003730	mRNA 3'-UTR binding	3/220	91/17697	0.1044	0.4502	0.4161	IGF2BP2/RBM38/MIR21	3
MF	GO:0051213	dioxygenase activity	3/220	91/17697	0.1044	0.4502	0.4161	HGD/PLOD2/PTGS1	3
MF	GO:0005516	calmodulin binding	5/220	200/17697	0.1046	0.4502	0.4161	CALD1/CAMSAP3/NRGN/MYLK/SYT7	5
MF	GO:0032549	ribonucleoside binding	8/220	382/17697	0.1049	0.4502	0.4161	TUBB1/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	8
MF	GO:0004180	carboxypeptidase activity	2/220	45/17697	0.1077	0.4502	0.4161	CTSA/AGBL5	2
MF	GO:0001882	nucleoside binding	8/220	389/17697	0.1131	0.4502	0.4161	TUBB1/RAB6B/IRGC/GNAZ/GNAS/RHOBTB1/ARL5C/RAB42	8
MF	GO:0016860	intramolecular oxidoreductase activity	2/220	47/17697	0.1157	0.4502	0.4161	PTGES3/ITGB3	2
MF	GO:0035254	glutamate receptor binding	2/220	47/17697	0.1157	0.4502	0.4161	CALM3/GNAS	2
MF	GO:0002162	dystroglycan binding	1/220	10/17697	0.1176	0.4502	0.4161	VCL	1
MF	GO:0008525	phosphatidylcholine transporter activity	1/220	10/17697	0.1176	0.4502	0.4161	PITPNM2	1
MF	GO:0017128	phospholipid scramblase activity	1/220	10/17697	0.1176	0.4502	0.4161	ANO6	1
MF	GO:0035615	clathrin adaptor activity	1/220	10/17697	0.1176	0.4502	0.4161	DAB2	1
MF	GO:0035620	ceramide transporter activity	1/220	10/17697	0.1176	0.4502	0.4161	PLEKHA8P1	1
MF	GO:0045294	alpha-catenin binding	1/220	10/17697	0.1176	0.4502	0.4161	VCL	1
MF	GO:0070513	death domain binding	1/220	10/17697	0.1176	0.4502	0.4161	CRADD	1
MF	GO:0098748	endocytic adaptor activity	1/220	10/17697	0.1176	0.4502	0.4161	DAB2	1
MF	GO:0030246	carbohydrate binding	6/220	271/17697	0.1227	0.4502	0.4161	PLOD2/PRG4/SIGLEC11/SELP/CLN5/ITLN1	6
MF	GO:0008009	chemokine activity	2/220	49/17697	0.1239	0.4502	0.4161	PPBP/PF4	2
MF	GO:0004865	protein serine/threonine phosphatase inhibitor activity	1/220	11/17697	0.1286	0.4502	0.4161	FAM122A	1
MF	GO:0005247	voltage-gated chloride channel activity	1/220	11/17697	0.1286	0.4502	0.4161	ANO6	1
MF	GO:0005522	profilin binding	1/220	11/17697	0.1286	0.4502	0.4161	CTTN	1
MF	GO:0008503	benzodiazepine receptor activity	1/220	11/17697	0.1286	0.4502	0.4161	GABRA3	1
MF	GO:0016679	oxidoreductase activity, acting on diphenols and related substances as donors	1/220	11/17697	0.1286	0.4502	0.4161	CYP1A1	1
MF	GO:0016813	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines	1/220	11/17697	0.1286	0.4502	0.4161	ARG2	1
MF	GO:0043422	protein kinase B binding	1/220	11/17697	0.1286	0.4502	0.4161	SRSF5	1
MF	GO:0045236	CXCR chemokine receptor binding	1/220	11/17697	0.1286	0.4502	0.4161	PF4	1
MF	GO:0048407	platelet-derived growth factor binding	1/220	11/17697	0.1286	0.4502	0.4161	PDGFA	1
MF	GO:0099186	structural constituent of postsynapse	1/220	11/17697	0.1286	0.4502	0.4161	POTEKP	1
MF	GO:0016830	carbon-carbon lyase activity	2/220	51/17697	0.1323	0.4502	0.4161	ODC1/GGCX	2
MF	GO:0005200	structural constituent of cytoskeleton	3/220	102/17697	0.1341	0.4502	0.4161	TUBB1/KRT6B/POTEKP	3
MF	GO:0005549	odorant binding	3/220	102/17697	0.1341	0.4502	0.4161	OR5M10/OR5P3/OR9Q1	3
MF	GO:0051087	chaperone binding	3/220	102/17697	0.1341	0.4502	0.4161	PTGES3/CLU/TBCC	3
MF	GO:0016853	isomerase activity	4/220	158/17697	0.1345	0.4502	0.4161	AMACR/PTGES3/ITGB3/FKBP14	4
MF	GO:0005070	SH3/SH2 adaptor activity	2/220	52/17697	0.1365	0.4502	0.4161	GRB14/ARHGAP6	2
MF	GO:0004222	metalloendopeptidase activity	3/220	103/17697	0.1369	0.4502	0.4161	MMP7/FAP/ADAMTS19	3
MF	GO:0061134	peptidase regulator activity	5/220	219/17697	0.138	0.4502	0.4161	PROS1/SERPINB11/C3/SNCA/VIL1	5
MF	GO:0003964	RNA-directed DNA polymerase activity	1/220	12/17697	0.1394	0.4502	0.4161	PTGES3	1
MF	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	1/220	12/17697	0.1394	0.4502	0.4161	CDKN1A	1
MF	GO:0008239	dipeptidyl-peptidase activity	1/220	12/17697	0.1394	0.4502	0.4161	FAP	1
MF	GO:0016004	phospholipase activator activity	1/220	12/17697	0.1394	0.4502	0.4161	ARHGAP6	1
MF	GO:0031994	insulin-like growth factor I binding	1/220	12/17697	0.1394	0.4502	0.4161	ITGB3	1
MF	GO:0032036	myosin heavy chain binding	1/220	12/17697	0.1394	0.4502	0.4161	MYL9	1
MF	GO:0042301	phosphate ion binding	1/220	12/17697	0.1394	0.4502	0.4161	GNG12	1
MF	GO:0051011	microtubule minus-end binding	1/220	12/17697	0.1394	0.4502	0.4161	CAMSAP3	1
MF	GO:0004652	polynucleotide adenylyltransferase activity	1/220	13/17697	0.1501	0.4502	0.4161	PAPOLG	1
MF	GO:0005172	vascular endothelial growth factor receptor binding	1/220	13/17697	0.1501	0.4502	0.4161	ITGB3	1
MF	GO:0008179	adenylate cyclase binding	1/220	13/17697	0.1501	0.4502	0.4161	CALM3	1
MF	GO:0022851	GABA-gated chloride ion channel activity	1/220	13/17697	0.1501	0.4502	0.4161	GABRA3	1
MF	GO:0034236	protein kinase A catalytic subunit binding	1/220	13/17697	0.1501	0.4502	0.4161	PRKAR2B	1
MF	GO:0072542	protein phosphatase activator activity	1/220	13/17697	0.1501	0.4502	0.4161	CALM3	1
MF	GO:0003707	steroid hormone receptor activity	2/220	56/17697	0.1536	0.4502	0.4161	HNF4G/RXRB	2
MF	GO:0043621	protein self-association	2/220	56/17697	0.1536	0.4502	0.4161	ZFYVE27/DMTN	2
MF	GO:0047485	protein N-terminus binding	3/220	109/17697	0.1543	0.4502	0.4161	CALM3/SNCA/PEX14	3
MF	GO:0005539	glycosaminoglycan binding	5/220	229/17697	0.1573	0.4502	0.4161	PCSK6/SELP/PF4/SULF1/MMP7	5
MF	GO:0030276	clathrin binding	2/220	57/17697	0.158	0.4502	0.4161	DAB2/SYT7	2
MF	GO:0008201	heparin binding	4/220	169/17697	0.1596	0.4502	0.4161	PCSK6/SELP/PF4/MMP7	4
MF	GO:0004065	arylsulfatase activity	1/220	14/17697	0.1607	0.4502	0.4161	SULF1	1
MF	GO:0031432	titin binding	1/220	14/17697	0.1607	0.4502	0.4161	CALM3	1
MF	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	1/220	14/17697	0.1607	0.4502	0.4161	SOCS3	1
MF	GO:0050998	nitric-oxide synthase binding	1/220	14/17697	0.1607	0.4502	0.4161	CALM3	1
MF	GO:0060229	lipase activator activity	1/220	14/17697	0.1607	0.4502	0.4161	ARHGAP6	1
MF	GO:0070330	aromatase activity	1/220	14/17697	0.1607	0.4502	0.4161	CYP2C18	1
MF	GO:0097001	ceramide binding	1/220	14/17697	0.1607	0.4502	0.4161	PLEKHA8P1	1
MF	GO:0004869	cysteine-type endopeptidase inhibitor activity	2/220	58/17697	0.1624	0.4502	0.4161	SNCA/VIL1	2
MF	GO:0008238	exopeptidase activity	3/220	113/17697	0.1663	0.4502	0.4161	CTSA/AGBL5/FAP	3
MF	GO:0005507	copper ion binding	2/220	59/17697	0.1668	0.4502	0.4161	LOX/SNCA	2
MF	GO:0097110	scaffold protein binding	2/220	59/17697	0.1668	0.4502	0.4161	GJA1/CAV2	2
MF	GO:0005024	transforming growth factor beta-activated receptor activity	1/220	15/17697	0.1711	0.4502	0.4161	LTBP1	1
MF	GO:0005243	gap junction channel activity	1/220	15/17697	0.1711	0.4502	0.4161	GJA1	1
MF	GO:0005523	tropomyosin binding	1/220	15/17697	0.1711	0.4502	0.4161	CALD1	1
MF	GO:0015271	outward rectifier potassium channel activity	1/220	15/17697	0.1711	0.4502	0.4161	KCNA2	1
MF	GO:0030553	cGMP binding	1/220	15/17697	0.1711	0.4502	0.4161	PDE5A	1
MF	GO:0045182	translation regulator activity	2/220	60/17697	0.1712	0.4502	0.4161	EIF2AK1/IGF2BP2	2
MF	GO:0048306	calcium-dependent protein binding	2/220	61/17697	0.1756	0.4502	0.4161	CALM3/SELP	2
MF	GO:0030145	manganese ion binding	2/220	62/17697	0.1801	0.4502	0.4161	PIM1/ARG2	2
MF	GO:0003756	protein disulfide isomerase activity	1/220	16/17697	0.1815	0.4502	0.4161	ITGB3	1
MF	GO:0005159	insulin-like growth factor receptor binding	1/220	16/17697	0.1815	0.4502	0.4161	GNAS	1
MF	GO:0005229	intracellular calcium activated chloride channel activity	1/220	16/17697	0.1815	0.4502	0.4161	ANO6	1
MF	GO:0005237	inhibitory extracellular ligand-gated ion channel activity	1/220	16/17697	0.1815	0.4502	0.4161	GABRA3	1
MF	GO:0008093	cytoskeletal adaptor activity	1/220	16/17697	0.1815	0.4502	0.4161	MAP1A	1
MF	GO:0016641	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	1/220	16/17697	0.1815	0.4502	0.4161	LOX	1
MF	GO:0016864	intramolecular oxidoreductase activity, transposing S-S bonds	1/220	16/17697	0.1815	0.4502	0.4161	ITGB3	1
MF	GO:0016881	acid-amino acid ligase activity	1/220	16/17697	0.1815	0.4502	0.4161	TTLL7	1
MF	GO:0019211	phosphatase activator activity	1/220	16/17697	0.1815	0.4502	0.4161	CALM3	1
MF	GO:0050780	dopamine receptor binding	1/220	16/17697	0.1815	0.4502	0.4161	GNAS	1
MF	GO:0052742	phosphatidylinositol kinase activity	1/220	16/17697	0.1815	0.4502	0.4161	PI4K2A	1
MF	GO:0061778	intracellular chloride channel activity	1/220	16/17697	0.1815	0.4502	0.4161	ANO6	1
MF	GO:0008237	metallopeptidase activity	4/220	181/17697	0.1889	0.4502	0.4161	AGBL5/MMP7/FAP/ADAMTS19	4
MF	GO:0035091	phosphatidylinositol binding	5/220	245/17697	0.1903	0.4502	0.4161	ING2/PITPNM2/NRGN/SYT7/VIL1	5
MF	GO:0008236	serine-type peptidase activity	4/220	182/17697	0.1914	0.4502	0.4161	CTSA/PCSK6/MMP7/FAP	4
MF	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	1/220	17/17697	0.1916	0.4502	0.4161	LTBP1	1
MF	GO:0005005	transmembrane-ephrin receptor activity	1/220	17/17697	0.1916	0.4502	0.4161	EPHB2	1
MF	GO:0008308	voltage-gated anion channel activity	1/220	17/17697	0.1916	0.4502	0.4161	ANO6	1
MF	GO:0008484	sulfuric ester hydrolase activity	1/220	17/17697	0.1916	0.4502	0.4161	SULF1	1
MF	GO:0031489	myosin V binding	1/220	17/17697	0.1916	0.4502	0.4161	RAB6B	1
MF	GO:0035014	phosphatidylinositol 3-kinase regulator activity	1/220	17/17697	0.1916	0.4502	0.4161	SOCS3	1
MF	GO:0035173	histone kinase activity	1/220	17/17697	0.1916	0.4502	0.4161	PRKAA2	1
MF	GO:0042813	Wnt-activated receptor activity	1/220	17/17697	0.1916	0.4502	0.4161	EGF	1
MF	GO:0043024	ribosomal small subunit binding	1/220	17/17697	0.1916	0.4502	0.4161	PIM1	1
MF	GO:0098918	structural constituent of synapse	1/220	17/17697	0.1916	0.4502	0.4161	POTEKP	1
MF	GO:0042379	chemokine receptor binding	2/220	66/17697	0.198	0.4618	0.4268	PPBP/PF4	2
MF	GO:1901681	sulfur compound binding	5/220	250/17697	0.2011	0.4618	0.4268	PCSK6/ACBD7/SELP/PF4/MMP7	5
MF	GO:0017171	serine hydrolase activity	4/220	186/17697	0.2015	0.4618	0.4268	CTSA/PCSK6/MMP7/FAP	4
MF	GO:0016755	transferase activity, transferring amino-acyl groups	1/220	18/17697	0.2017	0.4618	0.4268	F13A1	1
MF	GO:0016854	racemase and epimerase activity	1/220	18/17697	0.2017	0.4618	0.4268	AMACR	1
MF	GO:0016829	lyase activity	4/220	187/17697	0.2041	0.4648	0.4296	ODC1/PTS/CYP1A1/GGCX	4
MF	GO:0001972	retinoic acid binding	1/220	19/17697	0.2116	0.4679	0.4325	UGT1A1	1
MF	GO:0004890	GABA-A receptor activity	1/220	19/17697	0.2116	0.4679	0.4325	GABRA3	1
MF	GO:0005003	ephrin receptor activity	1/220	19/17697	0.2116	0.4679	0.4325	EPHB2	1
MF	GO:0031690	adrenergic receptor binding	1/220	19/17697	0.2116	0.4679	0.4325	GNAS	1
MF	GO:0070300	phosphatidic acid binding	1/220	19/17697	0.2116	0.4679	0.4325	NRGN	1
MF	GO:0098641	cadherin binding involved in cell-cell adhesion	1/220	19/17697	0.2116	0.4679	0.4325	PDLIM1	1
MF	GO:0002020	protease binding	3/220	128/17697	0.2133	0.4689	0.4334	ITGB3/CRADD/FAP	3
MF	GO:0031406	carboxylic acid binding	4/220	193/17697	0.2196	0.4689	0.4334	PLOD2/SIGLEC11/SELP/UGT1A1	4
MF	GO:0017124	SH3 domain binding	3/220	130/17697	0.2198	0.4689	0.4334	SH3BGRL2/GJA1/ARHGAP6	3
MF	GO:0005355	glucose transmembrane transporter activity	1/220	20/17697	0.2215	0.4689	0.4334	PPBP	1
MF	GO:0015149	hexose transmembrane transporter activity	1/220	20/17697	0.2215	0.4689	0.4334	PPBP	1
MF	GO:0016638	oxidoreductase activity, acting on the CH-NH2 group of donors	1/220	20/17697	0.2215	0.4689	0.4334	LOX	1
MF	GO:0031418	L-ascorbic acid binding	1/220	20/17697	0.2215	0.4689	0.4334	PLOD2	1
MF	GO:0061608	nuclear import signal receptor activity	1/220	20/17697	0.2215	0.4689	0.4334	NUTF2	1
MF	GO:0099095	ligand-gated anion channel activity	1/220	20/17697	0.2215	0.4689	0.4334	GABRA3	1
MF	GO:0022829	wide pore channel activity	1/220	21/17697	0.2311	0.47	0.4344	GJA1	1
MF	GO:0050750	low-density lipoprotein particle receptor binding	1/220	21/17697	0.2311	0.47	0.4344	CLU	1
MF	GO:0051428	peptide hormone receptor binding	1/220	21/17697	0.2311	0.47	0.4344	GNAS	1
MF	GO:0051861	glycolipid binding	1/220	21/17697	0.2311	0.47	0.4344	SELP	1
MF	GO:0070840	dynein complex binding	1/220	21/17697	0.2311	0.47	0.4344	SNCA	1
MF	GO:0004713	protein tyrosine kinase activity	3/220	134/17697	0.2329	0.47	0.4344	CLK1/CLK3/EPHB2	3
MF	GO:0001618	virus receptor activity	2/220	74/17697	0.2346	0.47	0.4344	ITGB3/ITGB5	2
MF	GO:0104005	hijacked molecular function	2/220	74/17697	0.2346	0.47	0.4344	ITGB3/ITGB5	2
MF	GO:0005254	chloride channel activity	2/220	75/17697	0.2392	0.47	0.4344	GABRA3/ANO6	2
MF	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	2/220	75/17697	0.2392	0.47	0.4344	SYT7/VIL1	2
MF	GO:0070405	ammonium ion binding	2/220	75/17697	0.2392	0.47	0.4344	PITPNM2/PCYT1B	2
MF	GO:0000062	fatty-acyl-CoA binding	1/220	22/17697	0.2407	0.47	0.4344	ACBD7	1
MF	GO:0005537	mannose binding	1/220	22/17697	0.2407	0.47	0.4344	CLN5	1
MF	GO:0015145	monosaccharide transmembrane transporter activity	1/220	22/17697	0.2407	0.47	0.4344	PPBP	1
MF	GO:0016917	GABA receptor activity	1/220	22/17697	0.2407	0.47	0.4344	GABRA3	1
MF	GO:0030021	extracellular matrix structural constituent conferring compression resistance	1/220	22/17697	0.2407	0.47	0.4344	PRG4	1
MF	GO:0050431	transforming growth factor beta binding	1/220	22/17697	0.2407	0.47	0.4344	LTBP1	1
MF	GO:0051537	2 iron, 2 sulfur cluster binding	1/220	22/17697	0.2407	0.47	0.4344	ISCA1	1
MF	GO:0016779	nucleotidyltransferase activity	3/220	137/17697	0.2428	0.472	0.4362	PTGES3/PCYT1B/PAPOLG	3
MF	GO:0005212	structural constituent of eye lens	1/220	23/17697	0.2502	0.476	0.44	CRYGN	1
MF	GO:0017134	fibroblast growth factor binding	1/220	23/17697	0.2502	0.476	0.44	ITGB3	1
MF	GO:0030552	cAMP binding	1/220	23/17697	0.2502	0.476	0.44	PRKAR2B	1
MF	GO:0044183	protein binding involved in protein folding	1/220	23/17697	0.2502	0.476	0.44	HSPA1L	1
MF	GO:0051371	muscle alpha-actinin binding	1/220	23/17697	0.2502	0.476	0.44	PDLIM1	1
MF	GO:0043177	organic acid binding	4/220	205/17697	0.2516	0.4768	0.4407	PLOD2/SIGLEC11/SELP/UGT1A1	4
MF	GO:0019199	transmembrane receptor protein kinase activity	2/220	79/17697	0.2576	0.4816	0.4451	LTBP1/EPHB2	2
MF	GO:0008198	ferrous iron binding	1/220	24/17697	0.2595	0.4816	0.4451	SNCA	1
MF	GO:0015295	solute:proton symporter activity	1/220	24/17697	0.2595	0.4816	0.4451	SLC15A5	1
MF	GO:0030627	pre-mRNA 5'-splice site binding	1/220	24/17697	0.2595	0.4816	0.4451	RNVU1-3	1
MF	GO:0051119	sugar transmembrane transporter activity	1/220	24/17697	0.2595	0.4816	0.4451	PPBP	1
MF	GO:0035591	signaling adaptor activity	2/220	80/17697	0.2622	0.4846	0.4479	GRB14/ARHGAP6	2
MF	GO:0001871	pattern binding	1/220	25/17697	0.2687	0.4906	0.4535	PRG4	1
MF	GO:0030247	polysaccharide binding	1/220	25/17697	0.2687	0.4906	0.4535	PRG4	1
MF	GO:0048027	mRNA 5'-UTR binding	1/220	25/17697	0.2687	0.4906	0.4535	IGF2BP2	1
MF	GO:0008013	beta-catenin binding	2/220	82/17697	0.2714	0.4916	0.4544	TAX1BP3/VCL	2
MF	GO:0019888	protein phosphatase regulator activity	2/220	82/17697	0.2714	0.4916	0.4544	CALM3/FAM122A	2
MF	GO:0070325	lipoprotein particle receptor binding	1/220	26/17697	0.2778	0.5012	0.4632	CLU	1
MF	GO:0003777	microtubule motor activity	2/220	84/17697	0.2806	0.5043	0.4661	KIF4A/KIF2A	2
MF	GO:0038024	cargo receptor activity	2/220	85/17697	0.2852	0.5053	0.467	DAB2/PRG4	2
MF	GO:0001968	fibronectin binding	1/220	27/17697	0.2868	0.5053	0.467	ITGB3	1
MF	GO:0016702	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	1/220	27/17697	0.2868	0.5053	0.467	HGD	1
MF	GO:0045499	chemorepellent activity	1/220	27/17697	0.2868	0.5053	0.467	NRG1	1
MF	GO:0046875	ephrin receptor binding	1/220	27/17697	0.2868	0.5053	0.467	ANKS1B	1
MF	GO:0030165	PDZ domain binding	2/220	86/17697	0.2898	0.5071	0.4686	GJA1/GNG12	2
MF	GO:0005184	neuropeptide hormone activity	1/220	28/17697	0.2957	0.5071	0.4686	SPX	1
MF	GO:0005227	calcium activated cation channel activity	1/220	28/17697	0.2957	0.5071	0.4686	ANO6	1
MF	GO:0005520	insulin-like growth factor binding	1/220	28/17697	0.2957	0.5071	0.4686	ITGB3	1
MF	GO:0016701	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen	1/220	28/17697	0.2957	0.5071	0.4686	HGD	1
MF	GO:0017056	structural constituent of nuclear pore	1/220	28/17697	0.2957	0.5071	0.4686	NUTF2	1
MF	GO:1901567	fatty acid derivative binding	1/220	28/17697	0.2957	0.5071	0.4686	ACBD7	1
MF	GO:0005253	anion channel activity	2/220	89/17697	0.3036	0.5143	0.4753	GABRA3/ANO6	2
MF	GO:0004181	metallocarboxypeptidase activity	1/220	29/17697	0.3045	0.5143	0.4753	AGBL5	1
MF	GO:0043539	protein serine/threonine kinase activator activity	1/220	29/17697	0.3045	0.5143	0.4753	CALM3	1
MF	GO:0070566	adenylyltransferase activity	1/220	29/17697	0.3045	0.5143	0.4753	PAPOLG	1
MF	GO:0004674	protein serine/threonine kinase activity	7/220	439/17697	0.3056	0.5143	0.4754	PIM1/LTBP1/EIF2AK1/CLK1/MYLK/CLK3/PRKAA2	7
MF	GO:0030332	cyclin binding	1/220	30/17697	0.3131	0.523	0.4834	CDKN1A	1
MF	GO:0043548	phosphatidylinositol 3-kinase binding	1/220	30/17697	0.3131	0.523	0.4834	CALM3	1
MF	GO:0004252	serine-type endopeptidase activity	3/220	160/17697	0.3203	0.5331	0.4927	PCSK6/MMP7/FAP	3
MF	GO:0140142	nucleocytoplasmic carrier activity	1/220	31/17697	0.3217	0.5334	0.493	NUTF2	1
MF	GO:1901981	phosphatidylinositol phosphate binding	3/220	161/17697	0.3237	0.5348	0.4943	NRGN/SYT7/VIL1	3
MF	GO:0008081	phosphoric diester hydrolase activity	2/220	94/17697	0.3265	0.5352	0.4946	PDE5A/PRKAR2B	2
MF	GO:0019956	chemokine binding	1/220	32/17697	0.3301	0.5352	0.4946	ITGB3	1
MF	GO:0035255	ionotropic glutamate receptor binding	1/220	32/17697	0.3301	0.5352	0.4946	GNAS	1
MF	GO:0071855	neuropeptide receptor binding	1/220	32/17697	0.3301	0.5352	0.4946	GNAS	1
MF	GO:1904680	peptide transmembrane transporter activity	1/220	32/17697	0.3301	0.5352	0.4946	SLC15A5	1
MF	GO:0005496	steroid binding	2/220	95/17697	0.3311	0.5352	0.4946	PGRMC1/UGT1A1	2
MF	GO:0019208	phosphatase regulator activity	2/220	96/17697	0.3356	0.5406	0.4996	CALM3/FAM122A	2